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3Abstract
Sub-Saharan Africa is thought to have the most genetic variation of any continent and to 
be the place of origin of anatomically modern human. Nevertheless it is the subject of 
relatively few studies of human genetic variation. This thesis contributes to redressing 
this imbalance. Sex-specific genetic systems (non-recombining portion of the Y 
chromosome (NRY) and mitochondrial DNA (mtDNA)) along with functional nuclear 
loci were characterised in multiple sub-Saharan African populations with large sample 
sizes to infer relationships of peoples and identify implications for healthcare. 
This thesis contains four projects which addressed questions in genetic anthropology, 
human evolution and pharmacogenetics utilising human genetic variation. In chapter 2, 
NRY analysis shows that a hypothesised paternal Yombe (Congo) ancestry of Palenque 
(Colombia), based on linguistic and historical evidence, is consistent with genetic data. 
Chapter 3, based on NRY data, demonstrates that a) multiple waves of migration 
occurred southwards during the expansion of Bantu-speaking peoples (EBSP), b) the 
eastern route displayed more recent migrations than the western route and c) the absence 
of substantial east to west NRY gene flow in sub-Saharan Africa over the past 
millennium. Chapter 4 suggests an eastern route out of Africa for the CASP12 truncated 
variant is more likely than a western route. (The stop-codon mutation was also dated to 
around 120,000 YBP). Chapter 5 demonstrates that a potentially functional CYP1A2
variant which has not been reported outside Africa is present at considerable frequencies 
in sub-Saharan African population groups and that exons associated with active sites in 
CYP1A genes are well conserved.
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1. Introduction
1.1. Geography, peoples and languages of sub-Saharan Africa
Sub-Saharan Africa is the entire African continent below the present day Saharan desert. 
It comprises of 45 politically defined countries (see Figure 1.1), samples from nine of 
which are included in this thesis. The corridor south of the Saharan desert is known as the 
Sahel and is a strip of semi-arid grassland stretching from the Atlantic Ocean on the west 
coast to Ethiopia on the east coast. Except for a few regions of highlands (e.g. Ethiopia) 
and deserts (e.g. Kalahari), sub-Saharan Africa is mainly comprised of tropical rainforests 
and wooded savannah (Cavalli-Sforza et al. 1994). Furthermore, the second largest 
tropical rainforest in the world is situated in the centre of sub-Saharan Africa in the 
Congo Basin (http://www.srl.caltech.edu/personnel/krubal/).  
Africa has been a populous continent throughout the history of mankind, especially prior 
to the Neolithic period, with areas in which agriculture and metallurgy were pioneered
showing the highest population densities in the continent. However, in the past few 
centuries, population growth in Africa saw a significant decline in the face of the slave 
trade in which the majority of slaves were shipped to the Americas (Cavalli-Sforza et al. 
1994). However, in recent generations, Africa has experienced significant population 
growth. Currently, Africa holds approximately 1 billion individuals with over 800 million 
living in sub-Saharan Africa (United Nations population database; 
http://esa.un.org/unpp/).
Except for the ‘Caucasoids’ living in North Africa, the peoples of Africa have been 
classified into five major groups (Hiernaux 1975), although the usefulness of this 
classification is doubtful. The ‘West African’ and ‘Bantu-speaking’ groups, who live in 
the savannah and tropical forest margins, are essentially agriculturists and form the 
majority of the African people today.  On the other hand, ‘Khoisan’ and ‘Pygmies and 
16
Pygmoids’ groups, who live in dry and tropical areas respectively, were mostly hunter-
gatherers before coming into contact with the two former groups. The relative 
technological development of ‘West African’ and ‘Bantu-speaking’ groups in food 
production has led to the heavy acculturation of hunter-gatherers and also resulted in 
heavy admixture between them and the agriculturists (Ehret 2002). 
Figure 1.1. A political map of Africa (obtained from http://www.mapsnworld.com/)
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The fifth group ‘Elongated Africans’ are thought to be well adapted to dry and hot 
climates and live mostly in the savannah near the Sahel. 
Africa is probably the most linguistically diverse continent in the world with nearly 1,400 
languages spoken, which is approximately a quarter of all languages worldwide.
Based on the classification proposed by Greenberg (1963), all African languages can be 
categorised under the following four major phyla: Niger-Kordofanian, Nilo-Saharan, 
Afro-Asiatic and Khoisan. The Niger-Kordofanian phylum is comprised of two branches, 
one very large and widespread (Niger-Congo) and one small and confined to Sudan 
(Kordofanian) (Ruhlen 1987). It should be noted, however, according to the Ethnologue 
(Ethnologue 2009), Kordofanian is included in the Niger-Congo family as a sub-phylum 
and the classification therefore equates Niger-Congo with Niger-Kordofanian. The Niger-
Congo sub-phylum is probably the largest group of languages found in sub-Saharan 
Africa with 1436 languages and over 350 million speakers (Ethnologue 2009). It is 
widely spread from Senegal in West Africa to Mozambique and South Africa (see Figure 
1.2). Bantoid is a branch within the Niger-Congo family which covers about half of the 
languages (691 languages) and from which Bantu languages developed. The Bantu sub-
group (also known as Narrow Bantu) contains 522 languages and has over 100 million 
speakers. 
Interestingly, although Bantu languages are spoken over a wide geographic area only a 
small part of the diversity of the Niger-Congo family is present in this sub-group. Since it 
is suggested that the expansion of language families is a result of the expansion of 
farming populations (Bellwood 2001), the success in propagation of Bantu languages is 
most likely due to the expansion of its speakers. The expansion of Bantu-speaking 
peoples (EBSP) is thought to have happened around 5000 years ago with their advance 
into sub-equitorial Africa.
The Nilo-Saharan group of languages is the second largest phylum in sub-Saharan Africa 
with 198 languages and about 40 million speakers extending geographically from Algeria 
18
to Tanzania (Ethnologue 2009). The majority of Nilo-Saharan speaking peoples are either 
pastoral nomads (south Sudan) or farmers (south Chad) (Cavalli-Sforza et al. 1994).
Figure 1.2. A linguistic map of Africa according to Greenberg (1963).
Picture obtained from http://www.freelang.net/
The Afro-Asiatic family consists of 353 languages with more than 350 million speakers. 
Although all the languages within this phylum are not confined to North Africa (some are 
present in the Middle East), it only has about a fifth of the language count of the Niger-
Kordafanian phylum with almost the same number of speakers. The Afro-Asiatic 
speaking peoples include the Berbers in Morocco, Chadic speakers in northern Nigeria, 
Omotic and Cushitic speakers in Ethiopia and Semitic speakers in Eritrea, Egypt, Libya 
and Algeria.
The smallest language phylum in the sub-Saharan region is the Khoisan family, which 
consists of 20 languages with nearly five hundred thousand speakers. Interestingly, 
almost all speakers are confined to South-West Africa (Kalahari Desert) where the EBSP 
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did not penetrate and which has been relatively isolated for a long period of time 
(Denbow 1990). Khoisan languages are also known as ‘click’ languages since click 
sounds are used as regular consonants. 
1.2. Genetic studies in sub-Saharan Africa
1.2.1. Classical genetic markers
Prior to the discovery and development of DNA genotyping techniques, genetic diversity 
among populations was measured based on variation observed at blood group loci (e.g. 
ABO blood group), Human Leukocyte Antigen (HLA) loci and blood protein 
electrophoretic mobility (Latter 1980; Ryman 1983). It was found that variation among 
major geographic regions accounts for a small percentage of total genetic variation and 
most of the genetic variation observed was within local populations. Cavalli-Sforza et al. 
(1988) looked at the variation of non-DNA markers on a much larger scale (120 alleles in 
42 worldwide populations). According to the phylogenetic relationship of populations 
investigated, the first bifurcation in the tree separated Africans from non-Africans. Based 
on correlations with archaeological data, this event was dated back 100 kya, which is 
consistent with the time of the expansion of anatomically modern humans ‘Out of 
Africa’. Furthermore, detailed examination of genetic variation within the African 
continent was conducted by Cavalli-Sforza and colleagues and published in the book The 
History and Geography of Human Genes (1994). 49 African populations (grouped 
according to their country, linguistic affiliation or ethnicity) were tested for 48 genes on 
average. The resultant phylogenetic tree bifurcates into a large cluster representing the 
sub-Saharan African populations and a small cluster representing northern and eastern 
African populations. A second bifurcation also splits the cluster into northern and eastern 
sub-clusters. Within the sub-Saharan cluster two major sub-clusters are apparent where 
one consists of Bantu and Nilotic speaking peoples and the other represents almost all 
West African populations, indicating genetic differentiation between Central-Southern 
African and West African populations. Furthermore, based on principal coordinate 
analysis (PCO) results, Bantu-speaking populations, show a higher level of similarity 
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among themselves than do West African populations indicating a more recent common 
origin consistent with EBSP. Except for a few deviations, the results of the analysis show 
that, similar to the study of worldwide populations (Cavalli-Sforza et al. 1988), a good 
correlation is observed between language and geography with genetics. 
1.2.2. DNA markers
The discovery of polymerase chain reaction (PCR), DNA fragment analysis (RFLP), 
DNA dideoxy sequencing and other genotyping techniques made it possible to ascertain 
genetic variation directly at the DNA level. In this section, a very brief summary of 
autosomal, non-recombining portion of Y chromosome (NRY) and mitochondrial DNA 
(mtDNA) genetic markers typed in African populations is given.
1.2.2.1. Autosomal markers
The early DNA studies of African populations concentrated on the analysis of diversity, 
based on genome-wide RFLP and STR markers (Bowcock et al. 1994) and variation 
within single genes (Tishkoff et al. 1996). Until recently the pattern of genome-wide 
diversity across geographically and ethnically diverse African populations has been
largely uncharacterized (Reed & Tishkoff 2006), which is mainly due to difficulties in 
collecting samples in the field. However, based on over 1300 autosomal markers typed in 
2432 Africans, the genetic structure of African populations and levels of diversity have 
been evaluated (Tishkoff et al. 2009). Interestingly, most studies ascertaining diversity of 
autosomal markers conducted on African samples (even though mostly having small 
sample sizes), rather than functional studies, have investigated the Out of Africa 
hypothesis of the origins of anatomically modern humans. 
Pharmacogenetic studies in African populations have been scarce compared with the 
number involving European and Asian (i.e. Japanese) populations (see, for example, the 
CYP allele database at http://www.cypalleles.ki.se/), yet have generated valuable results. 
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In the case of the highly polymorphic CYP2D6 gene, Masimirembwa et al. (1993) 
showed stark differences in the frequency of  Eurasian modal haplotypes in the Shona 
population (n = 76) of Zimbabwe and also noted a weak correlation between genotypes 
observed and phenotypic expectations (Masimirembwa et al. 1996a). The gene was 
further characterised by re-sequencing Shona samples and a novel SNP was found in 
exon 2 where a third of individuals carried this newly defined variant (CYP2D6*17). 
Interestingly, this variant explained the discrepancy observed at the phenotypic level in 
this African population (Masimirembwa et al. 1996b). This case study is a proof of 
concept that genotyping Eurasian-based diagnostic SNPs in African populations is not a 
safe approach in predicting phenotype variation. Therefore, it is very likely that valuable 
pharmacogenetic data will be generated by re-sequencing African populations of 
relatively large sample sizes in order to identify variants specific to African individuals 
that may affect phenotypic response. 
1.2.2.2. Sex-specific NRY and mtDNA markers
Analysis of NRY and mtDNA markers in African populations, unlike autosomal markers, 
has been quite extensive. Since these two genetic systems have smaller effective 
population sizes compared with autosomal markers, they are more prone to genetic drift 
(Destro-Bisol et al. 2004; Wood et al. 2005) and, hence, more likely to vary in frequency 
among populations. They have been used to study genetic relationships among groups, 
notwithstanding that each of them represents a single, albeit complex, locus. 
As shown in Cavalli-Sforza et al. (1994), mtDNA and NRY studies display genetic 
differentiation between North and East Africa and the remainder of Africa (see also 
Scozzari et al. 1999; Cruciani et al. 2002; Salas et al. 2002; Salas et al. 2004), which is in 
good correlation with linguistic evidence. Within sub-Saharan Africa, areas affected by 
the EBSP show a high level of homogeneity of both systems, with more similarity at the 
NRY, displaying very high frequencies of the modal EBSP NRY haplogroup (E1b1a) 
(Underhill et al. 2001; Wood et al. 2005; Berniell-Lee et al. 2009) (for further details on 
NRY and mtDNA diversity of Bantu-speaking peoples see chapter 3). Similar to areas 
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affected by EBSP, West African populations also show a high frequency of haplogroup 
E1b1a (Semino et al. 2002; Wood et al. 2005; Rosa et al. 2007). This finding is of 
importance since this NRY haplogroup may be a signature of the EBSP (Underhill et al.
2001). However, based on the frequency of E1b1a in West Africa, it can be envisaged 
that this haplogroup may have been present prior to the start of the expansion and, 
therefore, more widely spread across sub-Saharan Africa. At the mtDNA level, however, 
there seems to be a higher level of differentiation between West Africa and areas affected 
by EBSP (Salas et al. 2002; Rosa et al. 2004). Unlike EBSP populations, East African 
populations (e.g. Ethiopia, Eritrea and Sudan) are genetically distinct within sub-Saharan 
Africa due to their high genetic heterogeneity at both NRY and mtDNA loci (Passarino et 
al. 1998; Underhill et al. 2001; Salas et al. 2002; Kivisild et al. 2004). One possible
explanation is that, because of their geographic location, these populations have 
experienced substantial gene flow from North African and non-African populations 
(especially Arab populations). Some, at least, of the diversity may be the preservation of 
variation existing prior to the migration of Anatomically Modern Human ‘Out of Africa’. 
The NRY and mtDNA of Khoisan speaking peoples have been shown to be consistently
and substantially different from the same systems in all other sub-Saharan Africans 
(Watson et al. 1996; Knight et al. 2003). Since Khoisanids exclusively possess the most 
ancestral NRY and mtDNA types at high frequencies, they are thought to represent 
ancient remnants of paternal and maternal diversity in sub-Saharan Africa prior to EBSP
and, thus, are usually the earliest major outlier branch in most phylogenetic relationships
when conducting inter-population comparisons among African populations (Knight et al.
2003; Wood et al. 2005).
1.3. Rationale of the thesis: 
Sub-Saharan Africa is widely accepted to be the most likely place of origin of 
anatomically modern humans around 200 kya (Quintana-Murci et al. 1999; Jobling et al.
2004; Campbell & Tishkoff 2008). The evidence for this comes from observations that 
sub-Saharan African populations have higher genetic diversity than populations outside 
Africa (Bowcock et al. 1994; Excoffier 2002; Tishkoff et al. 2009) and that genotypic and 
phenotypic (human skull) diversity within populations is negatively correlated with 
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distance from Africa (Tishkoff et al. 1996; Prugnolle et al. 2005; Manica et al. 2007; 
Tishkoff et al. 2009). With nearly a third of all languages spoken and a population of 
about 600 million, sub-Saharan Africa has also the highest linguistic diversity on earth 
(Ethnologue 2009). Furthermore, due to the close relationship between language and 
ethnic identity, over 2000 distinct ethnolinguistic groups reside in sub-Saharan Africa 
(Tishkoff et al. 2009), which results in complex relationships among them. 
Since very little is known about genetic variation within sub-Saharan Africa, 
characterisation of multiple populations will be important for understanding the history 
and relationships of these populations at the fine scale and identifying major demographic 
events at the large scale. The results will provide useful insights into whether language, 
geography or ethnic identity is best correlated with genetic variation and which DNA 
markers or genetic systems are to be tested for a specific hypothesis. Furthermore, it will 
also be of great significance in improving the design of pharmacogenetic studies since 
genes encoding drug metabolising enzymes are more likely to be harbouring more 
mutations or simply may have sub-Saharan-specific mutations, as in CYP2D6. 
Most studies on sub-Saharan African populations have been based on either low sample 
numbers or limited number of poorly defined populations (Underhill et al. 2000; Pereira 
et al. 2001; Cruciani et al. 2002; Solus et al. 2004; Jiang et al. 2005; Berniell-Lee et al. 
2009). In functional studies, a further methodological limitation has been the 
ascertainment bias towards Eurasian markers. In chapters 2-5 the issue of sample sizes 
has been overcome by the use of the TCGA African DNA collection, which has over
20,000 DNA samples available from many populations defined by their ethnicities across 
the African continent. Polymorphism ascertainment bias was also overcome by re-
sequencing autosomal segments of interest in substantial numbers of African 
chromosomes, genotyping NRY STRs and sequencing the HVR-1 region of mtDNA.
Overall, this thesis provides fine-scale data on many populations at neutral and functional 
loci with probably the largest and most densely assembled sub-Saharan African data set 
yet reported.
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1.4. Overview of result chapters:
Among the four projects studied in this thesis, Chapters 2 and 3 utilise the variation 
observed at the NRY and mtDNA loci to address questions in genetic anthropology. 
Chapter 4, similar to the approach taken by Tishkoff et al. (1996), focuses on the 
variation within CASP12 to infer the most likely route of the truncated allele spreading 
out of Africa. Chapter 5 investigates genetic variability at both CYP1A loci through re-
sequencing and SNP genotyping and identifies implications for healthcare in sub-Saharan 
Africa.  
Chapter 2 uses sex-specific genetic data, which are used to examine the origins of a 
Colombian rural community (Palenque) who are believed to be descendants of a group of 
slaves originating from Africa, specifically Yombe, from Congo, a few centuries ago. In 
this investigation, it was shown that the distribution of the paternally inherited NRY 
variation in the Palenque was most similar to Yombe compared with the other 41 sub-
Saharan African populations, all of which could have contributed individuals to the 
Atlantic slave trade (2870 samples; median sample size of 54), including representatives 
of seven other Congolese groups. The NRY data supported the linguistic evidence that 
the Yombe were the most likely founding group of Palenque. 
Chapter 3 utilises the same set of sex-specific genetic data generated for 42 sub-Saharan 
African populations in chapter 2 (plus a population in Ethiopia (Anuak)) to shed further 
light on the expansion routes taken by the EBSP. To the best knowledge of the author, 
hitherto, genetic studies of the EBSP have been generating low resolution data even 
though the EBSP modal haplogroup has been further characterised (Karafet et al. 2008). 
Based on 2800 sub-Saharan African samples (43 populations), the E1b1a haplogroup was 
further characterised and new insights regarding the routes of the EBSP have been 
obtained.
Chapter 4 is based on CASP12 variation in sub-Saharan Africa and investigates the most 
likely route of the truncated allele (carrying the stop-codon in exon 4) spreading out of 
Africa (Xue et al. 2006). Based on 534 samples (five African, four European, two Middle 
25
Eastern and one East Asian populations), sub-Saharan African populations had fewer
truncated haplotypes and exhibited higher haplotype diversity than North African and
non-African populations. Patterns of haplotype diversity suggest that the truncated variant 
most likely left Africa via an eastern route into Eurasia. This is in good agreement with 
other studies suggesting a major eastern route of dispersal of Anatomically Modern 
Human ‘Out of Africa’.
Chapter 5 examines the distribution of genetic variation in Africa of two genes that 
encode drug metabolising enzymes Cytochrome P450 1A1 and 1A2 (CYP1A1 & 
CYP1A2). It describes the variation observed in both genes and reports levels of 
conservation at both loci. Similar to previous studies (Masimirembwa et al. 1996b; 
Veeramah et al. 2008b), many of the variants characterised in this study were African-
specific. Analysis of diversity in the two CYP1A genes in humans and their close primate 
relatives suggests that while there are strong forces acting to conserve the gene 
sequences, the diversity displayed by the peoples of sub-Saharan Africa, and Ethiopia in 
particular, presents an opportunity to research the detailed metabolic functions of the 
enzymes, which is not well understood. 
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2. The origins of the Palenque: a Kikongo 
speaking community in rural Colombia
2.1. Introduction
2.1.1. The history and language of Palenque
During the Atlantic slave trade, in many locations throughout the Caribbean and Latin 
America, runaway slaves established fortified villages in their pursuit of freedom. In 
Colombia, these walled towns (known as palenques) were famed for their resistance to
the Spanish military. This is evident from colonial records which tell the story of 
inhabitants successfully repulsing attacks by the authorities (Wade 1995). Despite their 
resistance, of the many palenques that existed in Colombia during the past few centuries, 
Palenque de San Basilio (see Figure 2.1) is claimed by UNESCO to be the only one that 
survives and in 2005 they designated the village a “Masterpiece of the Oral and 
Intangible Heritage of Humanity” (www.unesco.org/culture/ich).
Figure 2.1. Geographic location of the village of Palenque de San Basilio in Colombia.
Picture obtained from Google map (www.maps.google.com).
Palenque de San Basilio
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The people of Palenque de san Basilio (Palenque for short) are a community of about 
3,500 individuals living in two major districts, Arriba and Abajo. Their village is located 
some 70 km south east of the regional capital of Bolivar, Cartagena, in north-west 
Colombia (10.1°N, 75.2°W). They have remained largely isolated from the prevailing
Hispanic culture, living by subsistence farming together with a little cattle raising 
(Bickerton & Escalante 1970). Their oral history is of descent from a group of male
slaves who escaped captivity from nearby Cartagena (then Latin America’s major slave 
trade centre (Del Castillo 1984)) early in the 17th century.     
Another interesting feature of the Palenque is that they are the only Colombian black 
community that speaks a Creole Spanish known as Palenquero (Schwegler 2006). 
Linguists originally held the opinion that the early Palenque settlement was formed from 
an amalgamation of peoples of different African ethnicities and, therefore, spoke a 
mixture of languages (Schwegler 2009). This opinion was based mainly on the belief that 
in the 17th century, Cartagena held a large number of slaves with different ethnolinguistic 
backgrounds (Heywood & Thornton 2007). However, subsequent analysis of linguistic 
data led to the suggestion that the language of the founding group originated in the area 
of present day Congo and/or northern Angola (Bickerton & Escalante 1970; Granda 
1971).
More recently, thorough lexical research has established that Palenquero contains more 
than 200 words of African origin (Schwegler 2000 and 2002). Although the initial set of 
data had a few discrepancies, further research carried out over the past three decades 
claims that Kikongo is the only demonstrable donor of the African vocabulary in the 
Palenquero creole (Schwegler 2009). It is claimed that Palenquero, since its birth, has 
been locally preserved because of its relative geographic and cultural isolation
(Schwegler 2006). Another factor that may have reinforced homogeneity of ethnic 
identity in Palenque is an 18th-century law in Colombia which granted the residents of 
Palenque self-government and freedom providing that they did not accept fugitives or 
white people into their community (Bickerton & Escalante, 1970).
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In light of new linguistic data on the Kikongo origins of Palenquero, re-evaluation of the 
historical data was appropriate. Analysis of historical records indicated that, unlike the 
oral tradition, the establishment of Palenque had most likely occurred in the second half 
of the 17th century since slaves from the Kongo region in West Africa first started to 
arrive in Cartagena in large numbers in 1640. Consequently, it was no earlier than 1650 
that Kikongo speakers had a significant population size to create a group of rebels who 
would attempt to escape captivity (Del Castillo 1984).
The Kikongo group of languages encompasses several tongues, including Bembe, Kuni, 
Lari, Sundi, Vili and Yombe, which are all still extant, being spoken by many people in 
the Republic of Congo (Ethnologue 2009). Linguists have attempted to narrow down the 
most likely African root of Palenquero among the Kikongo languages. Although the 
recorded vocabulary in Palenquero does not suggest preference for any of the languages,
the ritual vocabulary (Schwegler 2009) and historical evidence (Monino 2007) suggest 
that Yombe is possibly the source. Today, the Yombe tongue is spoken by the Yombe 
people, an ethnic group mainly living in Pointe-Noire (Republic of the Congo). 
2.1.2. Genetics and origin of African Diasporas
Understanding the origins of people has always been fascinating and genetics has been 
shown to be very useful in revealing origins through DNA analysis (Jobling et al 2004). 
Variation at the non-recombining portion of the Y chromosome (NRY) and mitochondrial 
DNA (mtDNA) has been used in genealogical inquiries of paternal (Foster et al. 1998) 
and maternal (Ivanov et al. 1996) lineages respectively, with conclusive outcomes. This 
type of analysis has the potential for use in tracing the descendants of historical Diasporas 
and has proved quite convincing, especially in the case of Jewish populations (Thomas et 
al. 1998, Thomas et al 2000 and Thomas et al. 2002).  
Geographic origins of African Diasporas, in particular those created by the Atlantic slave 
trade, have also been investigated using sex-specific genetic systems (NRY and mtDNA) 
29
along with functional autosomal markers. NRY and mtDNA variation of peoples of Cape
Verde Islands was used to detect their paternal and maternal origins respectively 
(Goncalves et al. 2003 and Brehm et al. 2002). Although data obtained from Islands of 
Cape Verde indicate a homogeneous African maternal contribution, NRY shows high 
variability of lineages, with less than a fifth of individuals carrying the expansion of 
Bantu-speaking peoples (EBSP) modal haplogroup (E1b1a). This is an interesting finding 
because even though Cape Verde is in close proximity to West Africa, E1b1a is not the 
predominant haplogroup and the NRY pool reflects a greater European, rather than West 
African, descent.
  
Genetic characterisation of peoples of San Tomé Island (Gulf of Guinea) is another 
example of investigation into origins of African Diasporas. Autosomal markers (Tomas 
2002), mtDNA (Trovoada et al. 2004) and NRY (Goncalves et al. 2007) have been 
analysed to assess the extent of the African genetic contribution to the San Tomé Island 
population. Autosomal markers show approximately 90% genetic input from 
West/Central Africa, which is in agreement with the historical evidence of the major 
geographic sources of slaves. Furthermore, NRY data show that 84% of individuals carry 
the Bantu modal haplogroup (E1b1a) and variation in mtDNA indicates no European 
contribution. Overall the data is conclusive that, unlike Cape Verde Islands, the majority 
of people in San Tomé Island are of African descent and early enslaved settlers had an 
approximately equal sex ratio. 
Genetic analysis has also been used to research the origins of Palenque (Jimenez et al. 
1996; Arnaiz-Villena et al. 2009). Both studies typed HLA autosomal markers and found 
that the distribution of HLA antigens in Palenque is closer to that seen in West Africans 
than to other Colombians. Although the HLA data suggest an African ancestry 
component for Palenque, no study has previously been undertaken analysing NRY and 
mtDNA.
In all cases mentioned here, each group can be traced back to Africa and sometimes to 
broad geographical regions within Africa in concordance with historical information. 
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However, no attempt has been made to trace ancestry to specific localised regions or 
identified ethnic groups within Africa. This is primarily due to the lack of high-resolution 
genetic data in these studies, while the high level of genetic homogeneity, low coverage 
and patchy sampling in Africa are also key factors. As a consequence, at present, 
adopting genetic markers as signatures of a particular geographic location or ethnic 
identity in Africa should be undertaken with considerable caution.
2.1.3. Expectations of sex-specific genetic variation in the Palenque and EBSP
The Palenque are thought to have been in cultural and geographic isolation for most of 
their existence. However, during the past few decades, they have experienced more 
contact with people from outside their group (Schwegler 2009). Therefore, in recent 
times, an increased level of introgression is plausible. Assuming that the founding group 
were of recent African descent, genetic analysis can establish whether introgression from 
other groups has subsequently occurred or whether the Palenque have been in isolation 
from people living in the vicinity of the village (especially the Spanish). In the presence 
of little gene flow between the Palenque and the people outside, it can be expected that 
variation in NRY is low and that most chromosome types will be of those found in sub-
Saharan Africa, with a minor fraction of European and Hispanic types. As the oral 
tradition only covers the paternal ancestry of Palenque, no prior hypothesis involving 
their maternal ancestry, beyond an assumed sub-Saharan ancestry, was constructed. From 
colonial records, it is evident that in the second half of the 18th century, 178 black 
families occupied Palenque (Del Castillo 1984). Therefore, it can be envisaged that the 
majority of the females at that time had a recent African origin.
Sub-Saharan Africa is known for its high genetic diversity (Bowcock et al. 1994; 
Kaessman et al. 1999; Yu et al. 2002). However, this is not the case for NRY variation in 
areas affected by EBSP (Hammer et al. 2001). It is thought that the expansion, which was 
the result of elevated population growth following the introduction of farming, has 
brought about considerable similarity among sub-Saharan African population groups 
(Cruciani et al. 2002; Pereira et al. 2002). Genetic data, to date, indicate that population 
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groups in sub-Saharan Africa have a high proportion of E1b1a (previously known as E3a 
and hg8) samples (Pereira et al. 2002; Beleza et al. 2005; Rosa et al. 2007) and also have 
a characteristic common modal NRY STR haplotype (Thomas et al. 2000; Pereira et al. 
2002), indicating a high level of patrilineal genetic homogeneity. Furthermore, studies of 
mtDNA variation among sub-Saharan African population groups have also shown a 
pattern of considerable genetic similarity (Pereira et al. 2001; Salas et al. 2002; Salas et 
al. 2004). Consequently, it can be envisaged that almost all sub-Saharan African 
population groups characterised in this study will have similar genetic profiles. 
Although this level of genetic homogeneity (especially of NRY) among groups will 
hinder the process of finding the most similar group to Palenque, the considerable 
increase in the number of Y chromosome markers identified in recent years (Sims et al. 
2007; Karafet et al. 2008) has the potential to overcome this hurdle through the 
identification of NRY markers with differential frequency distributions in sub-Saharan 
African populations.
2.1.4. Aims
The principal aim of this study is to investigate whether genetic data are in accordance 
with the hypothesis of a Yombe founding group, a proposition drawn from 
anthropological data. A battery of NRY markers were analysed in datasets of a) Palenque, 
b) multiple groups from The Republic of Congo and c) peoples throughout sub-Saharan 
Africa. We acknowledge that while greater similarity between the Palenque and Yombe 
datasets than between the Palenque and any other group would strongly support the 
anthropological hypothesis, any alternative finding would not necessarily contradict it 
since there are many demographic processes that could lead to the loss from the 
community of NRY haplotypes contributed by the founders. We also analysed the 
hypervariable region (HVR-1) of mtDNA in Palenque and samples from across sub-
Saharan Africa to establish whether any pattern observed in the NRY was also present in 
mtDNA.
32
Furthermore, since it is claimed that the people of Arriba are more traditional and have 
better conserved Palenquero than the residents of Abajo, it has been suggested that the 
founding men of Arriba were born in Congo, whereas Abajo was populated with slaves 
born in Colombia (Yves Monino, personal communication based on field work in 
Palenque de San Basilio). I shall also test this hypothesis by grouping samples according 
to their district of residence (based on sociological data obtained in the field for each 
sample) and examine their genetic relationship with respect to sub-Saharan African and 
other populations. 
2.2. Materials and Methods
2.2.1. Sample Collection
Buccal swabs were collected from males over eighteen years old. The collection in 
Palenque de San Basilio (Bolivar, Colombia), while undertaken randomly, involved 
questioning potential donors to establish that no two of them shared a common paternal 
grandfather. Samples were collected from a very substantial proportion of individuals 
satisfying this criterion (estimated at >90%, n = 166; Abajo area n = 85, Arriba area n = 
52).  Samples collected in the Republic of Congo were made at local gatherings in 
different areas of Brazzaville, Pointe Noire and at the villages of Kakamoeka and 
Lovoulou, 90 km and 70 km inland from Pointe Noire respectively. Individuals offering 
to be donors were accepted randomly subject to establishing that they did not share a 
paternal grandfather with another donor.  Buccal swabs were collected anonymously with 
informed consent. 
Sociological data were also collected from each individual as follows: age, current 
residence, birthplace, self-declared cultural identity, first language, second language and 
religion, with similar information on the individual’s father, mother, paternal grandfather 
and maternal grandmother. The samples were classified into groups by cultural identity. 
Where collections from a particular group were made in more than one location (for 
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example, Yombe, where samples were collected in three towns: Pointe-Noire, Louvoulou 
and Kakamoeka), locations are represented by the mean of the latitudes and longitudes of 
all towns. Buccal swab samples from another 34 population groups representing West, 
Central-West and South-East Africa (n = 2,058), which could have potentially 
contributed to the Atlantic slave trade, were also included in the analysis (see Table 2.1).
Table 2.1. Details of population groups included in this study 
Geographic 
location
Population Group 
(Code)
Ethnic 
Identity Language Latitude Longitude N
Bankim (BA) Tikar Tikar 6.083 11.483 33
Foumban (FO) Bamoun Bamoun 5.729 10.902 117
Cameroon Wum (WU) Aghem Aghem 6.389 10.073 116
Bembe (BE) Bembe Bembe -4.795 11.846 109
Kuni (KU) Kuni Kuni -4.795 11.846 68
Lari (LA) Lari Lari -4.259 15.285 62
Mboshi (MB) Mboshi Mboshi -4.259 15.285 91
Sundi (SU) Sundi Sundi -4.259 15.285 25
Teke (TE) Teke Teke -4.259 15.285 63
Vili (VI) Vili Vili -4.795 11.846 108
Congo Yombe (YO) Yombe Yombe -4.432 12.108 65
Asante (AS) Asante Akan 6.106 -1.878 94
Ewe (EW) Ewe Ewe 6.6 0.467 88
Ghana Fante (FA) Fante Akan 5.817 -2.817 60
Chewa (CH) Chewa Nyanja -13.607 33.918 92
Tumbuka (TU) Tumbuka Tumbuka -14.27 34.79 61
Malawi Yao (YA) Yao Yao -12.77 33.874 56
Mozambique Sena (SE) Multiple Sena -17.442 35.027 62
Abak (AB) Annang Annang 5.05 7.717 56
Afaha Eket (AE) Ibibio Ibibio 4.717 7.867 48
Afaha Okpo (AO) Oron Oron 4.833 8.233 50
Afaha Ukwong (AU) Oron Oron 4.75 8.25 49
Awa-Onna (AW) Ibibio Ibibio 4.69 7.815 28
Calabar (CA) Igbo Igbo 4.95 8.317 99
Ediene Ikono (ED) Ibibio Ibibio 4.783 7.883 48
Efut Akpabuyo (EF) Efik Efik 4.908 8.442 48
Efut Odukpani (EO) Efik Efik 5.167 7.983 49
Ejagham-Akamkpa 
(EA) Ekoi Ejagham 5.35 8.35 47
Nigeria
Ejagham-Calabar (EC) Ekoi Ejagham 4.95 8.317 83
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Eziagu Nenwe (EZ) Igbo Igbo 6.117 7.517 49
Ikono (IK) Annang Annang 4.992 7.758 42
Itam (IT) Ibibio Ibibio 5.042 7.842 50
Nike Enugu (NE) Igbo Igbo 6.433 7.483 54
Nnung Ndem-Onna 
(NN) Ibibio Ibibio 4.633 7.85 48
Nsit (NS) Ibibio Ibibio 4.833 7.9 36
Ntan Ibiono (NT) Ibibio Ibibio 5.233 7.933 50
Obong Itam (OB) Ibibio Ibibio 5.133 7.967 50
Oku-Itu (OI) Ibibio Ibibio 5.133 7.933 49
Oku-Uyo (OU) Ibibio Ibibio 5.1 7.967 48
Ukpom Ete (UE) Ibibio Ibibio 4.62 7.65 50
Uwanse (UW) Efik Efik 4.95 8.317 50
South Africa Bantu-Pretoria (BN) Bantu Bantu -25.746 28.187 98
2.2.2. DNA Extraction
DNA from all Congolese and Palenque samples was extracted using the Gentra protein 
precipitation method (Gentra Systems, Minneapolis) (see Appendix A). Previously 
collected buccal swab DNA samples from ethnic groups across sub-Saharan Africa 
included in this study were extracted by standard phenol-chloroform method. The range 
and mean of sample sizes of these ethnic groups are 25-118 and 62 respectively.
2.2.3. Y-chromosome typing
A combination of Unique Event Polymorphisms (UEP) and short tandem repeats (STRs)
in the paternally inherited NRY were typed in all samples from Palenque (n=166) and the 
eight Congolese ethnic groups (n=597). The polymorphic markers are six STRs (DYS19, 
DYS388, DYS390, DYS391, DYS392 and DYS393) and four UEPs (M191, U175, U290 
and U181) characterising the E1b1a haplogroup, which is the modal haplogroup 
throughout the area of the expansion of the Bantu-speaking peoples. STR repeat sizes 
were assigned according to the nomenclature of Kayser et al. (1997). The four UEPs were
typed using a tetra primer ARMS PCR method (Ye et al. 2001) with minor modifications.
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The outer and two inner fragments were amplified in a 10-μl reaction volume containing 
1 μl (~ 1 ng) of template DNA, 1.6 μl (50 μM) dNTPs, 9.3 nM TaqStartmonoclonal 
antibody (BD Biosciences Clontech, Oxford, UK), 1 μl of 10x Taq buffer and 0.13 units
of Taq DNA polymerase (HT Biotech, Cambridge, UK) and outer and inner primers (see 
Table 2.2 for primer details). All samples (96-well plates) were then placed on a 
thermocycler under the following conditions: denaturation at 95ºC for 5 min, followed by 
35 cycles of denaturation (95ºC) for 45 s, annealing (see Table 2.2 for annealing 
temperatures) for 45 s and elongation (72ºC) for 45 s.
Table 2.2. Details of the primers used in the tetra-primer ARMS PCR reactions
UEP Primer name Primer sequence (5'-3')
Melting 
temperature 
(
o
C)
Fragment   
size (bp)
Primer 
concentration 
(μM)
PCR 
annealing 
temperature 
(
o
C)
Outer forward primer AATACCAGGCCGACATGGCAGCTA 64.4 0.15
Outer reverse primer CTACAAGCACGTACCACAGCGCCA 66.1
399
0.15
Inner forward primer CATTTTTTTCTTTACAACTTGACCAG 56.9 133 0.75
M191 
T>G
Inner reverse primer CACACCAAAATATCTCATATTTTCGTA 57.4 318 0.75
60.5
Outer forward primer CCTTTAACACACTTCACAACATGG 59.3 0.3
Outer reverse primer GTGTCACTTTTCATTGTCTGG 55.9
274
0.3
Inner forward primer CCACAGGTGCTAATGAAATCG 57.9 106 0.3
U175 
G>A
Inner reverse primer ATGACCAGGAGAAGTCAAAAT 54.0 209 0.3
53.0
Outer forward primer GCTATTGGAGAGCCTCGCTGTG 61.0 0.15
Outer reverse primer AGGAAGCAATTTTCCTACCTGCCA 59.5
449
0.15
Inner forward primer GATAGGTGTGGGAATTGATGGCATT 58.3 193 0.75
U290 
T>A
Inner reverse primer GATGGCCATCAGTCCCCAGT 60.4 300 0.75
61.0
Outer forward primer GGTCTAGTGCACAGTGGTATCCA 57.1 0.15
Outer reverse primer AGAGCTCTCTCAAATCTGTGTTGG 57.5
389
0.15
Inner forward primer AGTGTCTTTGTTTTGGCAAGAAC 61.8 123 0.75
U181 
C>T
Inner reverse primer CTACCCTTGTATCAGAATACAGTTCTTA 61.7 316 0.75
62.0
The final step of the PCR program was a 7 min extension at 72ºC before a 30 min hold at 
4ºC. Figure 2.2 shows examples of agarose gels for both alleles at all four E1b1a UEP.
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Figure 2.2. Scan of an agarose gel showing the result of tetra-primer ARMS PCR for the 
detection of E1b1a UEP alleles. 
Note: The common top PCR band in all samples is the outer (control) fragment. In all cases, the molecular 
DNA marker has 10 bands of sizes 1000 to 100 bp from top to bottom. For exact sizes of each fragment,
see Table 2.2.
Where samples were not E1b1a (no derived alleles at the 4 UEP markers), a further six to 
eleven UEPs (TCGA UEP1 and UEP2 kits: sY81, SRY4064, YAP, SRY10831, M13, 
M9, SRY465, M20, Tat, 92R7 & M17) were typed (Thomas et al. 1999). The four
E1b1a-specific UEPs were also typed for E1b1a samples (previously characterised) from 
the 34 sub-Saharan ethnic groups (n=2,014) detailed in Table 2.1. NRY haplogroups 
were classified according to the nomenclature of the Y Chromosome Consortium 
(Karafet et al. 2008) (see Figure 2.3).
2.2.4. mtDNA typing 
The mtDNA HVR-1 region of all Congolese groups and Palenque was sequenced as 
described by Thomas et al. (2002), but with the following modification: primers conL1-
mod, conL2 and conH3 were replaced by conL849 (CTA TCT CCC TAA TTG AAA 
ACA AAA TA), conL884 (TGT CCT TGT AGT ATA A) and conHmt3 (CCA GAT 
GTC GGA TAC AGT TC) respectively for better sequencing results. For all samples, 
HVR-1 Variable Site Only (VSO) haplotypes were determined by comparing generated 
HVR-1 sequences of nucleotide range 16020-16400 with the Cambridge Reference 
Sequence (Anderson et al. 1981). It should be noted that Andrews et al. (1999) re-
evaluated the mtDNA reference sequence by re-sequencing the entire mtDNA genome 
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and found no discrepancies in the HVR-1 region and therefore validated the use of the old 
sequence for the purposes of this study.
Figure 2.3. Genealogical relationships of UEP markers used to define NRY haplogroups
Note: E1b1a* is the E1b1a clade excluding E1b1a7 and E1b1a8
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VSO haplotypes were defined by the type of occurring mutations (substitution, insertion 
or deletion) and their corresponding nucleotide positions. In order to extend the dataset, 
HVR-1 Variable Site Only (VSO) haplotypes were also determined for population groups 
previously typed for the HVR-1 region (n = 30; all sub-Saharan groups except Sena, 
Tumbuka, Bantu speakers-Pretoria and Yao). As the nucleotide range of these samples 
for the HVR-1 region was 16023-16380, the HVR-1 coverage in Congolese samples and 
Palenque was reduced to this range for comparisons with these groups. 
Chromatograms of all samples were inspected visually. If no significant trace of noise 
was found, the ends of the sequence were then trimmed down to the standard nucleotide 
range (16020-16400) by visually inspecting the sequence. A contig was then formed for 
each set of 96 samples (i.e. one sequencing run) and each mutation site was examined 
visually to determine whether it was a SNP, insertion or deletion. All samples with any 
ambiguous sites were resequenced. 
2.2.5. Statistical analysis
Gene diversity and its standard error were estimated from unbiased formulae of Nei 
(1987). Mean number of pairwise nucleotide differences were also calculated for mtDNA 
HVR-1 sequences in each group. The genetic distances used were a) FST (Reynolds, Weir 
& Cockerham 1983) (based on UEP haplogroups, UEP+STR haplotypes and mtDNA 
HVR-1 VSO haplotypes), b) RST (Slatkin 1995) (based on six STR on the NRY) and c) 
the Kimura’s two-parameter model with gamma distribution of value 0.47 (Kimura 1980) 
(on mtDNA HVR-1 sequences). Significance of genetic distances was assessed by 
permutation test, where a null distribution is formed by calculating all possible values of 
the genetic distance under rearrangements of haplogroups/haplotypes in the two observed 
datasets. The permutation test was repeated over 1,000 times to give a null distribution. 
Pairwise genetic differences between population groups were also estimated using the 
Exact Test of Population Differentiation (ETPD) (Raymond & Rousset 1995), which is 
analogous to the Fisher’s Exact test with an m x n contingency table, where m is the 
number of groups and n is the number of haplotypes. All the above was performed using 
Arlequin software version 3.0 (Excoffier et al 2005). 
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Principal Component Analysis (PCA) was performed using the ‘R’ environment of 
statistical computing (www.R-project.org) by implementing the ‘princomp’ function 
based on E1b1a component haplogroup frequencies and visualised using the ‘plot’ 
function. PCA plots were used to visualise relationships among groups. When a candidate 
population group for the origin of Palenque, which has the most similar NRY 
distribution, did not have a significant difference from another population group in terms 
of their genetic distance (FST), the significance of difference between the two groups with 
respect to Palenque was assessed by comparing FST distributions of 100,000 bootstrap re-
sampled datasets. All bootstrap re-sampling was performed in the statistical package 
software R (2.4.0). 
2.3. Results 
2.3.1. Frequencies of NRY haplotypes and NRY-based genetic distances 
The frequencies of all NRY haplogroups in the Palenque and in 42 sub-Saharan groups 
analysed in this study are included in Table 2.3. The phylogenetic relationships of the 
haplogroups and a visual representation of the distribution of haplogroups can be seen in 
Figures 2.3 and 2.4 respectively.
Table 2.3. Haplogroup frequencies in Palenque and 42 sub-Saharan African population groups 
from seven broad geographic regions. Modal NRY haplogroup shown in bold type.
NRY UEP Haplogroup 
(according to the 
nomenclature proposed 
by Karafet et al. (2008)) E
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2
Palenque-Abajo  (PAB) 0.012 0.129 0.341 0.071 0.000 0.153 0.012 0.212 0.000 0.047 0.024 0.000 0.000
Palenque-Arriba (PAR) 0.019 0.096 0.173 0.231 0.000 0.192 0.096 0.154 0.019 0.000 0.019 0.000 0.000
Palenque total (PA) 0.013 0.120 0.267 0.120 0.000 0.180 0.040 0.200 0.007 0.027 0.027 0.000 0.000
Bembe (BE) 0.037 0.321 0.211 0.284 0.000 0.018 0.000 0.110 0.000 0.000 0.000 0.000 0.018
Kuni (KU) 0.015 0.515 0.162 0.176 0.000 0.000 0.044 0.074 0.000 0.000 0.015 0.000 0.000
Lari (LA) 0.000 0.484 0.177 0.194 0.000 0.000 0.032 0.113 0.000 0.000 0.000 0.000 0.000
Mboshi (MB) 0.000 0.440 0.286 0.187 0.000 0.011 0.044 0.000 0.000 0.000 0.033 0.000 0.000
Sundi (SU) 0.040 0.600 0.200 0.040 0.000 0.000 0.040 0.080 0.000 0.000 0.000 0.000 0.000
Teke (TE) 0.000 0.429 0.222 0.159 0.000 0.032 0.063 0.079 0.000 0.000 0.016 0.000 0.000
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Vili (VI) 0.056 0.500 0.250 0.139 0.000 0.009 0.028 0.019 0.000 0.000 0.000 0.000 0.000
Yombe (YO) 0.031 0.277 0.369 0.138 0.000 0.015 0.046 0.092 0.000 0.000 0.031 0.000 0.000
Congo Total 0.024 0.430 0.239 0.181 0.000 0.012 0.034 0.066 0.000 0.000 0.012 0.000 0.003
Bankim (BA) 0.364 0.182 0.152 0.152 0.000 0.030 0.061 0.061 0.000 0.000 0.000 0.000 0.000
Foumban (FO) 0.068 0.667 0.068 0.051 0.000 0.000 0.085 0.043 0.000 0.000 0.009 0.000 0.009
Wum (WU) 0.026 0.621 0.000 0.310 0.000 0.000 0.043 0.000 0.000 0.000 0.000 0.000 0.000
Cameroon Total 0.086 0.586 0.049 0.177 0.000 0.004 0.064 0.026 0.000 0.000 0.004 0.000 0.004
Asante (AS) 0.245 0.309 0.106 0.245 0.000 0.000 0.000 0.043 0.000 0.000 0.053 0.000 0.000
Ewe (EW) 0.114 0.420 0.102 0.273 0.000 0.023 0.023 0.045 0.000 0.000 0.000 0.000 0.000
Fante (FA) 0.300 0.250 0.167 0.217 0.000 0.033 0.000 0.017 0.000 0.000 0.017 0.000 0.000
Ghana Total 0.211 0.335 0.120 0.248 0.000 0.017 0.008 0.037 0.000 0.000 0.025 0.000 0.000
Chewa (CH) 0.043 0.239 0.293 0.130 0.054 0.000 0.076 0.130 0.011 0.000 0.000 0.000 0.022
Tumbuka (TU) 0.033 0.410 0.230 0.082 0.033 0.000 0.082 0.098 0.016 0.000 0.000 0.000 0.016
Yao (YA) 0.071 0.321 0.250 0.054 0.036 0.000 0.196 0.071 0.000 0.000 0.000 0.000 0.000
Malawi Total 0.048 0.311 0.263 0.096 0.043 0.000 0.110 0.105 0.010 0.000 0.000 0.000 0.014
Abak (AB) 0.054 0.357 0.107 0.161 0.232 0.000 0.054 0.036 0.000 0.000 0.000 0.000 0.000
Afaha Eket  (AE) 0.104 0.354 0.042 0.125 0.208 0.000 0.125 0.042 0.000 0.000 0.000 0.000 0.000
Afaha Okpo (AO) 0.020 0.460 0.060 0.080 0.280 0.000 0.020 0.060 0.000 0.000 0.000 0.020 0.000
Afaha Ukwong  (AU) 0.041 0.408 0.102 0.143 0.163 0.000 0.102 0.020 0.000 0.000 0.020 0.000 0.000
Awa-Onna (AW) 0.000 0.500 0.000 0.179 0.107 0.000 0.179 0.036 0.000 0.000 0.000 0.000 0.000
Calabar (CA) 0.061 0.475 0.121 0.101 0.141 0.000 0.071 0.010 0.000 0.000 0.010 0.010 0.000
Ediene Ikono  (ED) 0.083 0.479 0.042 0.083 0.125 0.000 0.125 0.063 0.000 0.000 0.000 0.000 0.000
Efut Akpabuyo  (EF) 0.125 0.438 0.042 0.042 0.125 0.021 0.188 0.021 0.000 0.000 0.000 0.000 0.000
Efut Odukpani  (EO) 0.020 0.449 0.143 0.082 0.204 0.000 0.061 0.041 0.000 0.000 0.000 0.000 0.000
Ejagham-Akamkpa (EA) 0.021 0.426 0.085 0.277 0.043 0.021 0.085 0.043 0.000 0.000 0.000 0.000 0.000
Ejagham-Calabar  (EC) 0.024 0.518 0.048 0.193 0.108 0.024 0.060 0.024 0.000 0.000 0.000 0.000 0.000
Eziagu Nenwe (EZ) 0.286 0.469 0.020 0.102 0.082 0.000 0.041 0.000 0.000 0.000 0.000 0.000 0.000
Ikono (IK) 0.000 0.429 0.167 0.143 0.071 0.000 0.167 0.024 0.000 0.000 0.000 0.000 0.000
Itam (IT) 0.080 0.520 0.060 0.120 0.160 0.000 0.040 0.000 0.000 0.000 0.020 0.000 0.000
Nike Enugu (NE) 0.019 0.685 0.000 0.074 0.130 0.000 0.056 0.019 0.000 0.000 0.000 0.019 0.000
Nnung Ndem-Onna  (NN) 0.042 0.563 0.063 0.250 0.021 0.000 0.021 0.021 0.000 0.000 0.000 0.021 0.000
Nsit (NS) 0.028 0.361 0.111 0.250 0.167 0.000 0.056 0.028 0.000 0.000 0.000 0.000 0.000
Ntan Ibiono (NT) 0.040 0.380 0.160 0.140 0.180 0.000 0.080 0.020 0.000 0.000 0.000 0.000 0.000
Obong Itam  (OB) 0.000 0.480 0.060 0.140 0.120 0.020 0.100 0.040 0.020 0.000 0.000 0.020 0.000
Oku-Itu (OI) 0.000 0.510 0.102 0.102 0.163 0.000 0.122 0.000 0.000 0.000 0.000 0.000 0.000
Oku-Uyo  (OU) 0.042 0.396 0.083 0.208 0.167 0.000 0.042 0.063 0.000 0.000 0.000 0.000 0.000
Ukpom Ete  (UE) 0.060 0.480 0.140 0.100 0.080 0.000 0.080 0.040 0.000 0.000 0.000 0.020 0.000
Uwanse (UW) 0.060 0.460 0.060 0.060 0.240 0.000 0.100 0.000 0.000 0.000 0.020 0.000 0.000
Nigeria Total 0.053 0.464 0.080 0.135 0.145 0.004 0.082 0.027 0.001 0.000 0.003 0.005 0.000
Bantu-speakers Pretoria 
(BN) 0.061 0.255 0.286 0.071 0.082 0.000 0.153 0.051 0.010 0.000 0.031 0.000 0.000
Sena-Mozambique (SE) 0.161 0.306 0.274 0.032 0.016 0.000 0.081 0.129 0.000 0.000 0.000 0.000 0.000
Grand Total 0.064 0.417 0.149 0.150 0.068 0.016 0.066 0.054 0.002 0.001 0.009 0.002 0.002
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Figure 2.4. Visual representation of haplogroup distributions in sub-Saharan African populations 
and Palenque.
Note: South-East Africa is represented by population groups CH, TU, YA, SE and BN.
The 15 typed UEP makers defined 13 observed NRY haplogroups, of which ten were 
observed in Palenque. The modal haplogroup in the Palenque was E1b1a8* (27%), but 
the two moieties of the village had different modal haplogroups: Abajo, E1b1a8* (34%); 
Arriba, E1b1a8a1* (23%); using the nomenclature of the Y-chromosome Consortium 
(Karafet et al. 2008). Gene diversity in Palenque, based on UEP haplogroups, was 0.830 
± 0.013, whereas the equivalent statistic in the sub-Saharan African dataset (n = 2,649) 
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was 0.753 ± 0.007 and in each individual group was lower than in Palenque, ranging 
from 0.514-0.820. Gene diversity for each broad geographic region is included in Table 
2.4. 
Table 2.4. Gene diversity measures based on UEP haplogroups and UEP+STR haplotypes in five 
broad geographic regions in sub-Saharan Africa.
  
Geographic 
region
NRY Marker 
Set
Gene 
Diversity ± 
SD
Gene Diversity 
Range among 
groups
Gene Diversity 
Mean (Variance)
N
UEP 0.613 ± 0.029 0.520-0.805 0.621 (0.025)
Cameroon (n=3)
UEP+STR 0.954 ± 0.005 0.893-0.962 0.924 (0.001)
266
UEP 0.721 ± 0.012 0.613-0.767 0.703 (0.003)
Congo (n=8)
UEP+STR 0.951 ± 0.003 0.928-0.957 0.941 (0.0001)
591
UEP 0.769 ± 0.012 0.731-0.784 0.764 (0.001)
Ghana (n=3)
UEP+STR 0.968 ± 0.004 0.962-0.974 0.968 (0.00004)
242
UEP 0.729 ± 0.011 0.514-0.802 0.724 (0.003)
Nigeria (n=23)
UEP+STR 0.969 ± 0.002 0.936-0.983 0.967 (0.0001)
1181
UEP 0.805 ± 0.011 0.766-0.820 0.799 (0.0004)
South East 
Africa (n=5)*
UEP+STR 0.971 ± 0.003 0.964-0.976 0.969 (0.00003)
369
*This region includes the following groups: CH, TU, YA, SE and BN.  N, n and SD are total sample size, 
number of groups and standard deviation respectively.
Haplotype (UEP+STR) sharing across groups is shown in Supplementary Table 2.S5, 
where it can be seen that the number and proportion of haplotypes shared between the 
Palenque and each other group ranges from 5-12 (0.111-0.267) and 7-68 (0.047-0.453).
Genetic distances between Palenque and the sub-Saharan African groups at the NRY 
UEP characterisation are provided in Supplementary Table 2.S1, where it can be seen that 
Chewa has the smallest Fst with Palenque and is not statistically significant. The second 
most similar group to Palenque was the Yombe, which had a non-significant Fst with 
Chewa (P = 0.595).
The NRY E1b1a clade comprised 52.0% of the Palenque and 86.6% of the 42 sub-
Saharan African groups (range of 73.2-95.9%, mean of 86.3% and variance of 0.3%) (see 
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Table 2.5). Restricting NRY UEP analysis just to the component haplogroups of this 
clade (NRY UEP-E1b1a) showed the genetic distance between Palenque and Yombe to 
be the smallest (genetic distances are included Supplementary Table 2.S2). 
Table 2.5. E1b1a clade proportions in five broad geographic regions in sub-Saharan Africa. 
Notations are the same as in Table 2.4.
Geographic region E1b1a frequency
E1b1a frequency 
Range among groups
E1b1a frequency 
Mean (Variance) N
Cameroon (n=3) 0.898 ± 0.019 0.848-0.957 0.887 (0.004) 266
Congo (n=8) 0.873 ± 0.014 0.810-0.944 0.867 (0.002) 591
Ghana (n=3) 0.913 ± 0.018 0.904-0.933 0.916 (0.0002) 242
Nigeria (n=23) 0.887 ± 0.010 0.771-0.959 0.874 (0.003) 1181
South East Africa (n=5) 0.764 ± 0.022 0.732-0.790 0.765 (0.0006) 369
2.3.2. Comparisons of NRY datasets
Supplementary Tables 2.S3 and 2.S4 show the results of pairwise comparisons using the 
Exact Test of Population Differentiation (ETPD) between all groups based on all NRY 
haplogroups and just the E1b1a component haplogroups. At both levels, the Cameroonian 
groups (Bankim, Foumban and Wum) along with Palenque showed the highest level of 
differentiation compared with all other groups, with ≥ 40 out of total of 42 significant 
differences observed. Notably, pairwise ETPD test of Palenque and all 42 sub-Saharan 
African groups (including the eight Congolese groups) were significant at 0.1% and 5% 
significance levels, based on UEP and UEP-E1b1a, except for Yombe (UEP P = 0.0011, 
UEP-E1b1a P = 0.504).
2.3.3 Yombe and Chewa
The two groups most similar to Palenque were not statistically distinguishable from each 
other at either UEP or E1b1a-UEP levels, using ETPD (P ≥ 0.318). Because a relatively 
higher level of differentiation was observed at the UEP-E1b1a level, genetic distance was 
recalculated at this level between Yombe-Palenque (YP) and Chewa-Palenque (CP) using 
Fst with bootstrap re-sampling of 100,000 repeats. 95% confidence intervals (the middle 
95% of estimated Fst values) of YP and CP pairwise Fst (see Table 2.6) showed no 
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indication of a closer relationship between Yombe and Palenque. However, estimates of 
mean and mode were lower in the YP distribution than in the CP distribution. 
Table 2.6. Summary statistics of bootstrap resampled Fst distributions based on E1b1a NRY 
clade using two definitions of Fst. Negative Fst results are artefacts obtained because of the 
computation method used. CI stands for confidence interval.
Fst definition Pairwise comparison 95% CI Mean Mode
Yombe-Palenque (YP) 0.0009 - 0.0476 0.0150 0.0035
Wright’s Fst
Chewa-Palenque (CP) 0.0032 - 0.0504 0.0190 0.0115
Yombe-Palenque (YP) -0.0061 - 0.0867 0.0225 0.0025
Reynolds’ Fst 
(Theta)
Chewa-Palenque (CP) -0.0004 - 0.0900 0.0305 0.0165
2.3.4 Principal Component Analysis
Principal component analysis was used to visualise patterns of genetic relationships 
among groups. Among the 42 groups Yombe and Chewa relatively had the same level of 
similarity to Palenque at the UEP level. However, based on UEP-E1b1a, the most similar 
group to Palenque was Yombe (see Figure 2.5).  
2.3.5. The distribution of mtDNA variation
The Palenque dataset contained 26 VSO haplotypes, based on sequencing 360 
nucleotides of the HVR-1 region of the mtDNA genome. The modal haplotype was at a 
frequency of 0.166 and five common haplotypes accounted, together, for 66.2% of the 
total. Nei’s gene diversity, based on VSO haplotypes, was 0.9031 ± 0.010. 
Across all sub-Saharan African groups (38 groups), 723 VSO haplotypes (427 singletons) 
were observed.  The modal haplotype frequency ranged from 0.040-0.147, where Obong 
Itam and Bankim had the lowest and highest frequency respectively. Gene diversity for 
the combined set was 0.9933 ± 0.004 and in individual groups ranged from 0.968 in 
Bankim to 0.997 in two Nigerian groups (Ejagham-Akamkpa and Obong Itam), with 
mean of 0.987 and variance of 0.00005.
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Figure 2.5. Visual representation of genetic relationships among all groups using PCA based on a) NRY UEP and b) NRY UEP-E1b1a.
Percentages in parentheses are the amount of variation explained by each component.
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The frequencies of all mtDNA haplotypes are included in Supplementary Table 2.S6. 
2.3.6. Comparison of mtDNA across datasets
Comparison of all 38 sub-Saharan groups, using Fst, showed 457 out of 703 (65%) to 
be significant at the 5% level. Individual groups had significant genetic distances with 
10-37 other groups. (Ukpom Ete had only 10 significant genetic distances, whereas 
Bankim, Bembe and Chewa had 37 each). Fst between Palenque and the sub-Saharan 
African groups were all significant (P < 0.0001) and were in the range of 0.037-0.066, 
where Oku-Uyo from Nigeria and Chewa had the lowest and highest genetic 
distances. 
Based on VSO haplotypes, all pairwise ETPD between Palenque and 42 sub-Saharan 
African groups (including the eight Congolese groups) were significant (P < 0.0001). 
2.3.7. Intra-village analysis of Palenque 
Summary statistics were calculated for both districts (Abajo and Arriba) in Palenque. 
The modal NRY haplogroups in Abajo and Arriba were E1b1a8* (34.1%) and 
E1b1a8a1* (23.1%) respectively (Table 2.3). The proportion of the E1b1a clade in 
Abajo and Arriba was 55.3% and 51.9% respectively (not significantly different). 
Gene diversity based on all UEP haplogroups in Abajo and Arriba was 0.8000 ± 
0.0242 and 0.8529 ± 0.0188 respectively. Restricting analysis to E1b1a NRY types, 
gene diversity in Abajo and Arriba was markedly reduced to 0.5597 ± 0.0632 and 
0.6809 ± 0.0495 respectively. At the UEP+STR level the modal haplotype was one 
step away from the EBSP modal haplotype (i.e. E1b1a-15-12-21-10-11-13) in Abajo 
(E1b1a-16-12-21-10-11-13; 10.6%) and in Arriba (E1b1a-15-12-21-10-12-13; 
19.2%), whereas the EBSP modal haplotype was at a frequency of 5.9% and 5.8% in 
Abajo and Arriba respectively. 
To investigate the hypothesis, derived from observed cultural differences and local 
opinion (Yves Monino, personal field notes), that the village areas of Abajo and 
Arriba can be distinguished from each other several statistical tests were performed 
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involving, separately, both the NRY and mtDNA genetic systems. Initially, a set of 
different genetic distance estimators were calculated based on NRY and mtDNA 
markers (see Table 2.7). 
Table 2.7. Genetic distances between Abajo and Arriba based on NRY and mtDNA markers. 
Significant p-values at 5% level are shown in bold type.
Genetic 
system
Marker/s
Distance 
estimator
Distance P-value
UEP ALL 0.027 0.018
UEP E1b1a only 0.116 0.027
UEP+STR ALL 0.019 <0.00001
UEP+STR E1b1a only
Fst
0.041 0.018
NRY 
STR Rst 0.023 0.045
HVR-1 VSO Fst <0.001 0.982
mtDNA
HVR-1 sequence K2P <0.001 0.712
Strikingly, genetic distances at the mtDNA level were not significant, whereas all 
distance measures based on NRY markers were significant at the 5% level.
Genetic difference of Abajo and Arriba was also assessed by ETPD. The NRY genetic 
system showed significant difference between Abajo and Arriba at the 5% level
(UEP, UEP-E1b1a and UEP+STR (see Table 2.7)), however, no significant genetic 
difference was found between the two districts based on mtDNA HVR-1 haplotypes 
(Fst) or sequences (π) (p > 0.98).
2.3.8 Abajo and Arriba in the context of sub-Saharan Africa
Genetic differences between each area of the village and the sub-Saharan Africa 
groups were independently assessed by the ETPD, based on NRY UEP and UEP 
E1b1a component haplogroups. Analysing UEP, both Abajo and Arriba were 
significantly different from all the sub-Saharan groups. Notably, analysing UEP 
haplogroups in the E1b1a clade, all groups were also significantly different from 
Abajo at the 5% level, except Yombe (p = 0.454) and Chewa (p = 0.082), whereas 
three groups could not be distinguished from the Arriba (Bembe (p = 0.272), Chewa 
(p = 0.069), Yombe (p = 0.063)).   
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Genetic distances between Abajo and Arriba, as separate datasets, and 42 population 
groups in sub-Saharan Africa were also calculated based on NRY UEP and UEP 
E1b1a component haplotypes, but not VSO haplotypes, since no significant genetic 
distance was observed between the two districts, based on mtDNA (see Table 2.7). 
Analysing UEP, Chewa were the closest to Abajo, whereas based on E1b1a 
component haplotypes, Yombe were. In the case of Arriba, neither Yombe nor Chewa 
were the closest.
2.4. Discussion
2.4.1 Answering the principal questions of the study 
There were three objectives of this study as enunciated in the introduction to this 
chapter:
1) are genetic data consistent with a Yombe-speaking paternal founding group of 
the Palenque?
2) is there any pattern in the distribution of maternal ancestry based on mtDNA 
HVR-1 haplotypes similar to that displayed by analysis of the NRY?
3) can the two groups of residents of Palenque de San Basilio, occupying Abajo 
and Arriba respectively, be distinguished from each other and, if so, are the  
founding residents of Arriba more likely to have been born in the Congo than 
were the founding residents of Abajo?
It is first necessary to consider which set of NRY and mtDNA markers are appropriate 
to provide the power necessary to undertake analyses. On the NRY there are the 
following choices: UEP haplogroups, UEP+STR haplotypes characterised by both 
SNPs and STRs, UEP haplogroups comprising the E1b1a clade and STRs without 
SNPs. With respect to mtDNA there are VSO haplotypes available which could be 
used with or without imputing haplogroups based on the haplotype and analysed 
either as haplotypes or on the basis of nucleotide diversity.
The choices were made for the reasons set out below:
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UEP haplotypes: these were analysed because their frequencies have been shown to 
vary among groups in ways that reflect common origin or gene flow (Underhill et al. 
2001). A problem in addressing the question posed in this study concerning the 
possible Yombe origin of the Palenque is that the Palenque are anticipated to have 
experienced extensive inward NRY gene flow from non-African populations, which 
the African groups have not, and that this, while not invalidating the adopted 
approach, might make interpretation of genetic distances calculated using UEP 
haplotypes more difficult.
E1b1a clade component haplotypes: analysis of these NRY have the benefits 
associated with the UEP haplotypes method above with an added advantage that NRY 
likely to be due to non-African gene flow into the Palenque are excluded from the 
analysis. E1b1a clade NRY are known to be strongly associated with the EBSP, 
which includes the Congo (Underhill et al. 2001; Cruciani et al. 2002; Wood et al. 
2005; Berniell-Lee et al. 2009). The clade represented 87% of the Congolese dataset, 
90% of Ghanaians, 76% of Malawians, 89% of Nigerians and 79% of the 
Mozambique collection. (Palenque 52%)
UEP+STR: characterising NRY at this level provides a fine level of resolution but 
suffers from the disadvantage that the number of shared chromosomes in cross group 
comparisons can be very low when groups are not closely related, either due to 
substantial time since a common origin or the absence of gene flow.  As a 
consequence calculations of Fst can be driven by very few shared NRY, with 
comparative values of Fst not being a reliable indicator of which group, from a large 
list of candidates, is the most likely source. It is, however, an appropriate method for 
comparing Abajo with Arriba using ETPD, since the number of shared chromosomes 
is substantial (see Supplementary Table 2.S5 for NRY UEP+STR sharing across all 
groups).
Rst: in this method genetic distance among populations is assessed by analysing 
variation in STR repeat lengths and the measure has been shown to increase linearly 
over time groups have been separated. In the present study the short period since the 
foundation of Palenque de San Basilio makes it unlikely that mutation of STR is the 
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important element in recognising the presence of a founding constituent within 
Palenque because it is the frequencies of shared lineages that is the best indicator of 
origin (see Thomas et al. 2000 and Veeramah et al. 2010) and Rst neither defines nor 
analyses lineage frequencies. Fst based on haplotype frequencies does utilise lineage 
frequencies and is, consequently, an appropriate method.
mtDNA VSO haplotypes: the VSO haplotype is suitable for analysis by Fst applied to 
haplotypes just as is the NRY haplotype. Over short time periods Fst between 
populations, based on the non-recombining VSO haplotype, is expected to increase in 
a similar way to Fst based on single-locus alleles, since variation in the HVR-1 
sequence, due to nucleotide mutation, is not expected to greatly affect the frequencies 
of haplotypes, although there is likely to be some increase in the number of 
population specific haplotypes (Veeramah et al. 2010). Although it has been 
suggested that mtDNA haplogroups can be inferred from HVR-1 sequences (Richards 
et al. 1998; Simoni et al. 2000), this view has been strongly challenged (Torroni et al. 
2000). Consequently, analysis was restricted to VSO haplotypes.
Nucleotide variation (π): calculating K2P between populations recognises both 
haplotypes and the quantum of variation among haplotypes, with increased difference
being related to the time since separation. In doing so it takes into account, by 
allocations of different weightings, the frequency of transversion and transition 
changes. Calculations are therefore less likely to be affected by recent gene flow 
(resulting in low genetic distances) (Hebert et al. 2003).
Applying the above appraisal of methods of assessing similarity to the data answers to 
the questions posed in the aims of this study are as follows:
2.4.1.1. Are genetic data consistent with a Yombe speaking paternal founding 
group of the Palenque?
Fst based on UEPs between Palenque and 42 sub-Saharan groups in analysis that 
included haplogroups comprising the E1b1a clade was lowest between Palenque and 
Yombe. Because there was no significant difference between Yombe and  Chewa at 
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the all UEP and E1b1a characterisations a bootstrap simulation was performed in 
which the two Fst distances were compared following 100,000 re-samplings with 
Palenque –Yombe showing the smallest distance. Notably, in ETPD tests at both the 
all NRY clades and E1b1a levels Yombe were the only group that did not record a 
significant difference with the Palenque dataset (p=0.504). I also note that haplogroup 
E1b1a8a1a, while being absent in both the Palenque and all the Congo datasets 
(including Yombe), was present at more than 5% in the Chewa. Consequently, my 
answer to the question posed is in the affirmative. The two PCA plots in Figure 2.3 
illustrate this showing a position of the Yombe closer to Palenque when the distances 
have been calculated by analysing all component haplogroups in just the E1b1a clade.     
2.4.1.2. Is there any pattern in the distribution of maternal ancestry based on 
mtDNA HVR-1 haplotypes or K2P distances similar to that displayed by analysis 
of the NRY?
Due to the high level of genetic diversity observed at the HVR-1 locus in sub-Saharan 
African population groups, which is thought to be a consequence of patrilocality, and 
the hypervariable nature of this segment of mtDNA, genetic distances have less power 
to differentiate among population groups and comparisons made in this study clearly 
indicate a negative answer.
2.4.1.3. Can the two groups of residents of Palenque de San Basilio occupying 
Abajo and Arriba respectively be distinguished from each other and, if so, are 
the residents of Arriba more similar to the peoples of the Congo than are the 
residents of Abajo?      
The two areas of the village can, on the basis of analysing NRY, be distinguished 
whether the analysis is undertaken using all NRY, just the E1b1a clade or UEP+STR 
(see Table 2.7). Quite contrary to this conclusion no significant difference was 
observed with respect to maternal inheritance. 
When addressing the issue of similarity between the village sub-groups and African 
datasets we note that, analysing all NRY clades, the only non-significant Fst is 
between Abajo and Yombe, while for Arriba the least distance was between it and the 
Chewa. At the preferred E1b1a clade level in the cases of both Abajo and Arriba a 
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Congolese group was closest (Yombe and Bembe respectively). In both cases the 
Chewa were the second least distant group. Consequently, the genetic data do not 
provide support for the hypothesis that the inhabitants of the Arriba area have an 
ancestry more associated with the Yombe.
The genetic distance between the two districts was at its highest at the UEP level 
based only on E1b1a samples, with the distance between Abajo and Arriba greater 
than 85% of pairwise distances observed among sub-Saharan African groups. The 
proposition, based on sociological observation, that the original inhabitants of Arriba 
were first-generation slaves while the original inhabitants of Abajo were born into 
slavery in Colombia is not supported by the data. If the inhabitants of Abajo were 
born into slavery in Colombia it is to be expected, given the propensity of male slave 
owners to impregnate their female slaves, that they would have a far greater 
proportion of European NRY (haplogroup P*(xR1a) than does Arriba. This is not the 
case in Palenque (Abajo 15%, Arriba 19%, Fisher’s exact test P = 0.639). 
Analysis of mtDNA revealed no significant difference between Abajo and Arriba 
based on genetic distances (Fst and K2P, P > 0.712) and ETPD (P = 0.987). This lack 
of maternally mediated structuring is consistent with recent gene flow.
2.4.2 Additional observations
2.4.2.1 European and African contributions to the Palenque NRY gene pool
NRY haplogroup P*(xR1a) accounted for 18% of the individuals in Palenque, 
suggesting a substantial contribution by European males. Among the P*(xR1a) 
individuals twelve unique UEP+STR haplotypes were present, with haplotypes 
having as many as seven mutation steps distance from each other. This indicates that 
the contribution of this haplogroup to Palenque involved many different males. 
Furthermore, this haplogroup is most frequently observed in Spain, the colonial ruling 
power in 17th century Colombia (for the distribution of this haplogroup in Europe see 
Table 2.9). 
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Haplogroup E* (xE1b1a), observed at high frequencies in North and East Africa (see 
Table 2.9), is present at 20% in Palenque. It is very unlikely that haplogroups 
P*(xR1a) and E*(xE1b1a) were present among slaves born in the Congo as both 
haplogroups are present at very low frequencies in sub-Saharan Africa (especially in 
groups on the West Coast). 
The presence of Spanish people, as colonial rulers, and the possible presence of slaves 
from North West Africa in Cartagena (taking into consideration that it was a multi-
ethnic slave trade port in the 17th century) make it more likely that admixture occurred 
after the slaves had been brought to Colombia from sub-Saharan Africa. However, it 
should be noted that this does not exclude the possibility that these haplogroups were 
introduced into the Palenque community after its formation. Haplogroup R1a, for 
example, which represented only (3%, n = 4) in Palenque (all having the same 
UEP+STR haplotype), is at high frequency in East Europe and Central Asia 
(Underhill et al. 2000) and was most likely contributed by peoples of adjacent 
Colombian communities. Overall, the results indicate that a significant amount of 
admixture has occurred in the Palenque population.
Moreover, 3% of samples belonged to haplogroup Y*(xBR,A3b2), which is one of 
the oldest human NRY lineages and is thought to be the remnant of indigenous 
populations living in sub-Saharan Africa prior to the EBSP (Underhill et al. 2001). 
52% of samples belong to the E1b1a clade (n = 78), which is almost absent from 
groups outside sub-Saharan Africa (see Table 2.9). The ‘Bantu modal haplotype’ 
(E1b1a-15-12-21-10-11-13) is not modal in the Palenque and the STR haplotype 
network does not have a star genealogy as observed in sub-Saharan African 
population groups. This pattern is consistent with a reasonably stable population and 
drift following formation. The described pattern of NRY types is therefore consistent 
both with a Yombe founding group and a substantial contribution of both African and 
non-African NRY. In the case of NRY haplogroups not usually observed in Africa, 
the respective NRY could, variously, have either been inherited from non-members of 
the village or when the NRY-carrying male joined the village. 
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Table 2.9. Frequency distribution of haplogroups P*(xR1a), E*(xE1b1a) and E1b1a in 
geographic locations across Europe, North Africa and East Africa.
Geographic location P*(xR1a) E*(xE1b1a) E1b1a N* Reference
Spain
Aragon 0.56 0.06 0.00 34
Andalusia (East) 0.72 0.04 0.00 95
Andalusia (West) 0.56 0.15 0.00 73
Asturias 0.50 0.15 0.00 20
Basque country 0.88 0.01 0.00 116
Castilla la Mancha 0.72 0.04 0.00 63
Castile (North East) 0.77 0.09 0.00 31
Castile (North West) 0.60 0.19 0.00 100
Catalonia 0.81 0.03 0.00 80
Extremadura 0.50 0.18 0.00 52
Galicia 0.57 0.17 0.00 88
Gascony   0.97** 0.00 0.00 24
Valencia 0.64 0.10 0.01 73
Adams et al. 2008
Portugal
North Portugal 0.59 0.15 0.00 60
South Portugal 0.47 0.17 0.01 78
Adams et al. 2008
England
Ashbourne 0.65 0.06 0.00 54
Southwell 0.64 0.07 0.00 70
Fakenham 0.57 0.02 0.00 53
North Walsham 0.58 0.04 0.00 26
Weale et al. 2002
Wales
Llangefni 0.89 0.04 0.00 80
Abergele 0.56 0.39 0.00 18
Weale et al. 2002
Friesland 0.55 0.02 0.00 94 Weale et al. 2002
Algeria 0.06 0.57 0.00 54 Arredi et al. 2004
Morocco 0.03 0.77 0.07 146 Bosch et al. 2001
Tunisia 0.07 0.50 0.01 148 Arredi et al. 2004
Ethiopia 0.00 0.48 0.00 95 Moran et al. 2004
*N represents the number of individuals from each location. **Maximum frequency of each 
haplogroup is shown in bold type. 
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2.4.2.2 NRY distribution in sub-Saharan Africa
The E1b1a clade, as expected, is observed at high frequency in all 42 sub-Saharan 
African population groups. Although this NRY clade is modal in these groups, its 
frequency is variable among groups, ranging from 73% in South Africa to 96% in 
Nigeria and Cameroon. 
Haplogroup Y*(xBR,A3b2) is found at its highest frequency  in Khoisan (Underhill et 
al. 2000) and Cameroon Grassfields  (Veeramah et al. 2008a) (44% and 23% 
respectively), but observed at very low frequencies with a patchy distribution in sub-
Saharan Africa (Rosa et al. 2007 and Berniell-Lee et al. 2009). The frequencies of this 
haplogroup in all 42 groups characterised in this study (range of 0-5%) is in good 
agreement with published data and supports the idea that the expansion of Bantu-
speaking peoples has dramatically influenced the pre-existing African NRY diversity.
Haplogroup E*(xE1b1a) was also present in most groups (range of 0-13%). The 
presence of haplogroup P*(xR1a) in sub-Saharan Africa at very low frequencies 
(range of 1-3%) may be the result of sporadic male introgression during the European 
colonisation of Africa.
2.4.2.3 Analysis of mtDNA variation in Palenque and sub-Saharan Africa
Gene diversity values, based on VSO haplotypes of the HVR-1 region, observed in 
sub-Saharan African groups are very similar to those found previously in West-
Central African groups (Salas et al. 2002; Salas et al. 2004). Furthermore, the overall 
gene diversity in Congo was identical to that reported in the neighbouring country 
Angola (Plaza et al. 2004). Overall comparison of mtDNA gene diversities shows a 
significant level of similarity in areas affected by the expansion of Bantu-speaking 
peoples. Gene diversity in Palenque, compared with sub-Saharan African groups, is 
significantly lower (P < 0.001) and shows a significant level of drift in the maternal 
inheritance, with only five haplotypes covering 67% of the haplotypes. However, 
when diversity is estimated based on mean pairwise nucleotide differences (π, which 
takes into account the phylogenetic relationships of sequences), a different pattern is 
observed where seven sub-Saharan African groups have lower π values than 
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Palenque. This difference is consistent with mean pairwise nucleotide difference
calculations being less sensitive to the effects of genetic drift; and values may even 
increase under such circumstances (Helgason et al. 2003). 
2.4.2.4 Differentiation based on mtDNA
As explained earlier in the discussion of the merits of alternative methods of 
comparing multiple datasets the appropriate choice of method when assessing relative 
genetic distances between Palenque and multiple sub-Saharan groups using Fst 
calculated by analysing VSO haplotypes depends on an adequate number of common 
haplotypes either within a group or shared between groups. If haplotypes shared 
between groups are rare and have a wide geographic distribution the smallest 
distances may represent no more than the stochastic presence or absence of the rare 
haplotypes.  The criterion of adequate sharing was arguably just satisfied in this study, 
with common haplotypes present in the Palenque dataset represented in 40.0% in the 
groups with which comparisons were made, and at between 7.3% to 16.6% of the 
samples. Genetic distances calculated using Fst and K2P are consistent both with 
multiple origins of the mtDNA observed in the Palenque and substantial gene flow 
between Abajo and Arriba.
2.4.2.5 Origins of Palenque
In seeking to identify the sub-Saharan group most similar in its paternal ancestry I 
took an approach similar to that taken by Di Giacomo et al. (2004), making use of 
detailed characterisation of chromosomes within the E1b1a haplogroup by 
recognising component haplogroups that comprise the clade. The five defined 
component-haplogroups were informative and permitted genetic distances between 
Palenque, Yombe and each of the other sub-Saharan groups to be discriminated. This 
approach to elucidating the origin-group of the Palenque is supported by the 
observation of the wide distribution and high frequency of the E1b1a clade in sub-
Saharan Africa and its relative absence in males without a recent EBSP paternal 
ancestry.
Although both Fst and ETPD comparisons indicated that Yombe were the sub-
Saharan group most similar to the Palenque there was an initially surprising 
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observation that the Chewa (a group far to the east in Malawi) was only a little less 
similar. Furthermore, based on UEP-E1b1a, the Chewa-Palenque genetic distance was 
not significantly different from zero. The difference between Chewa and Yombe was 
also assessed by ETPD using UEP-E1b1a with no significant difference recorded. The 
modal haplogroup in Palenque (E1b1a8*) was also modal in both Yombe and Chewa, 
while all other groups (except Bantu speakers-Pretoria) had E1b1a7 as their modal 
haplogroup. Nevertheless, Yombe and Chewa did have differences in their NRY 
profiles in that the Chewa, unlike the Yombe, had NRY belonging to the E1b1a8a1a 
haplogroup (5.4% n = 5), a haplogroup that was not observed in the Palenque or any 
Congolese group. Notably, this component haplogroup is currently the most derived 
component haplogroup in the E1b1a clade, with an average frequency in south-east 
African groups in this study of 5.3%. 
In The History of the Chewa (Ntara S.M. 1973) it is noted that, based on many Chewa 
traditions, the Chewa migrated from the Congo to Malawi approximately 500 years 
ago. This was of course only one or two hundred years before the Spanish began 
importing slaves from the Congo to Columbia. The most parsimonious explanation of 
the observed data is therefore that while the Yombe are the most closely related group 
to the Palenque the Chewa are in turn also closely related to both the Palenque and the 
Yombe, but did not contribute to the Palenque NRY gene pool since they had 
migrated out of the area before slaves were transported by the Spanish to Colombia. 
Presumably the Chewa acquired NRY belonging to the E1b1a8a1a haplogroup by 
introgression after they reached Malawi. The absence of NRY belonging to 
haplogroup E1b1a8a1a in both Yombe and Palenque further strengthens the 
conclusion that Yombe (a Congolese group) is a more likely origin group than are the 
Chewa (a Malawian group). However, it must be recognised that even though this 
study suggests a paternal Yombe origin for Palenque, this does not contradict the 
possibility that slaves from other parts of Congo joined the Palenque community 
either at its foundation or subsequently but that they were not in such number or 
authority so as to introduce the widespread use of their language.
The extent of genetic drift observed in Palenque and the presence of the high-
frequency mtDNA haplotypes present in the Palenque in multiple sub-Saharan 
African groups at low frequencies made it impossible to suggest a candidate group as 
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the most likely origin of Palenque. This is consistent with the oral history of the group 
which makes no mention of a founding group of females. It is also consistent with 
restricted absorption of women into the community and the retention of their female 
offspring, both scenarios being likely to produce the pattern of mtDNA haplotypes 
observed (i.e., a restricted number of types and high frequencies of those that are 
present). Notably, unlike the pattern observed for paternal descent the overwhelming 
majority of present day residents have a sub-Saharan maternal African ancestry.
2.4.3. Conclusion
This study, following similar methods of analysis to others that seek to trace origins 
of Diaspora (Thomas et al. 1998; Thomas et al. 2000; Thomas et al. 2002; Goncalves 
et al. 2007), has shown that sex-specific genetic systems have the potential to identify 
origins of peoples who have migrated thousands of miles and to trace their ancestry to 
a geographic location with a reasonable level of confidence, provided appropriate 
markers and methods are selected for the analysis. 
The main findings of this study are:
1) The Palenque have substantial sub-Saharan African ancestry inherited along both 
the paternal and maternal lines. 
2) Yombe, a Congolese group, is the most likely group from which the original 
settlers of Palenque, who have left present day descendents, came. 
3) There is significant male-mediated genetic structuring distinguishing the two 
districts (Abajo and Arriba) of Palenque. 
4) The analyses are in accordance with hypotheses based on linguistic and historical 
data, which suggested a) African Yombe speaking escaped slaves founded Palenque 
and b) the two areas of the village, Abajo and Arriba, have different paternal histories. 
They do not support the hypothesis that the original inhabitants of Arriba are more 
likely to have been born in the Congo than was the case for the original inhabitants of 
Abajo.
2.5. Supplementary Section for Chapter 2 
Because of their large size, for Supplementary Tables 2.S1, 2.S2, 2.S3, 2.S4, 2.S5 and 
2.S6 please see attached CD-ROM. 
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3. Genetic evidence pertaining to routes taken 
during the expansion of Bantu-speaking peoples 
(EBSP)
3.1. Introduction
3.1.1. Linguistic and archaeological analysis of EBSP
In many parts of the world, including Africa, the early development of agriculture has 
triggered significant population growth resulting in the expansion of early farming 
populations along with the expansion of language families (Bellwood 2001). This is 
mainly due to the many advantages of agricultural subsistence over foraging and thus 
agriculturists and their languages expanded at a revolutionary pace during the 
Holocene era (Diamond and Bellwood 2003). One unequivocal example of this 
phenomenon in Africa is the expansion of Bantu-speaking peoples (EBSP), which is 
thought to have started around 5000 years ago (Vansina 1995). 
Figure 3.1. Suggested expansion routes taken during the expansion of the Bantu-speaking
peoples, based on linguistic analysis
(http://www.public.asu.edu/~csteiner/).
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Based on linguistic evidence, the region on the border between eastern Nigeria and 
Cameroon is thought to be the location of origin of proto-Bantu languages (Newman, 
1995) (see Figure 3.1). Initially, farmers expanded east from this region and within 
1,500 years reached West-Central Africa. After that the expansion took  two 
directions with one wave moving along the south-western coast (West-Bantu route) 
and the other moving further east, forming the eastern Bantu core by 3,000 years 
before present (YBP) and moving along the south-eastern coast (East-Bantu route) 
(Pereira et al. 2001). The Bantu language subgroup that covers most of sub-equatorial 
Africa is, consequently, just one of the 177 subgroups of the Niger-Congo family 
(Diamond and Bellwood 2003) yet comprises a third of the languages that make up 
the largest phylum in the world, with more than 200 million speakers (Nurse 2006). 
This level of linguistic homogeneity among geographically distant populations across 
sub-Saharan Africa supports the notion that a rapid expansion of agriculturists has 
taken place. Although Bantu languages are similar, due to the separation of the two 
major waves around 3,500 YBP and the subsequent isolation of the various speakers,
modern Bantu languages can be divided into West and East Bantu (Holden 2002; 
Jobling et al. 2004) (see Figure 3.2).
Within sub-Saharan Africa, areas that have not experienced significant levels of   
EBSP migration exhibit non-Bantu languages, which do not belong to the Niger-
Congo phylum. These languages are mainly the Khoisanid languages in the southwest 
and a few Cushitic and Nilo-Saharan tongues in the northeast (Nurse 2006). It is also 
suggested that although the Bantu-speaking agriculturists may have replaced the local 
hunter-gatherers in their path they have also, in some places, co-existed and 
intermarried with the original inhabitants. These indigenous peoples are thought to be 
related to Khoisan and modern pygmies (Diamond and Bellwood 2003).
Based on archaeological evidence, the early expansion of proto-Bantu speakers was 
based on pre-Iron Age farming technology and did not involve smelting metals 
(Vansina 1995). The first sign of metallurgy south of the Sahara was found at Nok in 
Nigeria no earlier than 2,500 YBP (Cavalli-Sforza et al. 1994). Therefore, it is 
possible that, with the aid of the new technology, further expansions may have 
occurred after the first dispersal of farmers towards the south. Since the Bantu 
languages on the eastern route are shown to be more homogeneous compared with the 
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western route (Excoffier et al. 1987), it is reasonable to suggest that further 
expansions have mainly occurred on the eastern route. 
Figure 3.2. Broad relationships of the languages of groups referred to in this chapter based on 
Ethnologue (2009). Branch lengths are not informative. 
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3.1.2. Genetic analysis of EBSP
Early genetic studies of Bantu-speaking peoples were based on classical gene 
frequency data. Attempts were made to identify the genetic relationships among 
EBSP groups in the context of Africa as a whole (Excoffier et al. 1987 and Cavalli-
Sforza et al. 1994). The major finding of these studies is that Genetic Distances (Fst) 
among all EBSP groups are much less than the average Fst among West African and 
Nilo-Saharan groups, indicating a considerable level of homogeneity among EBSP 
groups. More recently, based on over 1,300 autosomal markers, the genetic structure 
of African populations was analysed (Tishkoff et al. 2009). Results show that 
populations from areas affected by the EBSP exhibit a high level of genetic 
homogeneity, which is in good agreement with the findings of other recent studies 
(Verdu et al. 2009) and earlier studies mentioned above. 
The EBSP impact on African demography has, over the past decade, mainly been 
studied by analysing paternal and maternal sex-specific genetic systems (non-
recombining region of Y chromosome (NRY) and mitochondrial DNA (mtDNA)
respectively). As both NRY and mtDNA genetic systems have smaller effective 
population sizes than autosomal markers, they are more prone to genetic drift (Roever 
et al. 2000; Destro-Bisol et al. 2004; Wood et al. 2005). Therefore, utilising NRY and 
mtDNA are more likely to reveal differences among groups than single linked 
autosomal markers.
The control region of the mtDNA sequence, due to its high mutation rate, has been 
extensively used in examining the impact of EBSP on the genetic landscape of sub-
Saharan Africa (Pereira et al. 2001; Salas et al. 2002; Salas et al. 2004; Beleza et al. 
2005). It has been postulated that some mtDNA haplogroups (e.g., L3b, L3e and L2a), 
based on their distribution in sub-Saharan Africa, are associated with the EBSP. The 
presence of haplogroup L1c at high frequency in some populations on the western 
route compared with the eastern route is thought to be the result of assimilation of 
local female hunter-gatherers (Salas et al. 2002). It has been suggested that since most 
agriculturist men marry local women and not vice versa (Destro-Bisol et al. 2004; 
Wood et al. 2005), the maternal genetic profile of EBSP groups is marked by high 
haplogroup diversity. Despite this level of diversity, great homogeneity exists among 
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groups, which results in lack of genetic differentiation at the maternal level (Castri et 
al. 2009).
The increase in the rate of identification of slowly mutating NRY binary markers (i.e., 
Unique Event Polymorphisms (UEPs)) (Hammer et al. 1995, Underhill et al. 1997, 
Underhill et al. 2000) triggered many studies to investigate the paternally mediated 
genetic relationships of sub-Saharan African populations. Scozzari et al. (1999) and 
Underhill et al. (2001) found UEP (M2 and its analogues such as DYS271G) present 
at high frequencies specifically in sub-Saharan Africa and suggested this marker as a 
signature of EBSP. Since then, this marker (now defining the E1b1a haplogroup) has 
been widely typed in many groups across sub-Saharan Africa (Pereira et al. 2002, 
Cruciani et al. 2002, Beleza et al. 2005 and Coelho et al. 2009) and, without 
exception, all studies have shown that the majority of NRY types belong to this 
haplogroup. Although sampling in most NRY studies of sub-Saharan Africa has, in 
the past, been quite patchy in terms of geographic coverage and sample sizes, the 
distribution of this haplogroup is relatively well described in both major EBSP waves: 
southeast (Luis et al. 2004) and southwest (Coelho et al. 2009), and also in Senegal 
(Semino et al. 2002) and Cameroon (Cruciani et al. 2002, Luis et al. 2004) in West 
Africa.
Nevertheless, despite the considerable increase in the number of Y chromosome 
markers identified in recent years (Karafet et al. 2008) and the identification of further 
UEP within E1b1a (Sims et al. 2007), except E1b1a7 (M191; Underhill et al. 2001 
and Cruciani et al. 2002), this very frequent haplogroup has not been further 
characterised in sub-Saharan African populations. As the EBSP shows a clearer 
genetic legacy in the paternally inherited genetic system compared with mtDNA 
(evident from high and similar frequencies of E1b1a) in sub-Saharan Africa (Berniell-
Lee et al. 2009), it is possible that fine-scale E1b1a typing of Bantu-speaking
communities throughout sub-Saharan Africa can shed light on routes taken during 
their expansion.
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3.1.3. Aims
The main aims of this study are to investigate whether further characterisation of the 
NRY E1b1a haplogroup in 43 sub-Saharan African population groups with diverse 
linguistic affiliations (see Figure 3.2) would differentiate Bantu-speaking population 
groups and throw light on routes taken during the EBSP. Frequencies of haplogroups 
in different regions and variation in diversity of STR will be examined. Analysis of 
the distribution of diversity and estimates of the time to the most recent common 
ancestor (TMRCA) of UEPs defining clades of the E1b1a haplogroup have the 
potential to increase knowledge of the times when demographic events took place and 
the general location of those events. A secondary aim is to make an initial assessment 
of the potential for analysis of variation in mtDNA haplotypes to provide evidence of 
similar or different events to those suggested by NRY analysis.
3.2. Materials and Methods
3.2.1. Samples
Buccal swabs were collected from males over eighteen years old unrelated at the 
paternal grandfather level yet randomly selected from 43 locations across sub-Saharan 
Africa. These locations mainly cover West, Central-West, East, South-East and South 
Africa (see Table 3.1). All of the groups characterised in this study speak a Niger-
Congo language except for the Anuak in south-west Ethiopia (representative of East 
Africa), who speak a Nilo-Saharan language.
Table 3.1. Details of population groups included in this study 
Geographic 
location Population Group (Code)
Ethnic 
Identity Language Latitude Longitude N
Bankim (BA) Tikar Tikar 6.083 11.483 33
Foumban (FO) Bamoun Bamoun 5.729 10.902 117
Cameroon Wum (WU) Aghem Aghem 6.389 10.073 116
Bembe (BE) Bembe Bembe -4.795 11.846 109
Kuni (KU) Kuni Kuni -4.795 11.846 68
Lari (LA) Lari Lari -4.259 15.285 62
Mboshi (MB) Mboshi Mboshi -4.259 15.285 91
Sundi (SU) Sundi Sundi -4.259 15.285 25
Congo
Teke (TE) Teke Teke -4.259 15.285 63
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Vili (VI) Vili Vili -4.795 11.846 108
Yombe (YO) Yombe Yombe -4.432 12.108 65
Ethiopia Anuak (AN) Anuak Anuak 7.953 34.412 108
Asante (AS) Asante Akan 6.106 -1.878 94
Ewe (EW) Ewe Ewe 6.6 0.467 88
Ghana Fante (FA) Fante Akan 5.817 -2.817 60
Chewa (CH) Chewa Nyanja -13.607 33.918 92
Tumbuka (TU) Tumbuka Tumbuka -14.27 34.79 61
Malawi Yao (YA) Yao Yao -12.77 33.874 56
Mozambique Sena (SE) Multiple Sena -17.442 35.027 62
Abak (AB) Annang Annang 5.05 7.717 56
Afaha Eket (AE) Ibibio Ibibio 4.717 7.867 48
Afaha Okpo (AO) Oron Oron 4.833 8.233 50
Afaha Ukwong (AU) Oron Oron 4.75 8.25 49
Awa-Onna (AW) Ibibio Ibibio 4.69 7.815 28
Calabar (CA) Igbo Igbo 4.95 8.317 99
Ediene Ikono (ED) Ibibio Ibibio 4.783 7.883 48
Efut Akpabuyo (EF) Efik Efik 4.908 8.442 48
Efut Odukpani (EO) Efik Efik 5.167 7.983 49
Ejagham-Akamkpa (EA) Ekoi Ejagham 5.35 8.35 47
Ejagham-Calabar (EC) Ekoi Ejagham 4.95 8.317 83
Eziagu Nenwe (EZ) Igbo Igbo 6.117 7.517 49
Ikono (IK) Annang Annang 4.992 7.758 42
Itam (IT) Ibibio Ibibio 5.042 7.842 50
Nike Enugu (NE) Igbo Igbo 6.433 7.483 54
Nnung Ndem-Onna (NN) Ibibio Ibibio 4.633 7.85 48
Nsit (NS) Ibibio Ibibio 4.833 7.9 36
Ntan Ibiono (NT) Ibibio Ibibio 5.233 7.933 50
Obong Itam (OB) Ibibio Ibibio 5.133 7.967 50
Oku-Itu (OI) Ibibio Ibibio 5.133 7.933 49
Oku-Uyo (OU) Ibibio Ibibio 5.1 7.967 48
Ukpom Ete (UE) Ibibio Ibibio 4.62 7.65 50
Nigeria Uwanse (UW) Efik Efik 4.95 8.317 50
South Africa Bantu speakers-Pretoria (BN) Bantu Bantu -25.746 28.187 98
All buccal swabs were collected anonymously with informed consent. Sociological 
data were also collected from most individuals including age, current residence, 
birthplace, self-declared cultural identity, first language, second language and (when 
available) religion of the individual, as well as similar information on the individual’s 
father, mother, paternal grandfather and maternal grandmother. The samples were 
classified into groups primarily by cultural identity, first language spoken, then by 
place of collection. Where collections from a particular group were made in more than 
one location, locations are represented by averages of coordinates.
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DNA from Congolese samples was extracted using the Gentra protein precipitation 
method (Gentra Systems, Minneapolis) (see Appendix A). Previously collected buccal 
swab DNA samples from ethnic groups across sub-Saharan Africa were extracted by 
standard phenol-chloroform method. The range and mean of sample sizes of the 43 
groups are 28-118 and 63 respectively.
3.2.2. Y-chromosome typing
A combination of Unique Event Polymorphisms (UEP) and Short Tandem repeats 
(STRs) in the paternally inherited NRY was typed in eight Congolese groups (n = 
597). The polymorphic markers are six STRs (DYS19, DYS388, DYS390, DYS391, 
DYS392 and DYS393) and four UEPs (M191, U175, U290 and U181) characterising
the E1b1a haplogroup, which is modal in most population groups affected by the 
EBSP in sub-Saharan Africa (Underhill et al. 2001). The four UEPs were typed using 
a tetra primer ARMS PCR method (Ye et al. 2001), with minor modifications. The 
outer and two inner fragments were amplified in a 10-μl reaction volume containing 1
μl (~ 1 ng) of template DNA, 1.6 μl (50 μM) dNTPs, 9.3 nM TaqStartmonoclonal 
antibody (BD Biosciences Clontech, Oxford, UK), 1 μl of 10x Taq buffer, 0.13 units
of Taq DNA polymerase (HT Biotech, Cambridge, UK) and outer and inner primers 
(see Table 3.2 for primer details). All samples (96-well plates) were then placed on a 
thermocycler under the following conditions: denaturation at 95oC for 5 min, followed 
by 35 cycles of denaturation (95oC) for 45 s, annealing (see Table 3.2 for annealing 
temperatures) for 45 s and elongation (72oC) for 45 s. The final step of the PCR 
program was a 7-min extension at 72oC before a 30-min hold at 4oC. 
Where samples were not E1b1a (no derived alleles at the 4 UEP markers), a further 
six to eleven UEPs (TCGA UEP1 and UEP2 kits: sY81, SRY4064, YAP, SRY10831, 
M13, M9, SRY465, M20, Tat, 92R7 & M17) were typed (Thomas et al. 1999). NRY 
haplogroups were classified according to the nomenclature of the Y Chromosome 
Consortium (Karafet et al. 2008) and STR repeat sizes were assigned according to the
nomenclature of Kayser et al. (1997). 
Additionally, the four E1b1a-specific UEPs were also typed for previously 
characterised E1b1a samples in the TCGA database (unpublished data) from the other 
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35 sub-Saharan population groups (n = 1820) mentioned in Table 3.1. Although the 
battery of NRY markers typed in TCGA UEP kits gives a relatively crude resolution 
of NRY haplogroups, the typing of four UEP markers within E1b1a seems to 
considerably increase the resolution of NRY types associated with EBSP (Sims et al.
2007).
Table 3.2. Details of the primers used in the tetra-primer ARMS PCR reactions 
UEP Primer name Primer sequence (5'-3')
Melting 
temperature 
(
o
C)
Fragment   
size (bp)
Primer 
concentration 
(μM)
PCR 
annealing 
temperature 
(
o
C)
Outer forward primer AATACCAGGCCGACATGGCAGCTA 64.4 0.15
Outer reverse primer CTACAAGCACGTACCACAGCGCCA 66.1
399
0.15
Inner forward primer CATTTTTTTCTTTACAACTTGACCAG 56.9 133 0.75
M191 
T>G
Inner reverse primer CACACCAAAATATCTCATATTTTCGTA 57.4 318 0.75
61.5
Outer forward primer CCTTTAACACACTTCACAACATGG 59.3 0.3
Outer reverse primer GTGTCACTTTTCATTGTCTGG 55.9
274
0.3
Inner forward primer CCACAGGTGCTAATGAAATCG 57.9 106 0.3
U175 
G>A
Inner reverse primer ATGACCAGGAGAAGTCAAAAT 54.0 209 0.3
53.0
Outer forward primer GCTATTGGAGAGCCTCGCTGTG 61.0 0.15
Outer reverse primer AGGAAGCAATTTTCCTACCTGCCA 59.5
449
0.15
Inner forward primer GATAGGTGTGGGAATTGATGGCATT 58.3 193 0.75
U290 
T>A
Inner reverse primer GATGGCCATCAGTCCCCAGT 60.4 300 0.75
60.0
Outer forward primer GGTCTAGTGCACAGTGGTATCCA 57.1 0.15
Outer reverse primer AGAGCTCTCTCAAATCTGTGTTGG 57.5
389
0.15
Inner forward primer AGTGTCTTTGTTTTGGCAAGAAC 61.8 123 0.75
U181 
C>T
Inner reverse primer CTACCCTTGTATCAGAATACAGTTCTTA 61.7 316 0.75
62.0
3.2.3. mtDNA typing
The mtDNA HVR-1 region of all Congolese groups and Chewa (Malawi) was 
sequenced as described by Thomas et al. (2002), but with the following modification: 
primers conL1-mod, conL2 and conH3 were replaced by conL849 (CTA TCT CCC 
TAA TTG AAA ACA AAA TA), conL884 (TGT CCT TGT AGT ATA A) and 
conHmt3 (CCA GAT GTC GGA TAC AGT TC) respectively for better sequencing 
results. For all samples, HVR-1 Variable Site Only (VSO) haplotypes were 
determined by comparing generated HVR-1 sequences of nucleotide range 16020-
16400 with the Cambridge Reference Sequence (Anderson et al. 1981). It should be 
noted that Andrews et al. (1999) re-evaluated the mtDNA reference sequence by 
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resequencing the entire mtDNA sequence and found no discrepancies in the HVR-1 
region and therefore validated the use of the old sequence for the purposes of this 
study.
VSO haplotypes were defined by the type of occurring mutations (substitution, 
insertion or deletion) and their corresponding nucleotide positions. Haplogroups were 
classified based on the scheme of Salas et al. (2004) for samples of recent African 
ancestry. In order to extend the dataset, HVR-1 Variable Site Only (VSO) haplotypes 
were also determined for population groups previously typed in Nigeria, Ghana and 
Cameroon for the HVR-1 region (29 groups as shown in Table 3.1) (Veeramah et al. 
2010). Unpublished HVR-1 data generated for the Anuak were also included as a 
representative of East Africa. As the nucleotide range of these samples for the HVR-1 
region was 16023-16380, the HVR-1 coverage in Congolese samples was reduced to 
this range for comparisons with these groups. 
The chromatogram of each sample was visually inspected across its whole length of 
sequence to check for high levels of background noise that would make it difficult to 
call bases. Subsequently, if no significant trace of noise was found, the ends of the 
sequence were then trimmed down to the standard nucleotide range (16020-16400) by 
visually inspecting the sequence. A contig is then formed for each set of 96 samples 
(i.e., one sequencing run) and each mutation site was examined visually to determine 
whether it is a substitution, insertion or deletion. All samples with any ambiguous 
sites were resequenced again. 
3.2.4. Statistical analysis
Gene diversity, h, and its standard error were estimated from unbiased formulae of 
Nei (1987). Mean number of pairwise nucleotide differences were calculated for 
mtDNA HVR-1 sequences in each group. Population genetic structure was estimated 
using Hierarchical Analysis of Molecular Variance (AMOVA) (Excoffier et al. 1992),
which takes into account the evolutionary relationship between pairs of haplotypes 
and generates a statistic called Fixation Index (FST), when a simple structure of 
populations within a single group is defined. However, when a hierarchical structure 
is defined three fixation indices, FST (among all groups), FSC (among groups within a 
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geographic region) and FCT (among geographic regions), are generated. Patterns of 
genetic differentiation were quantified using the following genetic distance measures,
estimated from AMOVA based φ-st values (Excoffier et al. 1992 and Michalakis & 
Excoffier 1996): a) FST (Reynolds, Weir & Cockerham 1983) (based on UEP 
haplogroups and mtDNA HVR-1 VSO haplotypes) and b) the Kimura’s two-
parameter model with gamma distribution of value 0.47 (Kimura 1980) (based on 
mtDNA HVR-1 sequences). Significance of Fixation Indices and genetic distances 
were assessed by permutation test where a null distribution is formed by calculating 
all possible values under rearrangements of haplotypes in the observed samples. The 
permutation test was repeated over 1,000 times to give rise to the null distribution. All 
the above was performed using Arlequin software version 3.0 (Excoffier et al. 2005). 
Principal Component Analysis (PCA) biplot was performed using the ‘R’ 
environment of statistical computing (www.R-project.org), by implementing the 
‘princomp’ function based on E1b1a component haplogroup frequencies and 
visualised using the ‘biplot’ function. The plot was used to visualise relationships 
among groups and identify clusterings with respect to the categorical variable (i.e., 
E1b1a component haplogroups). Average Squared Distances (ASD) were calculated 
in MS Excel and corresponding 95% confidence intervals were calculated as in 
Thomas et al. (1998) using ‘R’. Time to Most Recent Common Ancestor (TMRCA) 
was estimated using an average NRY STR mutation rate of 0.002 (Veeramah et al. 
2010) and generation time of 25 years. 
3.3. Results and Discussion 
3.3.1. NRY distribution in sub-Saharan Africa
Based on TCGA UEP1 and UEP2 kits, 13 NRY haplogroups can be defined. In the 
present dataset (n = 2,757) eight haplogroups were present, with E1b1a being modal 
across all groups (see Table 3.3). This haplogroup was in the range of 38.9-95.7%, 
with mean of 85.2 % and variance of 0.9%.  The pattern of NRY observed in these 43 
groups is in accordance with previously published data on sub-Saharan Africa 
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(Underhill et al. 2001; Cruciani et al. 2002; Wood et al. 2005; Luis et al. 2004; 
Berniell-Lee et al. 2009). One other major haplogroup observed in most groups is 
E*(xE1b1a), which is found at high frequencies north of the Sahara (Bosch et al. 
2001; Arredi et al. 2004), consistent with gene flow across the Sahara into sub-
Equitorial Africa. 
Table 3.3. Haplogroup frequencies in 43 sub-Saharan African population groups
NRY UEP Haplogroup 
(according to the 
nomenclature of the Y-
chromosome consortium
(2008))
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Bembe (BE) 0.018 0.110 0.018  0.853
a
Kuni (KU) 0.044 0.074 0.015 0.868
Lari (LA) 0.032 0.113 0.855
Mboshi (MB) 0.011 0.044 0.033 0.912
Sundi (SU) 0.040 0.080 0.880
Teke (TE) 0.032 0.063 0.079 0.016 0.810
Vili (VI) 0.009 0.028 0.019 0.944
Yombe (YO) 0.015 0.046 0.092 0.031 0.815
Congo Total 0.012 0.034 0.066 0.012 0.003 0.873
Foumban (FO) 0.085 0.043 0.009 0.009 0.855
Bankim (BA) 0.030 0.061 0.061 0.848
Wum (WU) 0.043 0.957
Cameroon Total 0.004 0.064 0.026 0.004 0.004 0.898
Asante (AS) 0.043 0.053 0.904
Fante (FA) 0.033 0.017 0.017 0.933
Ewe (EW) 0.023 0.023 0.045 0.909
Ghana Total 0.017 0.008 0.037 0.025 0.913
Chewa (CH) 0.076 0.130 0.011 0.022 0.761
Tumbuka (TU) 0.082 0.098 0.016 0.016 0.787
Yao (YA) 0.196 0.071 0.732
Malawi Total 0.110 0.105 0.010 0.014 0.761
Abak (AB) 0.054 0.036 0.911
Afaha Eket  (AE) 0.125 0.042 0.833
Afaha Okpo (AO) 0.020 0.060 0.020 0.900
Afaha Ukwong  (AU) 0.102 0.020 0.020 0.857
Awa-Onna (AW) 0.179 0.036 0.786
Calabar (CA) 0.071 0.010 0.010 0.010 0.899
Ediene Ikono  (ED) 0.125 0.063 0.813
Efut Akpabuyo  (EF) 0.021 0.188 0.021 0.771
Efut Odukpani  (EO) 0.061 0.041 0.898
Ejagham-Akamkpa (EA) 0.021 0.085 0.043 0.851
Ejagham-Calabar  (EC) 0.024 0.060 0.024 0.892
Eziagu Nenwe (EZ) 0.041 0.959
Ikono (IK) 0.167 0.024 0.810
Itam (IT) 0.040 0.020 0.940
Nike Enugu (NE) 0.056 0.019 0.019 0.907
Nnung Ndem-Onna  (NN) 0.021 0.021 0.021 0.938
Nsit (NS) 0.056 0.028 0.917
Ntan Ibiono (NT) 0.080 0.020 0.900
Obong Itam  (OB) 0.020 0.100 0.040 0.020 0.020 0.800
Oku-Itu (OI) 0.122 0.878
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Oku-Uyo  (OU) 0.042 0.063 0.896
Ukpom Ete  (UE) 0.080 0.040 0.020 0.860
Uwanse (UW) 0.100 0.020 0.880
Nigeria Total 0.004 0.082 0.027 0.001 0.003 0.005 0.877
Bantu speakers-Pretoria (BN) 0.153 0.051 0.010 0.031 0.755
Sena (SE) 0.081 0.129 0.790
Anuak (AN) 0.250 0.167 0.194 0.389
Grand Total 0.006 0.075 0.051 0.001 0.008 0.002 0.010 0.847
a Modal haplogroups are shown in bold type
Furthermore, 7.5% of all samples belong to the broad haplogroup BT*(xDE, KT), 
which reaches high frequency on the eastern coast of Africa from Ethiopia to South 
Africa (see Table 3.3). This haplogroup is present at higher frequencies in Europe 
(Scozzari et al. 2001 and Weale et al. 2002) and Asia (Weale et al. 2001) and may 
have entered Africa through back-migration. NRY haplogroup P*(xR1a) is most 
frequent outside Africa and reaches high frequency in West Europe (Weale et al. 
2002; Adams et al. 2008). Therefore, the sporadic presence of this haplogroup in 
groups located in West-Central Africa (see Table 3.3) is also thought to be the result 
of back-migration into Africa (Cruciani et al. 2002). As the haplogroups mentioned 
above (except E1b1a) are mostly broad paragroups, no inferences were made based 
on their frequency distributions since it could result in conclusions which could be 
misleading (Weale et al. 2003).
In-depth analysis of appropriate NRY haplogroups has been shown to be informative 
in understanding the peopling of a continent (Di Giacomo et al. 2004). Since E1b1a is 
modal in all groups investigated in this study (see Table 3.3) and also extensively 
reported to be associated with the EBSP (Underhill et al. 2001; Cruciani et al. 2002; 
Pereira et al. 2002; Berniell-Lee et al. 2009), this study was directed to the analysis of
samples belonging to the E1b1a haplogroup (E1b1a dataset; n =2,336, 84.7% of 
original samples), which were genotyped to assign chromosomes to the component 
haplogroups of E1b1a.
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3.3.2. Further characterisation of the E1b1a haplogroup
A further four UEP within E1b1a (see Figure 3.3) were typed in the E1b1a dataset 
samples in a hierarchical manner (see Table 3.4). These UEP cover most of the 
internal diversity within the E1b1a haplogroup observed in the HapMap Build 36 
Yoruba (YRI) dataset (www.hapmap.org) and a population of African Americans 
(Sims et al. 2007).
Figure 3.3. Phylogenetic tree of E1b1a component haplogroups characterised in this study.
Nei’s Gene diversity, based on E1b1a component haplogroups, for the whole set was 
0.678 ± 0.007. Except for Anuak, where all samples are E1b1a7 (h = 0), gene 
diversity ranged from 0.379-0.753 in individual groups (mean of 0.645 and variance 
of 0.007), with Foumban and Fante having the lowest and highest values respectively. 
This indicates that, although population groups in sub-Saharan Africa all have a high 
frequency of E1b1a, there is considerable internal variation within this haplogroup 
(see Figure 3.4), which potentially allows the groups to be differentiated analysing 
only the E1b1a dataset.
The modal STR haplotype (comprised of six STR loci) in 36 groups was the EBSP 
modal STR haplotype (15-12-21-10-11-13) (Thomas et al. 2000; Pereira et al. 2002), 
with a frequency range of 0.143-0.396, a mean of 0.233 and variance of 0.004. In the 
other seven groups (Anuak, Bankim, Foumban, Sena, Sundi, Vili and Wum) the 
EBSP modal haplotype had a frequency range of 0.024-0.147 and the modal 
haplotype a range of 0.143-0.667, one to four mutation steps away from the EBSP 
modal STR haplotype.
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Figure 3.4. Visual representation of E1b1a component-haplogroup distributions in sub-
Saharan African populations.
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Table 3.4. Frequency distribution of five E1b1a component haplogroups defined in this study.
NRY UEP Haplogroup 
(according to the 
nomenclature of the Y-
chromosome consortium
(2008))
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a
Bembe (BE) 0.043  0.376
a
0.247 0.333
Kuni (KU) 0.017 0.593 0.186 0.203
Lari (LA) 0.566 0.208 0.226
Mboshi (MB) 0.482 0.313 0.205
Sundi (SU) 0.045 0.682 0.227 0.045
Teke (TE) 0.529 0.275 0.196
Vili (VI) 0.059 0.529 0.265 0.147
Yombe (YO) 0.038 0.340 0.453 0.170
Congo Total 0.027 0.492 0.273 0.207
Bankim (BA) 0.429 0.214 0.179 0.179
Foumban (FO) 0.080 0.780 0.080 0.060
Wum (WU) 0.027 0.649 0.324
Cameroon Total 0.096 0.653 0.054 0.197
Asante (AS) 0.271 0.341 0.118 0.271
Ewe (EW) 0.125 0.463 0.113 0.300
Fante (FA) 0.321 0.268 0.179 0.232
Ghana Total 0.231 0.367 0.131 0.271
Chewa (CH) 0.057 0.314 0.386 0.171 0.071
Tumbuka (TU) 0.042 0.521 0.292 0.104 0.042
Yao (YA) 0.098 0.439 0.341 0.073 0.049
Malawi Total 0.063 0.409 0.346 0.126 0.057
Abak (AB) 0.059 0.392 0.118 0.176 0.255
Afaha Eket  (AE) 0.125 0.425 0.050 0.150 0.250
Afaha Okpo (AO) 0.022 0.511 0.067 0.089 0.311
Afaha Ukwong  (AU) 0.048 0.476 0.119 0.167 0.190
Awa-Onna (AW) 0.636 0.227 0.136
Calabar (CA) 0.067 0.528 0.135 0.112 0.157
Ediene Ikono  (ED) 0.103 0.590 0.051 0.103 0.154
Efut Akpabuyo  (EF) 0.162 0.568 0.054 0.054 0.162
Efut Odukpani  (EO) 0.023 0.500 0.159 0.091 0.227
Ejagham-Akamkpa (EA) 0.025 0.500 0.100 0.325 0.050
Ejagham-Calabar  (EC) 0.027 0.581 0.054 0.216 0.122
Eziagu Nenwe (EZ) 0.298 0.489 0.021 0.106 0.085
Ikono (IK) 0.529 0.206 0.176 0.088
Itam (IT) 0.085 0.553 0.064 0.128 0.170
Nike Enugu (NE) 0.020 0.755 0.082 0.143
Nnung Ndem-Onna  (NN) 0.044 0.600 0.067 0.267 0.022
Nsit (NS) 0.030 0.394 0.121 0.273 0.182
Ntan Ibiono (NT) 0.044 0.422 0.178 0.156 0.200
Obong Itam  (OB) 0.600 0.075 0.175 0.150
Oku-Itu (OI) 0.581 0.116 0.116 0.186
Oku-Uyo  (OU) 0.047 0.442 0.093 0.233 0.186
Ukpom Ete  (UE) 0.070 0.558 0.163 0.116 0.093
Uwanse (UW) 0.068 0.523 0.068 0.068 0.273
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Nigeria Total 0.061 0.529 0.092 0.153 0.165
Bantu speakers-Pretoria 
(BN) 0.081 0.338 0.378 0.095 0.108
Sena (SE) 0.204 0.388 0.347 0.041 0.020
Anuak (AN) 1.000
Grand Total 0.076 0.509 0.162 0.172 0.081
a Modal sub-haplogroups within E1b1a are shown in bold type
Note: Where a haplogroup is absent (frequency of zero), the corresponding cell is shaded in grey.
Notably, when haplotypes were defined by both UEP and STR markers combined the 
EBSP modal haplotype was observed almost exclusively within the E1b1a8 clade 
(i.e., the sum of E1b1a8*, E1b1a8a1* and E1b1a8a1a) rather than E1b1a7 (Fisher’s 
exact test p-value << 0.00001). This finding is consistent with the scarcity of the 
EBSP modal haplotype in the seven groups mentioned above since they have a much 
smaller E1b1a8 proportion than any other group in this study.
3.3.3. Can geographic regions in sub-Saharan Africa and individual population 
groups within them be differentiated based on E1b1a UEP markers?
The AMOVA based global fixation index (FST) for the E1b1a dataset (43 groups) was 
0.0694 and highly significant (P<0.0001), displaying substantial genetic heterogeneity 
among population groups. 
Principal component analysis biplot was performed to identify population structuring 
in sub-Saharan Africa, based on all individual population groups (see Figure 3.5). On 
the basis of the first two dimensions, which capture 72% of variation, populations 
were grouped into four major clusters corresponding to Nigerian, Ghanaian, 
Congolese and South-East African groups. 
In constrast, Cameroonian groups did not show any clustering. The main determinants
(explanatory variables) of these clusterings were the E1b1a component haplogroups, 
except E1b1a8a1*. Among the four clusters, Congolese and South-East African 
groups showed the highest level of similarity (based on E1b1a8* frequency). 
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Groups clustered based on E1b1a* were mainly Ghanaian, whereas groups clustered 
based on E1b1a8a1a were mainly Nigerian. Furthermore, based on the defined E1b1a 
component haplogroups, a considerable degree of inter-population diversity is also 
observed within clusters.
Figure 3.5. PCA biplot of 43 sub-Saharan African population groups based on E1b1a 
component haplogroups. 
Note: Percentages in parentheses are the amount of variation explained by each principal component.
Cameroonian groups are indicated by a blue underline.
Groups were then analysed in separate groupings, based on the geographic clusters 
observed, and AMOVA based fixation indices (FST) were estimated (see Table 3.5). 
The low figures of FST observed in four geographic regions are consistent with either 
a recent common origin or high inter-group gene flow. The large significant Fst value 
in Cameroon is consistent with the observation in the PCA biplot.
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Furthermore, the level of genetic structure was also examined among the geographic 
groupings in a pairwise manner (see Table 3.6). All pairwise distances were highly 
significant (P < 0.0001) and population structuring was evident. In particular, Anuak 
had the highest degree of differentiation from all other groupings (Fst > 0.163).
Table 3.5. AMOVA fixation indices in five geographic regions in sub-Saharan Africa
Geographic 
location
AMOVA FST P-value
Ghana (n = 3) 0.016 0.038
Nigeria (n = 23) 0.014 0.002
Cameroon (n = 3) 0.177 <0.0001
Congo (n = 8) 0.019 0.003
South East Africa*   
(n = 5)
0.004 0.234
Significant P-values at the 5% level are shown in bold type. *This region includes the following 
groups: CH, TU, YA, SE and BN.
It should be noted from other studies that the Anuak are not to be considered 
representative of Ethiopia (Browning 2009). The main body of the Anuak live in 
southern Sudan. They were included in this study because they are an eastern Africa 
Nilo-Saharan speaking people with a considerable proportion of E1b1a chromosomes.
Table 3.6. AMOVA-based fixation indices (FST) among geographic locations and P-values.
CAM CON ETH GHA NIG SE
CAM <0.0001 <0.0001 <0.0001 <0.0001 <0.0001
CON 0.060 <0.0001 <0.0001 <0.0001 <0.0001
ETH 0.163 0.266 <0.0001 <0.0001 <0.0001
GHA 0.082 0.056 0.359 <0.0001 <0.0001
NIG 0.034 0.048 0.193 0.068 <0.0001
SE 0.127 0.025 0.346 0.065 0.072
Lower left triangle reports AMOVA-based FCT values and the upper right triangle reports the 
corresponding P-values. a Abbreviations for the geographic regions are : CAM: Cameroon, CON: 
Congo, GHA: Ghana, NIG: Nigeria, SE: South East Africa and ETH: Ethiopia.
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Overall, the FST results suggest that, based on UEP variation within E1b1a, there is an 
affinity between the West African and South East African groupings, which cover an 
area that includes both the proposed place of origin and of expansion of the Bantu-
speaking peoples.
Table 3.7 records the presence or otherwise of the component haplogroups of E1b1a 
in the different regions of sub-Saharan Africa. While the Anuak of Ethiopia only 
displayed haplogroup E1b1a7 all the haplogroups were represented in Nigeria and the 
three south east African sample sets (Malawi, Mozambique and South Africa). 
Notably, Ghana, Cameroon and Congo all lacked haplogroup E1b1a8a1a.
3.3.4 Estimating TMRCA of the clade-defining UEPs
The TMRCA for each clade defining UEP was estimated based on ASD  since 
TMRCA and ASD have a linear relationship with mutation rate as the constant (ASD 
= μt) (Thomas et al. 1998). They are recorded in Table 3.7 and are completely 
consistent with the genealogy in Figure 3.3, with the most recent dates associated with 
the finer branches. The TMRCA for the UEP defining the entire E1b1a clade was 
estimated at between 6,200-6,600 YBP which is more than a millennium before the 
proposed start of the EBSP (Berniell-Lee et al. 2009). 
The TMRCA for E1b1a7 was estimated at between 4,800 – 5,300YBP, in good 
agreement with the linguistically-based time of the commencement of the EBSP. This 
component haplogroup was modal in 38 groups across sub-Saharan Africa, with the 
highest frequencies observed in Foumban (Cameroon), Nike Enugu (Nigeria) and 
Anuak (Ethiopia). Overall, the data are consistent with the M191 mutation initially 
appearing around 5,000YBP in present day Nigeria, since the highest STR gene 
diversity was observed in this region (h = 0.931).
TMRCA for the E1b1a8 clade was estimated at 1,900 – 2,200YBP, which is very 
similar to the earlier estimate by Veeramah et al. (2010). Since this clade is 
widespread across many areas of sub-Saharan Africa (especially west of Nigeria in 
Ghana) and the highest STR gene diversity was found in Nigeria (h = 0.885), it is 
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likely that the U175 mutation arose in this area about 2,000 YBP and expanded both 
west and south. The wide distribution of E1b1a8 suggests that the expansion of the 
U175 mutation took place rapidly, which may be a consequence of the development 
of metallurgy in the region around 2,500 YBP (Cavalli-Sforza et al. 1994), initiating a 
further expansion of people, this time with some carrying the U175 mutation. 
With respect to people belonging to sub-haplogroup E1b1a8* (only carrying the U175 
mutation and not U290, U181 or both), the data indicate a substantial presence in all 
regions (>40% excluding Cameroon, 25.1% Cameroon). The TMRCA of the U290 
mutation (defining the E1b1a8a1 clade) was dated to between 1,400 – 1,700 YBP. 
This mutation is also widespread, falling below 20% only in the Sena dataset 
representing Mozambique. 
The TMRCA for U181, which is diagnostic of the most derived element of the E1b1a 
clade, component haplogroup E1b1a8a1a, characterised in this study, was estimated at 
1,100 – 1,600 YBP. Interestingly, unlike the other E1b1a component haplogroups, 
E1b1a8a1a did not have a widespread presence in sub-Saharan Africa and was only 
found in groups located in Nigeria and south-east Africa. Based on STR gene 
diversity within E1b1a8a1a (Nigeria (h = 0.626) and South East Africa (h = 0.399)), it 
is more likely that this haplogroup originated in Nigeria than in South East Africa. 
Therefore, the data support an interpretation that men with NRY of the E1b1a8a1a 
haplogroup initially migrated east and then southwards on the eastern coast. It is 
unlikely that they would have taken a western route without leaving representatives of 
this haplogroup in the sample sets from Congo. The haplogroup appears to have a 
recent origin and NRY belonging to it have expanded at a very high rate of about 
90km per generation (i.e., ~ 5000km in 55 generations) along the eastern route. 
Finally, the results also suggest that significant NRY flow from the eastern coast to 
the west coast is unlikely during the past 1,000 years or so since if it had occurred, the 
presence of E1b1a8a1 NRY on the western coast would be expected. The association 
of the eastern route with haplogroup E1b1a8a1a could be further examined by typing 
samples from Kenya and Tanzania in East Africa, where the E1b1a haplogroup has 
been reported as modal (Luis et al. 2004). 
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Table 3.7. Details of E1b1a UEP internal diversity, estimated TMRCA dates and distribution of E1b1a component haplogroups in sub-Saharan Africa along 
with STR gene diversity within component haplogroups.
Geographic presence and gene diversity
West Africa
West Central 
Africa East Africa
South East 
Africa
Clade 
defining 
marker
Gene 
Diversity 
(h) (SD)
ASD (95% CI)
TMRCA 
(YBP)
Haplogroup(s)
Ghana Nigeria Cameroon Congo Ethiopia Total
E1b1a* a YES YES YES YES NO YES
E1b1a7 YES YES YES YES YES YES
E1b1a8* YES YES YES YES NO YES
E1b1a8a1* YES YES YES YES NO YES
sY81
0.925 
(0.003)
0.510 
(0.494-0.527)
6,175-6,588
E1b1a8a1a NO YES NO NO NO YES
M191
0.920 
(0.003)
0.404 
(0.384-0.424)
4,800-5,300
E1b1a7
YES (h=0.879) YES (h=0.931) YES (h=0.888) YES (h=0.875) YES (h = 0.516) YES (h=0.911)
E1b1a8* YES (h=0.874) YES (h=0.885) YES (h=0.846) YES (h=0.799) NO YES (h=0.784)
E1b1a8a1* YES YES YES YES NO YESU175
0.775 
(0.014)
0.161 
(0.149-0.173)
1,863-2,163
E1b1a8a1a NO YES NO NO NO YES
E1b1a8a1* YES (h=0.781) YES (h=0.606) YES (h=0.802) YES (h=0.584) NO YES (h=0.763)
U290
0.679 
(0.021)
0.125 
(0.113-0.138)
1,413-1,725
E1b1a8a1a NO YES NO NO NO YES
U181
0.608 
(0.040)
0.109
(0.088-0.131)
1,100-1,638 E1b1a8a1a NO YES (h=0.626) NO NO NO YES (h=0.399)
a Since E1b1a* is a paragroup and making inferences based on its distribution may be misleading, STR gene diversity values were not calculated.
81
3.3.5. The distribution of mtDNA haplotypes across sub-Saharan Africa
The HVR-1 region of mtDNA was sequenced in a total of 683 samples from eight 
Congolese groups and Chewa in Malawi. HVR-1 sequencing data for 29 groups 
representing Cameroon (n =3), Ghana (n =3) and Nigeria (n = 23) were taken from 
Veeramah et al. (2010) and HVR-1 data for Anuak (Ethiopia) was taken from the 
TCGA database (unpublished data). Although assignments to mtDNA haplogroups 
have been made based only on the HVR-1 sequence (Richards et al. 1998), this was 
not done in this study because there are reports that such assignments are not robust
(Torroni et al. 2000). However, in another study of over 300 samples from Ethiopian 
groups in which both the HVR-1 sequence and 23 haplotype-defining markers from 
the coding region were typed only one case of homoplasy of the HVR-1 sequence 
across haplogroups was observed and that involved two phylogenetically closely 
related clades (unpublished PhD thesis in preparation, Plaster 2010). The analysis in 
this section is based on HVR-1 sequences without imputation of haplogroups. In the 
entire dataset, a total of 792 VSO haplotypes were identified, of which 477 were 
singletons (60.2%) while the modal haplotype represented 0.03 of the total. Nei’s 
gene diversity for the whole dataset was very high (h = 0.994 ± 0.0003). Nei’s gene 
diversity in the various datasets ranged from 0.968-0.997, with a mean of 0.987 and 
variance of 0.00005. The range of gene diversity observed in these groups is very 
similar to those observed previously in sub-Saharan African groups (Salas et al. 2002; 
2004). Mean number of pairwise nucleotide differences (π) in the whole dataset was 
8.85 ± 4.08 and ranged from 6.69 - 9.98 in individual groups, with a mean of 8.68 and 
variance of 0.55. 
Of the 315 haplotypes that were not singletons only 45 were represented by 10 or 
more samples (see Table 3.8). Of these only one, a singleton, was observed in the 
South East Africa dataset but not in the Congo and all but two haplotypes were 
observed in the West African dataset (Ghana, Nigeria and Cameroon).  Two of the ten 
or more mtDNA haplotypes were observed only in the Congo dataset (see Table 3.8). 
There were two non-singleton haplotypes (n=7, ~10%) observed in the South East 
African dataset that were not seen in any of the other datasets.  
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AMOVA-based fixation indices (FST, FSC and FCT) were estimated, based on the six 
geographic regions defined earlier, using VSO haplotypes. The fixation index FST
(among population groups) was very low (0.0088), yet highly significant (p < 0.0001).
The values of fixation indices FCT (0.0054, p < 0.0001) and FSC (0.0034, p < 0.0001) 
indicate that more genetic variation is present among the defined geographic regions 
than among groups in a single region. When the fixation indices were computed based 
on Kimura’s 2P (K2P) distance (using HVR-1 sequences), the variation among groups 
(FST) increased to 0.027 (p < 0.0001). According to the results, most of the variation 
was found to be among the geographic regions (FCT = 0.023, p < 0.0001) rather than 
within each region (FSC = 0.004, p < 0.0001). The higher level of differentiation 
observed is probably due to the incorporation of the phylogenetic relationship of 
sequences (with the correction of nucleotide substitution rates for transitions and 
transversions) by K2P, which VSO haplotypes do not take into account. 
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Table 3.8. VSO haplotypes of ten or more total counts in different regions of sub-Saharan Africa.
East Africa South East Africa
Ethiopia MalawiVSO haplotype Total West Africa Total Congo
AN CH
Grand total
126C, 187T, 189C, 223T, 264T, 270T, 278T, 293G, 311C, 65 9 74
126C, 187T, 189C, 223T, 264T, 270T, 278T, 311C, 38 7 1 46
129A, 209C, 223T, 292T, 295T, 311C, 41 3 44
223T, 278T, 294T, 309G, 37 4 3 44
172C, 183C, 189C, 223T, 320T, 35 7 42
129A, 148T, 168T, 172C, 187T, 188G, 189C, 223T, 230G, 311C, 320T, 31 6 3 1 41
223T, 327T, 28 5 5 38
223T, 265T, 20 12 4 36
124C, 223T, 278T, 362C, 28 5 1 1 35
223T, 320T, 30 2 32
189C, 192T, 223T, 278T, 294T, 309G, 21 10 31
124C, 223T, 278T, 311C, 362C, 24 6 30
148T, 172C, 187T, 188G, 189C, 223T, 230G, 311C, 320T, 2 15 2 11 30
189C, 223T, 278T, 294T, 309G, 28 1 29
172C, 189C, 223T, 320T, 24 2 26
129A, 148T, 168T, 172C, 187T, 188G, 189C, 223T, 230G, 278T, 293G, 311C, 320T, 8 14 3 25
223T, 278T, 286T, 294T, 309G, 15 7 3 25
92C, 223T, 278T, 286T, 294T, 309G, 18 3 21
114A, 129A, 213A, 223T, 278T, 354T, 16 4 20
209C, 223T, 292T, 311C, 20 20
129A, 145A, 187T, 189C, 213A, 223T, 265C, 278T, 286G, 294T, 311C, 360T, 19 19
223T, 278T, 294T, 309G, 368C, 18 1 19
209C, 223T, 311C, 5 13 18
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129A, 187T, 189C, 223T, 274A, 278T, 293G, 294T, 311C, 360T, 17 17
223T, 311C, 320T, 16 1 17
129A, 187T, 189C, 223T, 265C, 278T, 286G, 294T, 311C, 360T, 12 4 16
38G, 86C, 129A, 187T, 189C, 223T, 278T, 284G, 293G, 294T, 311C, 360T, 16 16
92C, 223T, 278T, 294T, 309G, 14 2 16
93C, 148T, 172C, 187T, 188G, 189C, 223T, 230G, 311C, 320T, 6 9 1 16
124C, 223T, 15 15
185T, 223T, 311C, 327T, 2 13 15
124C, 183C, 189C, 223T, 278T, 304C, 311C, 14 14
124C, 223T, 256T, 368C, 11 3 14
51G, 223T, 264T, 5 5 3 13
93C, 223T, 265T, 11 2 13
114A, 129A, 213A, 223T, 278T, 355T, 362C, 10 2 12
129A, 223T, 278T, 294T, 309G, 12 12
209C, 218T, 223T, 292T, 311C, 9 3 12
223T, 264T, 278T, 9 3 12
129A, 148T, 172C, 187T, 188G, 189C, 223T, 230G, 311C, 320T, 1 10 11
223T, 278T, 294T, 7 4 11
129A, 187T, 189C, 214T, 223T, 265C, 278T, 286A, 291T, 294T, 311C, 360T, 1 9 10
189C, 192T, 223T, 278T, 294T, 10 10
189C, 192T, 223T, 278T, 294T, 362C, 10 10
93C, 124C, 223T, 278T, 362C, 1 6 1 2 10
Total 749 242 7 39 1037
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3.3.6. Conclusion
This study demonstrates that large, anthropologically well defined sample sets from 
groups in sub-Saharan Africa, along with the right choice of markers, can shed light 
on past demographic events and the distribution of human genetic diversity in this 
region. Based on a) typing four informative UEPs within the NRY E1b1a clade in 
over 2,300 samples from multiple regions, b) analysing frequencies of the 
haplogroups in the different regions of the continent and STR diversity within the 
haplogroups and c) estimating TMRCAs of clade-defining UEPs, a pattern was 
revealed consistent with: a) multiple waves of migration from West Africa 
southwards, b) a later migration with rapid gene-flow southward along the eastern 
side of Africa, independent of earlier migration on the western side and c) the absence 
of substantial east to west NRY gene flow in sub-Saharan Africa over the past 
millennium. It is noteworthy that estimates of TMRCA for each defining UEP were 
consistent with the genealogy. Also consistent with the above interpretation is the 
observation that Nigeria and Cameroon displayed the highest E1b1a STR diversity of 
any region, as would be expected if this region is, as suggested by linguistic and 
archaeological evidence, the birthplace of the EBSP. 
Analysis of mtDNA HVR-1 haplotypes on the other hand provides no evidence of 
multiple waves of maternally mediated gene flow (nor does it support an argument 
that such events did not occur). However, this genetic system does provide evidence 
of significant inter-regional variation and probable recruitment of local women into 
the migrating wave of Bantu speakers (based upon observations of mtDNA 
haplotypes in significant numbers present in Congo (>20%) and Mozambique (10%) 
that were not seen in a large West African dataset.
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4. The CASP12 stop-codon and its route out of 
Africa
4.1. Introduction
4.1.1. Evolution of CASP12 gene 
Human caspases are a family of cysteine proteases involved in inflammatory immune 
response and apoptosis (Fischer et al. 2002; Saleh et al. 2004; Yeretssian et al. 2009). 
Phylogenetically, the Caspase-12 gene (CASP12) has been grouped with the genes 
encoding caspases-1, 4 and 5 (CASP1, CASP4 and CASP5), which are all involved in 
inflammatory cytokine production. Although its orthologue in mice has been found to 
be involved in endoplasmic reticulum stress-mediated apoptosis (Nakagawa et al. 
2000), the mutation at the third position of the SHG box in human Caspase-12 
(G205S) excludes the possibility of such activity (Fischer et al. 2002 and Lamkanfi et 
al. 2004).
At the genic level, human CASP12 is found on chromosome 11q22.3 and the highest 
expression level is found in the lung (Fischer et al. 2002). The longest transcript was 
found to be 1401bp in length, comprised of eight exons. However, this transcript was 
only found to be expressed at low levels, while the majority of transcripts were found 
to be shorter, mainly lacking exon 3. Moreover, all the transcripts missing exon 3 
were found to have a premature stop-codon in exon 4 (rs497116), resulting in the 
formation of a truncated CASP12 protein. Therefore, it was thought that due to this 
nonsense mutation, CASP12 was not functional in humans (Fischer et al. 2002). 
However, further characterisation of this gene in more samples from diverse 
populations showed that a full length allele (active) also exists and is present at a 
frequency of 11.4% in individuals with African ancestry from South Africa (n =153) 
and 10.8% in African Americans (n = 623), whereas European-descent (n = 187) and 
Asian (n = 160) samples only exhibited the stop-codon allele (Saleh et al. 2004). The 
frequency distribution of the truncated allele was examined in more population groups 
within and outside Africa and a similar pattern was observed where the active variant 
was at high frequency in sub-Saharan Africa and only sporadically found outside 
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Africa (Kachapati et al. 2006; Xue et al. 2006). In addition, based on diversity indices, 
it was shown by Xue et al. (2006) that the active variant is the ancestral state of 
CASP12 and the stop-codon had occurred on its background rather than the earlier 
notion that a reverse mutation had abolished the stop-codon allele in some individuals 
resulting in the full length allele (Kamfanki et al. 2004). Using the phylogeny based
time to the most recent common ancestor (TMRCA) method (Bandelt 1999), the SNP 
creating the stop-codon was estimated to have occurred over 100,000 years ago, prior 
to the expansion of anatomically modern human out of Africa (Xue et al. 2006). It 
was also suggested that the worldwide frequency distribution of the stop-codon allele 
(at fixation outside Africa except for a few Middle Eastern populations and Chinese 
Han) is mainly due to recent strong positive selection occurring in the Palaeolithic 
period around 60 KYA. 
4.1.2. Phenotypic effects of CASP12 variation
At the phenotypic level, it has been suggested that individuals with the non-truncated 
form produce lower levels of cytokines following stimulation by bacterial 
lipopolysaccharides and thus have a lower innate immune response. This attenuation 
of the immune response by the active Caspase 12 could result in the development of 
sepsis (Saleh et al. 2004). This finding was further corroborated by animal studies 
where CASP12-deficient mice showed greater resistance to bacterial infection (Saleh 
et al. 2006). Therefore, it was proposed by Xue et al. (2006) that resistance to severe 
sepsis was the selective advantage associated with the truncated allele. Due to the 
presence of a single high frequency inactive haplotype (defined by SNPs) in 
population groups representing sub-Saharan Africa, Europe and Asia, it was 
suggested that further research might identify the most likely route and date by which 
the stop-codon polymorphism started to expand from the African continent (Xue et al. 
2006).
4.1.3. Aims
The aim of this project is to establish the most likely geographic route taken by the 
truncated gene in its exit from Africa; in particular, whether it was more likely from 
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West Africa into Europe or from East Africa into the Middle East, or both are equally 
likely. The frequencies of the full length and truncated variants of CASP12 will be 
determined in multiple groups in both East (n=380) and West (n=373) Africa. If there 
is no significant difference in the distribution of the stop-codon frequency between 
East and West, one or more polymorphisms, in linkage disequilibrium (LD) with the 
stop-codon but variable in frequency between East and West Africa, in the vicinity of 
the stop-codon will be sought through re-sequencing  This will be of great advantage 
since polymorphisms in complete or high LD with the stop-codon may be 
differentially present in east, west and outside of Africa and therefore may be used to 
suggest the most likely route taken by the truncated allele out of Africa.
4.2. Methods 
4.2.1. Samples
Buccal swab samples from males over eighteen years old, unrelated at the paternal 
grandfather level but otherwise randomly selected from twelve sub-Saharan African, 
two North African and two Middle Eastern groups, were used to type the CASP12
stop-codon SNP (rs497116). In sub-Saharan Africa, seven groups represented West 
Africa and areas covered by the expansion of Bantu-speaking peoples (West 
Africa/EBSP ascertainment panel; n =373) and five groups represented Ethiopia 
(Ethiopian ascertainment panel; n = 380). The West Africa/EBSP ascertainment panel 
comprised the following population groups: Mozambique (Sena; n = 51), Ghana 
(Asante and Bulsa; n = 57), Malawi (Chewa; n = 50), Congo Brazzaville (Bakongo; n 
= 55), Cameroon Grassfields (Mambela; n = 65), Lake Chad (Shewa Arabs; n = 65) 
and Sudan (Kordafanians; n = 30). The Ethiopian ascertainment panel comprised five 
ethnic groups namely Afar, Amhara, Oromo, Anuak and Maale with equal sample 
sizes (n = 76). The two North African groups were from Morocco (n = 48) and 
Algeria (n = 48), and the two Middle Eastern groups were from Yemen (n = 48) and 
Iran (n =48). 
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 Introns surrounding exon 4 of CASP12 were resequenced in buccal swab DNA 
samples collected from Oromo and Amhara (n=95), representing East Africa, 
Mozambique and Ghana (n = 95), representing West Africa and EBSP. In order to 
obtain a better distribution of CASP12 haplotypes outside Africa, another eight groups 
representing North Africa (Morocco and Algeria), the Middle East (Iran and Yemen), 
Europe (Wales, Friesland and Ukraine) and Asia (China) (equal sample size of 48; 
total of 384) were also re-sequenced for intron 4 only. This choice was made during 
this study based on the observation that this intron carried a short tandem repeat 
(STR) polymorphism with differential frequency distribution between populations 
representing East and West Africa.
4.2.2. Genotyping
Tetra-primer ARMS PCR (Ye et al. 2001) with minor modifications was used to 
genotype the stop-codon SNP. The outer and two inner fragments were amplified in a 
10-μl reaction volume containing 1 μl (~ 1 ng) of template DNA, 1.5 pg of each outer 
primer, 7.5 pg of each allele-specific primer (inner primers), 1.6 μl (50 μM) dNTPs, 
9.3 nM TaqStartmonoclonal antibody (BD Biosciences Clontech, Oxford, UK), 1 μl 
of 10x Taq buffer and 0.13 units of Taq DNA polymerase (HT Biotech, Cambridge, 
UK) (see Table 4.1 for primer details). All samples (96-well plates) were then placed 
on a thermocycler under the following conditions: denaturation at 95oC for 5 min, 
followed by 35 cycles of 95oC for 45 s, 61oC for 45 s and 72oC for 45 s. The final step 
of the PCR program was a 7-min extension at 72oC, before a 30-min hold at 4oC. PCR 
bands were run on a 2% (w/v) agarose gel and visualised under UV light. 
Table 4.1. Details of the primers used in the tetra-primer ARMS PCR reaction
Primer name Primer sequence (5'-3')
Melting 
temperature 
(
o
C)
GC %
Fragment   
size (bp)
Primer 
concentration (μM)
CASP12-EX4-OUT-F ACGAGGGTGTATTTTCATGCAG 56.4 45.5 0.15
CASP12-EX4-OUT-R CTTGCTCTTTCAGCTGCCAA 57.2 50.0
401
0.15
CASP12-T-ALLELE AACTTGACCTTTTGGGGAGGT 57.5 47.6 179 0.75
CASP12-C-ALLELE CAAGGTTTTCAAGTAGATCGCG 55.3 45.5 264 0.75
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4.2.3. Re-sequencing
DNA resequencing was undertaken to identify polymorphisms in the vicinity of the 
stop-codon in the following manner. Two sets of primers were designed to amplify 
two overlapping PCR fragments with the first covering 690 bp of intron 3 flanking 
exon 4 (690 bp) and the second fragment (739 bp) including all exon 4 (173 bp) and 
437 bp of flanking region of intron 4 (see Table 4.2 for primer details). Each fragment
was amplified separately in 10-μl reaction volumes containing 1 μl (~ 1 ng) of
template DNA, 1.5 pg of each primer (forward and reverse), 1.6 μl (50 μM) dNTPs, 
9.3 nM TaqStartmonoclonal antibody (BD Biosciences Clontech, Oxford, UK), 1 μl 
of 10x Taq buffer and 0.13 units of Taq DNA polymerase (HT Biotech, Cambridge, 
UK). The reaction mixtures (96-well plates) were incubated at 95oC for 4 min, 
followed by 39 cycles of 95oC for 1 min, 61oC for 1 min and 72oC for 1 min.  The 
final step of the PCR program was a 7 min extension at 72oC before a 30 min hold at 
4oC.
Table 4.2. Primer details for the PCR fragments amplifying exon 4 and flanking introns in 
CASP12.
PCR fragment Primer Name Sequence (5' - 3')
Length 
(bp) Tm (°C) GC %
CASP12-INT3-F CCAGGTCAGTAAGAAGCAGAAGGA 24 58.9 50.0
Intron 3 (690 bp)
CASP12-INT3-R CACAGAATGACTTTCCCCAGGA 22 57.8 50.0
CASP12-INT4-F ACGAGGGTGTATTTTCATGCAGAA 24 57.4 41.7Exon 4-Intron 4 
(739 bp)
CASP12-INT4-R GTGTGTGTGATTTGTTCCCCCTA 23 58.1 47.8
PCR products were purified by mixing 30 μl of a 1 to 2 mix of water and HM-MC 
(40%  PEG- 8000, 1 M NaCl, 2 mM Tris-HCl (pH 7.5), 0.2 mM EDTA, 3.5 mM 
MgCl2) to each sample. The mixtures were then centrifuged at 2240 g for 45 min, 
followed by centrifuging the inverted PCR plate for 1 min at 13x g in order to discard 
the supernatant. 150 μl of 70 % ethanol was added to each sample and the plate was 
centrifuged at 2240 x g for 25 min. The resultant supernatant was discarded by the 
same method as above. Samples were then dried on a thermocycler at 65oC for 5 min
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followed by eluting each sample with 30 μl of distilled water. Finally, the eluted 
samples were mixed gently to resuspend the DNA pellet.
The same forward and reverse PCR primers were used for resequencing in both 
directions. PCR fragments were sequenced in 10-μl reaction volumes containing 2 μl 
of the purified PCR product, 0.16 μM of sequencing primer, 0.35 μl of BigDye 
termination mix v3.1 (Applied Biosystems) and 2.15 μl of the accompanied 5x 
sequencing buffer. The samples were placed on a thermocycler under the following 
conditions: 25 cycles of 96oC for 10 seconds, 55oC for 5 seconds and 60oC for 4 
minutes.
To purify the sequencing reaction products, 2.5µl of 125 mM EDTA and 30 µl of 
100% ethanol were added to each sample, thoroughly mixed and left at room 
temperature for 10 min. The mixture was centrifuged for 60 min at 2240 x g, followed 
by centrifuging the inverted PCR plate at 13x g for 1 min to discard the supernatant. 
30 μl of 70 % ethanol was then added to each sample and centrifuged for 10 minutes 
at 2240 x g. The resultant supernatant was again discarded by inverting the PCR plate 
and centrifuging for 1 min at 13x g. Samples were then dried for 5 minutes at 65 ºC 
before adding 10 μl of Hi-Di formamide prior to electrophoresis. Finally, samples 
were run on an ABI 3730 genetic analyser and analysed using Sequencher 4.7 
software (Gene Codes Corporation, USA). The chromatogram of each sample was 
visually inspected across its entire length to check for high levels of background noise 
that would make it difficult to call bases. Subsequently, if no significant trace of noise 
was found, the ends of the sequence were trimmed down to the reference sequence 
(usually 50bp after the start of the PCR fragment in the direction sequenced). A contig 
was then formed for each set of 96 samples (i.e., one sequencing run) and each 
mutation site examined visually to determine whether it was a substitution, insertion, 
deletion or a tandem repeat. All samples with any ambiguous sites were resequenced. 
4.2.4. Statistical analysis
Haplotypes were inferred by parsimony and checked using the Excoffier-Laval-
Balding (ELB) and Expectation Maximisation (EM) algorithms (Excoffier et al. 2003 
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and Excoffier & Slatkin 1995 respectively). Pairwise linkage disequilibrium (LD) was 
assessed between loci by estimating D´. Gene diversity, h, and its standard error were 
estimated from unbiased formulae of Nei (1987). Patterns of genetic differentiation
were quantified using FST (Reynolds, Weir & Cockerham 1983) estimated from 
AMOVA-based φ-st values (Excoffier et al. 1992 and Michalakis & Excoffier 1996). 
Significance of genetic distances was assessed by permutation test where a null 
distribution is formed by calculating all possible values under rearrangements of 
haplotypes in the observed samples. The permutation test was repeated over 1,000 
times to give the null distribution. All the above was performed using Arlequin 
software version 3.0 (Excoffier et al. 2005). 
Using MS Excel, deviation from Hardy-Weinberg expectations was assessed at each 
locus and its significance was examined based on the Chi-squared distribution. A two-
tailed Z test was also undertaken in MS Excel to test significance of gene diversity 
differences. Principal Coordinates Analysis (PCO) was performed using the ‘R’ 
environment of statistical computing (www.R-project.org) by implementing the 
‘cmdscale’ function on pairwise FST matrices and visualised using the ‘plot’ function. 
The plot was used to visualise relationships among groups. Average Square Distances 
(ASD) were also calculated in MS Excel and corresponding 95% confidence intervals 
were calculated as in Thomas et al. (1998) using ‘R’. The Time to Most Recent 
Common Ancestor (TMRCA) were estimated using a STR mutation rate of  1.94 x 
10-4  for a dinucleotide STR (Huang et al. 2002) and generation time of 25 years. 
Relationships of CASP12 haplotypes were displayed via a reduced-median network
constructed within Network 4.56 (Fluxus Engineering).
4.3. Results and discussion
4.3.1. Is there difference in the prevalence of the nonsense mutation between 
populations in West Africa and East Africa?
The prevalence of the nonsense mutation was assessed in all samples as described 
above. The nonsense mutation is present at high frequency (see Figure 4.1) across all 
sub-Saharan African populations. Deviation from Hardy-Weinberg equilibrium 
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(HWE) was tested, with only the Afar indicating deviation from it (p >0.125, Afar 
p=0.0012). 
Figure 4.1. The distribution of the truncated CASP12 gene variant in five Ethiopian ethnic 
groups and eleven countries.
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Note: The error bars here represent the standard deviation of each allele frequency
The deviation from HWE observed in Afar remained significant after applying a 
Bonferroni correction. It is possible that the deviation arises from abrogation of one or 
more assumptions made in formulating HWE expectations, in this case quite possibly 
that of random mating given the reported high level of consanguineous unions among 
the Afar (Getachew 2001).  Based on the stop-codon allele frequencies, there was no 
significant difference between the West African (i.e., Ghana and Cameroon) and 
Ethiopian groups (Fisher’s exact test p = 0.355). 
4.3.2. Is there variation in the genomic regions flanking the nonsense mutation?
Given that there was no statistically significant difference in the prevalence of the 
nonsense mutation between West and East African groupings, the genomic regions 
flanking the nonsense mutation were examined to identify variations which might be 
used to construct haplotypes (that included the nonsense mutation) that were at 
different frequencies in the two regions. Figure 4.2 shows the region resequenced 
(1300 base pairs in total) in 43 Ghanaian samples representing West African 
populations and 76 Oromo samples representing Ethiopia. Figure 4.2 and Table 4.3 
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detail the variant sites and their frequencies. Seven variants were single base 
substitutions and one was a variable short tandem repeat (STR). Of the single base 
substitutions, three were novel and, of these previously unreported alleles, one was 
only observed in a single individual.
Figure 4.2. The graphical representation of the resequenced genomic region flanking the 
stop-codon in exon 4 of CASP12 gene (human assembly GRCh37). Exonic sequence is 
shown in red and identified polymorphisms are highlighted in blue (SNPs) and green (STR).
Table 4.3. Details of CASP12 polymorphisms identified in this study.
Name of 
variant
Type of variant
Nucleotide 
change
dbSNP ID
Mutation 
type
MAF 
(Ethiopia)
MAF          
(Ghana)
INT2A SNP A/G Novel 0.000 0.027
EX3A SNP C/T rs617983 Missense 0.070 0.054
EX3B SNP A/G Novel Sense 0.023 0.000
EX3C SNP G/T rs73629659 Missense 0.016 0.068
INT3A SNP C/G Novel 0.000 0.014
EX4A SNP C/T rs497116 Nonsense 0.078 0.081
INT4A SNP G/T rs648264 0.078 0.081
INT4B STR (GT)9-16 Novel NA** NA
* SNP ID was obtained from the NCBI SNP database (http://www.ncbi.nlm.nih.gov/SNP) **NA: Not 
Applicable
Exon 3
Exon 4
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4.3.3 Is there evidence of recombination in the genomic region that includes the 
nonsense mutation and its flanking regions?
To examine whether recombination could be detected in the region which includes the 
stop-codon, a phylogeny-based method (Hudson & Kaplan 1985; Maynard Smith & 
Smith 1998) was implemented. This method works on the basis that, if there is neither 
recombination nor homoplasy, the number of variable sites is equal to the number of 
steps in a most-parsimonious tree. By adopting parsimony, a genealogical tree of all 
single base substitutions identified was constructed (see Figure 4.3).
Figure 4.3. Genealogical tree of single-base substitutions identified in the re-sequenced 
region. Nodes are proportional to the frequencies of each sequence. The arrows show the 
ancestral sequence and the circled marker is the nonsense mutation step.
The number of variable sites was equal to the number of tree steps. Moreover, the tree 
produced is the only possible genealogical relationship among the identified variable 
sites. Therefore, it is possible to assume that no recombination has taken place in this 
region. Furthermore, linkage disequilibrium patterns observed in this region also 
provided no evidence of recombination (D´ of 1 among all loci). Consequently, 
distributions of haplotypes carrying the stop-codon were examined between East and 
West Africa.
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4.3.4   Given that there is no evidence of recombination what is the estimated 
prevalence of haplotypes (including nonsense mutation STR haplotypes) in the 
African and non-African groups?
Estimated haplotype frequencies based upon single nucleotide substitutions are 
included in Table 4.4, while Table 4.5 contains frequencies of all STR sizes of 
chromosomes homozygous for the nonsense allele (T dataset).
Table 4.4. Frequencies of inferred SNP haplotypes, based on parsimony and the ELB 
algorithm, in Ghana and Ethiopia. Haplotypes 1-3 carry the ancestral allele (underlined) at the
stop-codon SNP.
Haplotype 
number
Haplotype 
sequence
Ghana Ethiopia Total
1 ACGGCCG 0.027 0.008 0.015
2 ATGGCCG 0.054 0.047 0.050
3 ATAGCCG 0.000 0.023 0.015
4 ACGGCTT 0.824 0.906 0.876
5 ACGTCTT 0.068 0.016 0.035
6 GCGGGTT 0.014 0.000 0.005
7 GCGGCTT 0.014 0.000 0.005
Gene diversity was calculated based on STR alleles observed in the T dataset and 
ranged in individual populations from 0.316-0.641, where Wales and Ghana had the 
lowest and highest values. Samples were then pooled into African and non-African 
datasets and gene diversities were calculated. Diversity of the African dataset (h = 
0.557) was higher than the non-African dataset (h = 0.374) and the difference was 
highly significant (P < 0.0001). The significant reduction of genetic diversity from 
Africa to outside is consistent with the diversity pattern of other nuclear loci 
investigated (Tishkoff et al. 2009).
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Table 4.5. The distribution of CASP12 truncated haplotypes in multiple geographic locations. 
Haplotypes are defined by the stop-codon allele (T) and the novel STR alleles (range of 10-
16) in intron 4.
4.3.5. Using STR variation to calculate genetic distances
There was no significant difference between the distributions of nucleotide 
substitution defined haplotypes between West and East Africa (FST < 0.001, P = 
0.445). The same two geographic regions, based on the distribution of STR alleles 
(using just the nonsense mutation bearing chromosomes for which STR status could 
be unambiguously assigned), were compared using pairwise genetic distances. 
Pairwise RST was estimated to be < 0.001 (P = 0.618), while FST was 0.083 and highly 
significant (P = 0.002). Since genetic differentiation between East and West Africa 
was obtained only using FST based on the STR alleles shown in Table 4.5, all other 
comparisons among the ten populations typed for the stop-codon and the STR marker 
were undertaken in the same manner (see Table 4.6). Based on FST values, one cluster 
was apparent, which comprised of the three European populations along with Iran and 
Yemen (FST ≤ 0.024, P > 0.05).
CASP12 truncated haplotypes
Geographic location
T 10 T 11 T 12 T 13 T 14 T 15 T 16
Ghana (GHA) 0.186 0.443 0.371
Ethiopia (ETH) 0.008 0.042 0.691 0.225 0.017 0.017
Iran (IRA) 0.011 0.793 0.011 0.022 0.163
Yemen (YEM) 0.050 0.800 0.063 0.063 0.024
Algeria (ALG) 0.011 0.649 0.181 0.096 0.064
Morocco (MOR) 0.011 0.644 0.133 0.156 0.056
China (CHI) 0.094 0.690 0.024 0.192
Wales (WAL) 0.817 0.049 0.134
Friesland (FRI) 0.766 0.106 0.128
Ukraine (UKR) 0.819 0.021 0.074 0.074 0.011
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Table 4.6. Pairwise genetic distances (Fst) based on STR alleles restricted to the T dataset in 
ten populations.
Ghana Ethiopia Iran Yemen Algeria Morocco China Wales Friesland
Ethiopia 0.083
Iran 0.274 0.081
Yemen 0.214 0.036 0.024
Algeria 0.089 0.004 0.061 0.033
Morocco 0.113 0.022 0.062 0.032 <0.001
China 0.175 0.065 0.074 0.026 0.034 0.013
Wales 0.296 0.087 <0.001 0.016 0.065 0.061 0.065
Friesland 0.258 0.077 0.002 0.015 0.043 0.032 0.033 <0.001
Ukraine 0.283 0.070 0.007 <0.001 0.052 0.046 0.044 <0.001 <0.001
Significant pairwise genetic distances (P < 0.05) are shown in bold red.
 The PCO plot in Figure 4.4 enables the relative positions of the groups to be 
visualised. Ghana, representing West Africa, is clearly at a greater distance from the 
non-African groups than is Ethiopia. 
Figure 4.4. PCO plot of pairwise Fst genetic distances based on CASP12 truncated
haplotypes
          Percentages in parentheses represent the amount of variation explained by each eigen vector.
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The greater similarity of non-African groups to Ethiopia could be the consequence of 
back migration into Africa from the Arabian Peninsula or elsewhere, either associated 
with the migration of Semitic speakers some 5,000 years ago (Cavalli-Sforza et al. 
1994), or some other event. However, the smaller distance between Ethiopians and 
North Africans than between Ethiopians and Yemeni argues against this explanation, 
leaving the suggestion that the nonsense mutation is more likely to have taken a route 
out of Africa via the East (represented in this study by Ethiopians) than the West 
(represented in this study by Ghanaians). 
4.3.6 Using variation in the STR, is the estimated age of the nonsense mutation 
consistent with the mutation occurring prior to the migration of Anatomically 
Modern Human out of Africa?
  
If the nonsense mutation predated the mass migration of Anatomically Modern 
Human out of Africa it would be expected to have an age of at least 60000 years 
(Quintana-Murci 1999; Campbell & Tishkoff 2010). To estimate its age, Average 
Squared Distance (ASD) was calculated for the STR alleles of the nonsense mutation 
containing chromosomes to which the STR size could be unambiguously assigned 
(i.e., homozygous pairs of chromosomes) to estimate a time to The Most Recent 
Common Ancestor (TMRCA). To avoid complications associated with any bottleneck 
during the migration out of Africa (as evident by the significantly reduced STR gene 
diversity outside Africa), only African samples were used in the calculation. The 
observed ASD value was 0.864 and the 95% confidence interval was 0.717-1.029. 
Assuming a mutation rate of 1.94 x 10-4 (Huang et al. 2002) and a generation time of 
25 years, the nonsense mutation can be dated back to 92400-132600 years ago, a date 
which is consistent with it having occurred shortly before the exodus out of Africa. 
4.3.7. Conclusion
Overall, it has been shown like many previous studies (Kachapati et al. 2006 and Xue 
et al. 2006) that the truncated CASP12 variant is at high frequency in many parts of 
Africa and is almost fixed outside Africa. The analysis in this study suggests that the 
truncated variant most likely left Africa via an eastern route into Eurasia. This is in 
good agreement with other studies suggesting a major eastern route of dispersal of 
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Anatomically Modern Human out of Africa, based on mtDNA (Quintana-Murci et al.. 
1999) and nuclear markers (Tishkoff et al. 2009). The estimated age of the truncated 
variant is consistent both with the wide distribution of the truncated variant in sub-
Saharan Africa and its origin prior to the migration out of Africa. 
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5. Analysing variation in CYP1A1 and CYP1A2: 
relevance for healthcare, human evolution and 
anthropology in Africa
5.1. Introduction
5.1.1. Drug-metabolising Enzymes
In nature, organisms, including humans, have evolved complex systems that 
inactivate and detoxify foreign chemicals (i.e., xenobiotics) including dietary 
constituents (Rang and Dale 2006, Buxton 2006). In general, four processes are 
responsible for the rate at which a xenobiotic compound passes through the human 
body (Weinshilboum 2003). The first step is absorption, when the molecule is 
absorbed into the bloodstream. The second step is the distribution of the molecule to 
the site of action where it interacts with target molecules. The third step is metabolism 
(i.e. biotransformation), where the structure and properties of the ingested molecule
are altered. (Although sometimes this alteration could result in bioactivation, it is 
usually in the form of either inactivation or water solubilisation (Buxton 2006)). The 
final step is excretion, where the metabolised molecule is removed from the body 
through renal elimination. 
Although genetic variation may influence all four processes, since they involve many 
different proteins encoded by genes, metabolism has received the most attention. 
Hitherto, more than 30 gene families have been indentified which are involved in 
metabolising xenobiotics including drugs (Evans and McLeod 2003). Historically, 
drug metabolising enzymes (DME) have been divided into two groups (phase I and 
II), based on the type of their reactions (Weinshilboum 2003). Phase I reactions are 
catabolic (e.g., oxidation, reduction and hydrolysis), whereas phase II reactions are 
anabolic (e.g., acetylation and methylation) and involve conjugation (Rang and Dale 
2006). Major enzymes in phase I reactions are cytochrome P450 monooxygenases 
(CYP), flavin-contatining monooxygenases (FMO) and epoxide hydrolases (EH). In 
phase II metabolism, several enzyme families are also known and the more important 
among them are UDP-glucuronosyltransferases (UGT), glutathione-S-transferases 
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(GST), sulfotransferases (SULT), N-acetyltransferases (NAT), and methyltransferases 
(MT) (Buxton 2006).
5.1.2. CYP Superfamily
Cytochrome P450 enzymes (CYPs for short) are a superfamily of diverse but related 
proteins, all of which contain a haem group that is non-covalently attached to the 
polypeptide chain (Rang and Dale 2006). They are believed to be the most important 
of the enzymes that catalyze phase I drug metabolism (Weinshilboum 2003).These 
enzymes were first found in rat liver microsomes by Klingenberg (1958). When 
combined with carbon monoxide, they showed a characteristic intense absorption 
band at 450nm when treated with dithionite and hence the name P450. However, it 
was a few years later that the nature of these enzymes (referred to as ‘pigments’) as 
novel cytochrome hemeproteins was identified (Omura and Sato 1962; 1964). 
Their function was also characterised and they were shown to be involved in the 
hydroxylation of several steroids and drugs (Porter and Coon 1991). It should be 
noted that the function of CYPs is always coupled with another enzyme known as 
NADPH-dependent P450 reductase (Rang and Dale 2006). Therefore, the lack of this 
enzyme, which supplies the electron and H+ required by CYPs to oxidise substrates, is 
detrimental to CYP activity (see steps 2 and 4 in Figure 5.1). It is now known that 
beside being powerful in vivo oxidising agents, able to catalyse the oxidative 
biotransformation of a wide range of chemically and biologically unrelated exogenous 
and endogenous substrates (Porter and Coon 1991), CYPs can also catalyse many 
other reactions including N-dealkylation, O-dealkylation, deamination, and 
dehalogenation (Gonzalez and Tukey 2006)
CYPs have been identified across all kingdoms of life including animals, plants, 
fungi, protists and bacteria (Nelson 2009). Based on the identification of more than 20 
CYPs in bacterial strains, it is thought that cytochromes P450 arose before the split of 
bacteria and eukaryotes (Nelson 1999). This has further led to the suggestion that 
CYPs may have existed throughout nature for more than three billion years (Nebert 
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and Russell 2002) and have expanded via divergent evolution (Nebert and Gonzalez 
1987).
Figure 5.1. Schematic representation of the CYP450 catalytic cycle
                            (Figure taken from http://www.reactome.org/figures/p450_cat_cycle.JPG)
The number of putatively functional CYPs varies across species, especially among the 
eukaryotes with the range of 2-323 where the lowest and highest were found in yeast 
and plant species respectively (Nelson 2004). The first systematic standardised 
nomenclature for a protein superfamily was made for CYPs, which was based on 
phylogenetic relationships (Nebert et al. 1987; Nebert and Gonzalez 1987). The 
criteria used to classify CYP proteins into families and subfamilies is amino-acid 
sequence identity. Currently, enzymes that share ≥40% amino-acid identity are 
assigned to a particular family (e.g., CYP1), whereas those sharing ≥55% identity 
make up a particular subfamily (e.g., CYP1A) (Nebert and Russell 2002).
104
In terms of function, different CYPs have distinct, but often overlapping, substrate 
specificities, with some enzymes acting on the same substrates as each other but at 
different rates (Rang and Dale 2006). The structural and functional data on CYPs 
suggest that enzymatic conformational flexibility may be central to the ability of 
CYPs to bind a diverse array of substrates (Coon 2005) and therefore at times have 
overlapping functions.
5.1.3. Human CYP and Pharmacogenetics
In humans, 57 putatively functional genes (18 families and 42 sub-families) along 
with numerous pseudogenes have been identified (Nelson 2004). This number of 
functionally related but distinct genes results in the synthesis of a variety of CYP 
isozymes that are able to catalyse the metabolism of widely different chemical 
structures. It has been estimated, therefore, that CYP substrates number over 200,000,
which include several types of endobiotics and many xenobiotics (Urban et al. 2001). 
Endogenous substrate classes identified include fatty acids, eicosanoids, steroids, bile 
acids, retinoids and vitamin D3 derivatives, whereas exogenous substrates include 
pharmaceutical drugs, environmental pollutants and plant products (Nerbert and 
Russell 2002). CYPs were originally thought to be a hepatic system. However, it is 
now known that CYPs are also expressed in many other tissues, albeit to a lesser 
extent, including lungs and the intestine (Ingelman-Sundberg 2004a).
Factors such as age, sex, disease state and drug interactions result in variable drug 
response in individuals and variation in CYP isozymes can also influence drug 
response significantly (Pirmohamed and Park 2004). Therefore, pharmacogenetics, 
which is the study of differential drug response based on genetic variation in 
individuals (Weinshilboum 2003), is of considerable importance. It is thought that 
CYP isozymes catalyse 75% of phase I metabolism of pharmaceutical drugs with 
CYP families 1-3 being mostly responsible. Interestingly, genes in CYP families 1-3 
are less conserved evolutionary compared with CYP families 5-51 and display
important genetic polymorphisms (Ingelman-Sundberg 2004a). These polymorphisms 
may lead to abolished, reduced, altered and increased activity of the encoded enzyme 
(Pirmohamed and Park 2004). Furthermore, since the biotransformation of 
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xenobiotics by CYPs can lead to toxicity by metabolic activation of procarcinogens 
and drugs (Ingelman-Sundberg 2004a), polymorphisms affecting the rate of 
expression are also of key importance.
Polymorphic CYPs have also been associated with the development of a significant 
number of adverse drug reactions (ADRs) (Ingelman-Sundberg 2004b). This is due to 
the observation that about 60% of ADR-related drugs are metabolised by phase I 
polymorphic enzymes and 86% of those belong to the CYP superfamily (Phillips et 
al. 2001). It is now generally recognised that ADR is an important issue in both drug 
treatment and drug development. A study by Lazarou et al. (1998) showed that 
serious ADRs occur in 7% of hospitalised patients and around 0.3% develop fatal 
ADRs resulting in around 100,000 deaths a year in the United States of America (US) 
alone. Another study has shown that the cost of ADRs is an estimated $100 billion per 
year in the US (Marshall 1997). Interestingly, similar to the position in the US, a pilot 
study found that around 8% of all hospital admissions in UK were also due to ADRs 
(Green et al. 2000). Detailed characterisation of genetic variation in CYP genes would 
be one way forward to tackle this problem since drugs could be administered based on 
the genotype of an individual or a common variant in a population group. 
Consequently, pharmacogenetics of CYPs has the potential to identify the right dose 
for each patient without the need to eliminate drugs based on their pharmacokinetic 
properties (Ingelman-Sundberg 1999).
Figure 5.2. Proportion of phase I pharmaceutical drug metabolism by CYP isozymes
Adapted from Mechanisms of Drug Interactions I in Drug interactions of infectious diseases by
Kashuba and Bertino (2005) Humana Press.
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As mentioned earlier, CYP 1-3 families are mostly responsible for drug metabolism 
(see Figure 5.2). However, just a few sub-families (CYP1A, CYP2C, CYP2D and 
CYP3A) cover most of this metabolism, with CYP1A metabolising around 11% of 
drugs, with only two functional genes (Kashuba and Bertino 2005). The biochemistry 
and genetics of CYP1A proteins and corresponding genes will be dealt with in more 
detail below.
5.1.4. CYP1A Subfamily
The human CYP1A enzyme subfamily is comprised of two members, CYP1A1 and 
CYP1A2. These two enzymes have ~70% amino-acid sequence identity (Urban et al. 
2001; Moorthy 2008) and the genes encoding these two enzymes form a cluster in a 
region spanning 39kb on human chromosome 15q22ter (Corchero et al. 2001). It is 
thought that these two genes originated around 250 million years ago (Nebert and 
Gonzalez 1987; Heilmann et al. 1988) after the evolutionary split of sea and land 
animals and that CYP1A2 came into existence via duplication of CYP1A1 and further 
diverged (Nelson et al. 1996).
The expression of CYP1A genes is induced by polycyclic aromatic hydrocarbons 
(PAHs) (e.g., benzo[a]pyrene), β-naphthoflavone (BNF) and other compounds 
(Moorthy 2008). This is, at least in part, achieved through the binding of these 
molecules to a transcription factor known as the aryl hydrocarbon receptor (AHR) 
(Nebert and Russell 2002). After binding, the ligand-activated cytoplasmic AHR 
translocates to the nucleus where, after forming a heterodimer with another nuclear 
factor, interacts with AHR response elements (AHREs; also called XREs (xenobiotic 
response elements)) located upstream of CYP1A genes in multiple copies (Corchero et 
al. 2001). This cascade of reactions results in the initiation of transcription. CYP1A 
enzymes are expressed in many tissues, with CYP1A2 being expressed principally in 
the liver and CYP1A1 mainly in extrahepatic tissues including lungs and intestine 
(Moorthy 2008).
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Members of the CYP1A family have major roles in the biotransformation of a variety 
of xenobiotics (Daly 2003). They are responsible for both detoxification and 
metabolic activation of PAHs and aromatic and heterocyclic amines found in cigarette 
smoke, combustion products and charcoal grilled food (Nebert and Russell 2002; 
Nebert et al. 2004).
Furthermore, CYP1A enzymes have also been studied extensively based on their 
potential influence in the development of chemically induced cancers in humans
(Urban et al. 2001). This is based on their roles in the metabolic activation of 
substrates into electrophilic reactive intermediates, leading to the activation of 
procarcinogens and induction of toxicities (Ioannides and Parke 1990; Moorthy 
2008). Therefore, analysing the genetic variation underlying interindividual 
differences in regulation and metabolic activity of CYP1A enzymes is clinically very 
important.
5.1.5. CYP1A1
CYP1A1 is a well-studied cytochrome P450 enzyme, which is present in all 
vertebrates (Nelson 1996). CYP1A1 has very low constitutive expression. However, 
induced expression by PAHs occurs in virtually all tissues and cell types (Nebert et al. 
2004). Among all different tissues, lung is thought to be the main place where it is 
expressed (Chang and Waxman 2006). Furthermore, many of the inducers of 
CYP1A1 are in turn metabolised by the very same enzyme (Nebert et al. 2004).
CYP1A1 is not best known for pharmaceutical drug metabolism even though it can 
metabolise some drugs (Moorthy 2008). Except for the metabolism of eicosanoids, 
which are endogenous signalling molecules (Nebert and Karp 2008), CYP1A1 is
known to be mostly involved in the metabolism of various PAH procarcinogens such 
as benzo[a]pyrene (Beresford 1993; Perera 1997).
Among all xenobiotic metabolising enzymes in CYP 1-3 families, which are mostly
functionally polymorphic (Ingelman-Sundberg 2004a, 2004b), an exception is the
CYP1A1 enzyme, which, along with CYP2E1, is evolutionary well conserved. The 
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reason for this conservation is thought to be due to the importance of these enzymes 
in endobiotic metabolism (Ingelman-Sundberg 2002).
The cDNA of CYP1A1 was cloned (2.6 kb) by Jaiswal et al. (1985) and the peptide 
sequence of the enzyme was 512 amino acids long. The structure of the gene was later 
revealed by Kajawiri et al. (1986). This gene spans a region of 6kb and has seven 
exons, where the first exon is untranslated (5’UTR).
Analyses of sequence variation within CYP1A1 have been undertaken 
(www.cypalleles.ki.se). However, most studies resulted in the identification of 
polymorphisms that were either rare or private. In addition, due to the potential 
significance of this gene in tumourigenesis, many studies have concentrated on the 
relationship of CYP1A1 polymorphisms and various cancers (especially lung cancer).
For example, a CYP1A1 variant (rs4646903; previously known as MspI) at the 3’ end 
of the gene, which is associated with elevated expression, has been shown to be more 
frequent in patients with lung cancer (Xu et al. 1996). It is worth mentioning that 
some studies have also refuted such an association (Moorthy 2008).
Recently, systematic studies of CYP1A1 gene polymorphisms were undertaken by 
Solus et al. (2004), Jiang et al. (2005) and Jorge-Nebert et al. (2009). Solus et al. 
(2004) resequenced all exons and flanking intronic regions in 11 major drug 
metabolising and carcinogen-activating CYP genes including CYP1A1 and CYP1A2 in 
93 samples, which included individuals of Caucasian, African and Asian descent. Out 
of a total of 19 polymorphisms detected, 17 were in transcribed regions with eight 
being non-synonymous and one being synonymous. The other eight were found in the 
3’ UTR (four were novel), while no polymorphisms were found in the 5’ UTR. 
Interestingly, although non-coding DNA (intronic and intergenic) regions usually 
tolerate more variation, only two polymorphisms were found in such regions.
Furthermore, each SNP had an overall minor allele frequency (MAF) of less than 5%, 
except for one SNP (MAF = 0.11), which was only found in non-Africans. Jiang et al. 
(2005) carried out a similar study but only found four SNPs (non-synonymous) in the 
coding region, all being identified by Solus et al. (2004), along with eight 3’ UTR 
SNPs. The lack of identification of the other five exonic SNPs reported by Solus et al. 
(2004) in this study is most likely due to the low sample size used (n = 24). In none of 
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the studies was a common genetic variant CYP1A1 with serious deficiency of enzyme 
activity identified.
Since sub-Saharan African individuals have not been well represented in these 
studies, by resequencing 750 samples (twelve population groups) distributed across 
sub-Saharan Africa, I investigated whether sub-Saharan African populations were 
near fixation for the ancestral variant of CYP1A1 or have frequent variants (> 5%) 
which were not identified in previous studies due to relatively small sample sizes. 
This study will be of great importance as it has the potential to discover many more 
polymorphisms in this gene, which might explain the interindividual phenotypic 
variation observed. 
 5.1.6. CYP1A2
CYP1A2 is another CYP enzyme which has been studied extensively. It is 
constitutively expressed in the liver (Guengerich et al. 1999) and also induced by 
PAHs in liver and other tissues such as the gastrointestinal tract, pancreas and brain 
(Jorge-Nebert et al. 2010). CYP1A2 is involved in the metabolism of many 
environmental compounds such as heterocyclic amines (Nebert et al. 2004). 
Furthermore, most carcinogenic arylamines are also known to be metabolised by this 
enzyme (Butler et al. 1989; Guengerich et al. 1992). 
CYP1A2 is also responsible for the oxidative metabolism of many drugs, as well as 
caffeine (Butler et al. 1989), e.g., theophylline (Sarkar et al. 1992), paracetamol
(Patten et al. 1993) and lidocaine (Orlando et al. 2004). To date, many endogenous
substrates have also been identified for the CYP1A2 enzyme such as bilirubin 
(Zaccaro et al. 2001), melatonin (Facciola et al. 2001) and uroporphyrinogen 
(Moorthy 2008). The constitutive expression of CYP1A2 in mammals further 
suggests that this enzyme serves some important endogenous function (Urban et al. 
2001). 
The cDNA of CYP1A2 was cloned (3.1 kb) by Jaiswal et al. (1986) and the peptide 
sequence of the enzyme was found to be 516 amino acids long including the initiation 
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methionine. The structure of this 7.8 kb-long gene was later identified by Ikeya et al. 
(1989). CYP1A2, which is the duplicated copy of CYP1A1, has also seven exons, with 
the first exon being untranslated (5’UTR). The level of conservation among these two 
genes is even more evident since exons 2, 4, 5 and 6 are very similar in both 
nucleotide composition and total number of bases (Ikeya et al. 1989). 
There are around 60-fold differences in hepatic CYP1A2 activity at the 
interindividual level (Butler et al. 1989; Eaton et al. 1995; Nebert et al. 2004). 
Although polymorphisms have been reported to alter CYP1A2 enzyme activity in 
both directions (www.cypalleles.ki.se), most polymorphisms were either genotyped in 
a single ethnic group (Nakajima et al. 1999; Sachse et al. 1999) or found to be absent 
in the wider population (Allorge et al. 2003). Therefore, none of the polymorphisms 
reported could unequivocally explain the remarkable differences in levels of CYP1A2 
enzyme activity. 
However, with the aid of new technology, many studies have taken the resequencing 
approach to screen the whole gene for novel polymorphisms in relatively larger 
samples comprised of different ethnic groups (Solus et al. 2004, Jiang et al. 2005 and 
Jorge-Nebert et al. 2009). Even though it has been established that the people of sub-
Saharan Africa have the highest human genetic diversity (Tishkoff et al. 2009), the 
African contribution to the samples in these studies has started to increase only in the 
recent years (Browning 2009).  
The CYP1A2 gene has recently been resequenced by the Environmental Genome 
Project (EGP) in a set of sub-Saharan African samples (Yoruba, n=12) and 11 SNPs 
were identified (http://egp.gs.washington.edu/). In the present study, four of the SNPs 
characterised in EGP were typed to generate functional haplotypes extending over
most of the gene (Intron1 to 3’UTR) in samples from West Africa and the areas 
covered by the expansion of Bantu-speaking peoples (EBSP).
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5.1.7. Aims
1) To characterise variation in frequency of CYP1A2 haplotypes among peoples 
of Africa, using a four-SNP-defined haplotype hypothesised to capture all or 
almost all variation in the coding and flanking intronic regions of the gene.
2) To resequence the exons and flanking introns of CYP1A1 in the EBSP 
Ascertainment Plate and the Ethiopian Ascertainment Plate (see Methods 
below), to characterise variation in the coding and flanking intronic regions of 
this gene in Africa.
3) To assess the predicted phenotypic effect(s) of variation identified in 1) and 2) 
and to draw inferences concerning drug efficacy and safety having regard to 
healthcare policies in Africa.
4) To compare CYP1A1 and CYP1A2 data produced in this study with those 
published in the literature and publically available databases (see Methods 
below). To compare: a) EBSP with Ethiopia and with other human data, b) 
CYP1A1 and CYP1A2  and c) data from humans and other primates. 
5) To assess evidence of selective pressure by applying tests of departure from 
neutrality.
6) Compare the pattern of variation among African ethnic groups (EBSP and 
Ethiopian ascertainment plates) for CYP1A1 and CYP1A2 with each other and 
with the patterns for other genes and genetic systems (e.g., NRY and mtDNA) 
to establish similarity or dissimilarity of patterns.
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5.2. Materials and Methods
5.2.1. Samples
5.2.1.1. Sub-Saharan Africa
An ‘ascertainment plate’ (a panel of DNA samples from seven population groups or 
locations: Sena (Mozambique; n = 51), Mambela (Somie, Cameroon; n = 65), Asante 
and Bulsa (Ghana; n = 57), Shewa Arabs (Lake Chad; n = 65), Chewa (Malawi; n = 
50), Bakongo (Brazzaville, Republic of the Congo; n = 55) and Sudanese 
Kordofanians; n = 30) was assembled for use in genotyping and resequencing. These 
populations collectively are distributed throughout West Africa and the regions of the 
EBSP plus Sudan. DNA concentrations of a large set of samples from all populations 
were assessed by genomic DNA gel electrophoresis and samples that contained the 
greatest quantity of DNA were selected from the above groups. The DNA 
concentration of each sample was adjusted to approximately 1ng/μl by dilution with 
dH20 and comparison with DNA standards of known concentration. A similar 
ascertainment panel was also assembled from five major ethnic groups of Ethiopia 
(Afar (n = 76), Amhara (n = 77), Anuak (n = 76), Maale (n = 76) and Oromo (n = 
76)), representing a North East-South West transect (For further details see Browning 
2009).
All buccal swabs were collected anonymously with informed consent. Sociological 
data were also collected from each individual including age, birthplace, self-declared 
cultural identity, first language, second language and in most cases religion, as well as 
similar information on the individual’s father, mother, paternal grandfather and 
maternal grandmother. The samples were classified into groups primarily by cultural 
identity, first language spoken, then by place of collection. Where collections from a 
particular group were made in more than one location, locations are represented by 
averages of coordinates.
DNA from Congolese samples was extracted using the Gentra protein precipitation 
method (Gentra Systems, Minneapolis). Previously collected buccal swab DNA 
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samples from West Africa and areas covered by the EBSP were extracted by standard 
phenol-chloroform method. For details of the Gentra method, see Appendix A. 
5.2.1.2. Environmental Genome Project 
The Environmental Genome Project (EGP) of the NIEHS at Washington University 
(http://egp.gs.washington.edu/) has resequenced over one hundred genes involved in 
metabolism, of which 17 are CYPs including CYP1A1 and CYP1A2. These two genes 
have been resequenced in a total of 95 samples from the following ethnic affiliations: 
Nigerian (Yoruba) (n =12), African American (n =15), European (Utah residents, 
USA) (n= 22), Hispanic (n=22), Japanese (n=12) and Chinese (Han) (n=12). The 
resequencing data was retrieved from the EGP database and included in the analyses 
of this study.
5.2.2. Polymerase Chain Reaction (PCR) and Sequencing of CYP1A1 Exons
5.2.2.1. PCR of CYP1A1 Exons
CYP1A1 exons 3, 4, 5 and 6 and their flanking introns were amplified in two PCR 
fragments. This was achievable since these exons are both relatively small (range of 
81-110 bp) and in close proximity to each other (see Table 5.1 for primer details).
Each fragment was amplified separately in 10-μl reaction volumes containing 1 μl (~ 
1 ng) of template DNA, 1.5 ng of each primer (forward and reverse), 1.6 μl (50 μM) 
dNTPs, 9.3 nM TaqStartmonoclonal antibody (BD Biosciences Clontech, Oxford, 
UK), 1 μl of 10x Taq buffer and 0.13 units of Taq DNA polymerase (HT Biotech, 
Cambridge, UK). All samples (96-well plates) were then placed on a thermocycler 
under the following conditions: denaturation at 95°C for 5 min, followed by 35 cycles 
of 95°C for 45 s, 66°C for 45 s and 72°C for 45 s. The final step of the PCR program 
was a 7-min extension at 72°C before a 30-min hold at 4°C.
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Table 5.1. Primer details for the PCR fragments amplifying exons 3-6 of CYP1A1
PCR fragment
Primer 
Name Sequence (5' - 3')
Length 
(bp) Tm (°C) GC %
1A1-Ex34-F AAGCTGGGACAACAGCCTCAG 21 60.7°C 57.1%Exons 3 & 4       
(520 bp)
1A1-Ex34-R ACACAGGGACAAGATGGATGCAGG 24 61.9°C 54.2%
1A1-Ex56-F GTAGTGGCTCCCTTCAAAGGGGTC 24 62.3°C 58.3%Exons 5 & 6       
(537 bp)
1A1-Ex56-R CCATGGACAGGAGGATCAATGC 22 59.1°C 54.5%
5.2.2.2. PCR purification
PCR products were purified by mixing 30 μl of a 1 to 2 mix of water and HM-MC 
(40%  PEG- 8000, 1 M NaCl, 2 mM Tris-HCl (pH 7.5), 0.2 mM EDTA, 3.5 mM 
MgCl2) to each sample. The mixtures were then centrifuged at 2240 g for 45 min, 
followed by centrifuging the inverted PCR plate for 1 min at 13 g in order to discard 
the supernatant. 150 μl of 70 % ethanol was added to each sample and the plate was 
centrifuged at 2240x g for 25 min. The resultant supernatant was discarded by the 
same method as above. Samples were then dried on a thermocycler at 65 C for 5 min,
followed by eluting each sample with 30 μl of distilled water. Finally, the eluted 
samples were mixed gently to resuspend the DNA pellet.
5.2.2.3. Dideoxy Sequencing of CYP1A1 Exons
Sequencing was performed using the same forward and reverse primers used in the 
PCR reactions. PCR fragments were sequenced in 15-μl reaction volumes containing 
6 μl of the purified PCR product, 0.16 μM of sequencing primer, 0.75 μl of BigDye 
termination mix v1.1 (Applied Biosystems) and 5 μl of the accompanied sequencing 
buffer. The samples were placed on a thermocycler under the following conditions: 25 
cycles of 96°C for 10 seconds, 55°C for 5 seconds and 60°C for 4 minutes.
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5.2.2.4. Post-Sequencing Treatment
To purify the sequencing reaction products, 2.5µl of 125 mM EDTA and 30 µl of 
100% ethanol were added to each sample, thoroughly mixed and left at room 
temperature for 10 min. The mixture was centrifuged for 60 min at 2240x g, followed 
by centrifuging the inverted PCR plate at 13x g for 1 min to discard the supernatant. 
30 μl of 70 % ethanol was then added to each sample and centrifuged for 10 minutes 
at 2240x g. The resultant supernatant was again discarded by inverting the PCR plate 
and centrifuging for 1 min at 13x g. Samples were then dried for 5 minutes at 65ºC 
before adding 10 μl of Hi-Di formamide (Applied Biosystems) prior to 
electrophoresis. Finally, samples were run on an ABI 3730 genetic analyser and 
analysed using Sequencher 4.7 software (Gene Codes Corporation, USA).
5.2.2.5. Analysis of Output
The chromatogram of each sample was visually inspected across its whole length of 
sequence to check for high levels of background noise that would make it difficult to 
call bases. Subsequently, if no significant trace of noise was found, a contig was then 
formed for each set of 96 samples (i.e., one sequencing plate) and each mutation site 
was examined by eye to determine whether it was a substitution, insertion or deletion. 
All samples with any ambiguous sites were resequenced. Polymorphisms which were 
found in the forward sequence of a sample were confirmed by resequencing the 
reverse strand.
5.2.3. Multiplex PCR-Minisequencing (Single Base Extension Assay)
In order to generate genotypic data for CYP1A2 SNPs, a multiplex Polymerase Chain 
Reaction-Minisequencing (PCR-M) assay was developed. This method reduces the 
time and cost of genotyping by combining multiple PCR and minisequencing 
reactions in one tube. 
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5.2.3.1. Multiplex PCR
Four PCR fragments were amplified simultaneously in a single reaction using four 
sets of primers (see Table 5.2). All eight primers were designed using the FastPCR 
software (Kalendar, Lee & Schulman 2009). The ‘multiplex PCR’ option in this 
software allows for primers to be chosen with minimal molecular hybridisation within 
and between all oligonucleotides. The specificity of each primer was checked locally 
using an alignment of genic sequence between CYP1A2 and CYP1A1. The primers 
were also checked against the whole genome for specificity, using the BLAST 
program (ncbi.nlm.nih.gov/blast).
Table 5.2. Primer details of the four PCR fragments in the multiplex PCR assay
PCR fragment Primer Name Sequence (5' - 3')
Length 
(bp) Tm (°C) GC %
1A2-2392-F ACAACCCTGCCAATCTCAAGCACC 24 62.7°C 54.2%
2392 (880 bp)
1A2-2392-R CCATCTGTACCAACTGCAGGGA 22 59.8°C 54.5%
1A2-4409-F CTAGCAGAGTCCTGCAATGTG 21 56.8°C 52.4%
4409 (771 bp)
1A2-4409-R AGCTGCTGGAATTATAGGGGCCTA 24 60.2°C 50.0%
1A2-6509-F CCGTGAGTACATACCCCTCACGAA 24 60.6°C 54.2%
6509 (511 bp)
1A2-6509-R CATCACCTGTAACAAACGTCTTGG 24 57.3°C 45.8%
1A2-9570-F TAGTAGAGACGGGTTTCACCA 21 55.6°C 47.6%
9570 (326 bp)
1A2-9570-R AAGCCAGTCACAAAAGACCACTC 23 58.4°C 47.8%
A 20-μl PCR reaction mix was comprised of the following reagents: 2μl (~ 1μM) of 
genomic DNA (gDNA) and 0.06 μl (50 μM) of forward and reverse primers for each 
fragment, in the presence of 2 μl of 10x Taq buffer, 5 μl (25 μM) of dNTPs, 23.3 nM 
TaqStartmonoclonal antibody (BD Biosciences Clontech, Oxford, UK) and 0.33 units
of Taq DNA polymerase (HT Biotech, Cambridge, UK). The reaction mixtures were 
incubated at 95ºC for 4 min, followed by 33 cycles of 95ºC for 1 min, 63.5ºC for 1 
min and 72ºC for 1 min. The final step of the PCR was a 7-min extension at 72ºC. 
The PCR products were then analyzed electrophoretically on an ethidium bromide-
stained 2% Agarose gel (see Figure 5.3).
117
Figure 5.3. Scan of an agarose gel showing the result of the multiplex PCR.
Note: The molecular DNA marker has 10 bands of sizes 1000 to 100 bp from top to bottom.
5.2.3.2. Multiplex PCR Purification
Excess primers and dNTPs were removed from multiplex PCR reactions using 
Exonuclease I (Exo I) and Shrimp Alkaline Phosphatase (SAP). Exo I catalyses the 
cleavage of single-stranded oligonucleotides (i.e., primers) into their constituent 
nucleotides in a 3’ → 5’ fashion, while SAP removes the 5’- phosphate group of 
dNTP molecules. The degradation of PCR primers and de-phosphorylation of 
unincorporated dNTPs enables the subsequent minisequencing reaction to be 
implemented in an efficient manner with almost no interference.
Due to the high viscosity of the enzyme solutions and minute volumes required, a 
master mix was made up of SAP and Exo I with a 5 to 3 ratio respectively (in units). 
The purification mix per sample comprised of 0.8 units of Exo I and 1.33 units of 
SAP. This was added to 4 μl of PCR product and the following program was run in a 
thermocycler: incubation at 37ºC for 60 min, inactivation of enzymes at 75ºC for 15 
min and cooling at 4ºC for 30 min. When the next step (minisequencing) was not 
carried out immediately, samples were stored at – 20ºC.
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5.2.3.3. Minisequencing
The minisequencing reaction, which is a single-base primer extension method 
(Sokolov 1990; Pastinen et al. 1997), was also multiplexed and all four SNPs were 
typed simultaneously. Minisequencing primers were designed manually so that 
extended primers differed in size by a minimum of 3-4 base pairs, for better 
differentiation of fluorescent peaks and easier detection of alleles (see Table 5.3). A 
master mix of ABI Prism SNaPshot Multiplex Kit (Applied Biosystems) and primer 
mix (four minisequencing primers) was made in a 2:1 ratio respectively. 2.33 μl of the 
master mix was then added to 1 μl of purified PCR product. The thermal cycling was 
performed under the following conditions for 25 cycles: 96ºC for 10 s, 50ºC for 5 s
and 60ºC for 30 s.
5.2.3.4. Minisequencing Purification
Extended minisequencing primers were purified using the Calf Intestinal Phosphatase 
(CIP). CIP removes the 5’- phosphoryl group from unincorporated fluorescent 
ddNTPs and prevents them from co-migrating with extended primers during 
electrophoresis. This purification step was performed in the following way: 1 μl of a 
master mix consisting of CIP, 10x CIP buffer and dH2O (0.43 μl, 0.33 μl and 0.23 μl 
per sample) was added to each minisequencing reaction sample and incubated at 37ºC
for 1 hour, followed by 75ºC for 15 min.
Table 5.3. Details of the primers used in the multiplex minisequencing reaction
Primer Name Sequence (5' - 3')
Length 
(bp)
Orientation
EXT-2392-F GATAAAGAATGCCCTGGGGAGG 22 Sense
EXT-4409-F GCACAGCAAGAAGGGGCCTAGAGCCAG 27 Sense
EXT-6509-F GAAGGCTGTTTGTCCCTGCTAGGAACTGTTTA 32 Sense
EXT-9570-R GGGTGATGAAAATGTTCTAAAATTAATTGTGGGCCGG 37 Anti-sense
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5.2.3.5. Electrophoresis of Minisequencing Products
To each cleaned-up minisequencing sample (~ 4 μl), 16 μl of Hi-Di formamide was 
added. The samples were then denatured at 95ºC for 4 min before they were snap-
cooled on ice. Finally, samples were run on ABI PRISM 3100 Genetic Analyser 
(Applied Biosystems) and the output was analysed using GeneScan ver 3.7. 
5.2.4. Statistical Analysis
Deviation from Hardy-Weinberg expectations was assessed at each locus and its 
significance was examined using a permutation test. Pairwise linkage disequilibrium 
(LD) was also assessed between loci by estimating D´ and r2. Haplotypes were 
inferred by parsimony and checked using the Excoffier-Laval-Balding (ELB) and 
Expectation Maximisation (EM) algorithms (Excoffier et al. 2003 and Excoffier & 
Slatkin 1995 respectively). Genetic diversity, h, and its standard error were estimated 
from unbiased formulae of Nei (1987). Mean number of pairwise nucleotide 
differences were also calculated for CYP1A1 sequences in each group. Population 
genetic structure was estimated using Hierarchical Analysis of Molecular Variance 
(AMOVA) (Excoffier et al. 1992), which takes into account the evolutionary 
relationship between pairs of haplotypes and generates a statistic called Fixation 
Index (FST), when a simple structure of populations within a single group was 
defined. When a hierarchical structure was defined, three fixation indices FST (among 
all groups), FSC (among groups within a geographic region) and FCT (among 
geographic regions) were generated. Patterns of genetic differentiation were 
quantified using the following genetic distance measures estimated from AMOVA-
based φst values (Excoffier et al. 1992; Michalakis & Excoffier 1996): a) FST
(Reynolds, Weir & Cockerham 1983) (based on CYP1A1 and CYP1A2 haplotypes) 
and b) Kimura’s two-parameter (K2P) model with gamma distribution of value 0.47 
(Kimura 1980) (based on CYP1A1 sequences). Significance of Fixation Indices and 
genetic distances were assessed by permutation test, where a null distribution is 
formed by calculating all possible values under rearrangements of haplotypes in the 
observed samples. The permutation test is usually repeated 10,000 times to give rise 
to the null distribution. Exact Test of Population Differentiation (ETPD) is an 
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analogue of a Fisher’s Exact test but the size of the contingency table is extended to 
the number of populations being compared (two in a pairwise population comparison 
or greater in a global test) by the total number of different haplotypes present 
(Raymond & Rousset 1995). Several tests of departure from neutrality such as 
Tajima’s D (Tajima 1989), Fu’s F (Fu 1997), McDonald-Kreitman (MK) test 
(McDonald and Kreitman 1991) and Fu and Li’s D and F tests (Fu and Li 1993) were 
carried out in order to identify signals of selection. All the above was performed using 
Arlequin software version 3.0 (Excoffier et al. 2005) except for the MK and Fu & Li’s 
D and F tests, which were performed using the DNAsp software (www.ub.edu/dnasp).
LD parameters were also estimated by GOLD (Abecasis & Cookson 2000) and 
compared with those obtained by Arlequin. Principal Component Analysis (PCA) and 
Principal Coordinates Analysis (PCO) were performed, using the ‘R’ environment of 
statistical computing (www.R-project.org) by implementing the ‘princomp’ and 
‘cmdscale’ functions respectively, on pairwise FST and K2P matrices and visualised 
using the ‘plot’ function. Both plots were used to visualise relationships among 
groups. 2x2 Fisher’s exact test and test of equality of variances (F-test) were 
performed in R using the ‘fisher.test’ and ‘var.test’ functions. Relationships of
CYP1A1 and CYP1A2 haplotypes were displayed via reduced-median networks
constructed within Network 4.56 (Fluxus Engineering). The Freeman-Halton 2x3 
extension of the Fisher exact probability test (Freeman and Halton 1951) was 
performed using the online calculator available at 
http://faculty.vassar.edu/lowry/fisher2x3.html.
5.2.5. Haplotype tagging SNP selection criteria
The four SNPs genotyped in CYP1A2 were chosen applying the following criteria 
(based on the resequencing data obtained by EGP):
Select:
1.  Polymorphic sites on each side, but within one thousand base pairs, of the 
transcribed region of CYP1A2 that displayed greatest heterozygosity in the EGP 
Yoruba dataset.
2. All predicted to affect function lying between the two polymorphisms selected in 1 
(i.e., non-synonymous and frame-shift mutations) unless they were singletons.
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3. Select only one polymorphism in any set in total linkage disequilibrium (keeping 
the functional variants).
5.2.6. Sequence alignment
Alignment of the exonic and intronic sequences of the human, chimpanzee, gorilla 
and macaque CYP1A genes was available in Ensembl (release 58; May 2010). All 
coding sequence (CDS) alignments (exons) between human CYP1A1 and CYP1A2
were performed using TranslatorX (Abascal et al. 2010). The method used by this 
software is to translate the CDS and perform an alignment of amino acid sequences. 
The alignment is then used as a template to align corresponding CDS sequences based 
on codons and not individual nucleotides. Since alignments provide a measure of 
homology between nucleotide and amino-acid sequences and that CDS identity
diverges more rapidly than the amino-acid sequence (due to the degenerate nature of 
the genetic code), coding sequence alignments based on corresponding amino-acid 
alignments give a more accurate estimate of divergence.
5.2.7. Prediction of the effect of non-synonymous mutations on protein 
functionality
The effects of non-synonymous variants were assessed based on the extent of 
physiochemical differences between the ancestral and derived amino-acid residues, 
using the classification shown in Figure 5.4. 
Furthermore, a more detailed prediction was also made by using PolyPhen (Ramensky 
et al. 2002), which can be publicly accessed at http://genetics.bwh.harvard.edu/pph/ . 
PolyPhen initially checks whether the amino-acid substitution occurs in any site with 
annotated functional motifs. Furthermore, it aligns the protein sequence of the gene 
carrying the non-synoymous variant with its orthologues and determines the level of 
incompatibility of the substitution at that site by calculating the difference of position-
specific independent counts (PSIC) (Sunyaev et al. 1999) scores of two variants. The
higher a PSIC score difference, the higher the functional impact that is predicted for a 
particular amino-acid substitution. At PSIC ≥ 1.5, the functional damage is considered 
to be significant.
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Figure 5.4. Amino acid molecular structures and their classification according to
physiochemical properties
                          Figure obtained from http://kimwootae.com.ne.kr/apbiology/chap2.htm
5.3. Results
5.3.1. CYP1A1
5.3.1.1. Genetic variation in CYP1A1
A total of 978 bp of DNA sequence, covering exons 3 (127 bp), 4 (90 bp), 5 (124 
bp) and 6 (87 bp), introns 3 (87 bp), 4 (91 bp) and 5 (145 bp) and flanking regions 
of introns 2 (132 bp) and 6 (94 bp), was obtained for 622 samples from twelve 
sub-Saharan African population groups. 14 variants were identified, of which 
twelve were single-base substitutions and the other two were indels. A single-base 
substitution was defined as a ‘Single-Nucleotide Polymorphism’ (SNP) when the 
minor allele was observed more than once and found at a frequency ≥ 1% in any 
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single population group, otherwise it was defined as a rare variant. The details of 
all polymorphisms identified are given in Table 5.4. Exons 3 and 5 have almost 
the same nucleotide length, however, exon 3 carried seven (half of total) 
polymorphisms, while exon 5 was found to be monomorphic in 699 individuals 
from sub-Saharan Africa. The ratio of the number of non-synonymous to 
synonymous polymorphisms was 6:4. In the Ethiopian ascertainment panel, the 
ratio was 6:3, which was similar to that displayed in the EBSP ascertainment 
panel (2:1). Among the twelve single-base substitutions, nine transitions and three 
transversions were observed, where half of the transitions were of one type (Y; 
C↔T). Furthermore, 8 of 9 transition variants occurred in coding regions. The 
two indels identified were observed in exon 6 and only found to be present in the 
EBSP ascertainment panel. The 3-bp deletion at the start of the exon results in a 
single amino-acid (aa) residue (Threonine) deletion, while keeping the transcript 
in frame. However, the 1-bp insertion in the middle of the exon creates a 
frameshift and results in a premature stop-codon. The truncated protein (416 aa) 
lacks the peptide sequence encoded by exon 7 and therefore is 96 aa shorter than 
the ancestral transcript (512 aa). Except one (position 1390; rs34260157), all 
polymorphisms were only found in a heterozygote state.
Table 5.4. CYP1A1 variants  identified in this study.
Position 
(A in ATG 
is +1)
Location        Flanking sequence Nucleotide 
change
Amino Acid 
change
dbSNP ID*
1383 Exon 3 TACCTAAGGG*CACATCCGGG C > T
1390 Exon 3 GGGCCACATC*GGGACATCAC C > T R > W rs34260157**
1412 Exon 3 GACAGCCTGA*TGAGCACTGT T > C I > T rs4987133
1418 Exon 3 CTGATTGAGC*CTGTCAGGAG A > C H > P
1455 Exon 3 ACGCCAATGT*CAGCTGTCAG C > A
1481 Exon 3 AAGATCATTA*CATCGTCTTG A > G N > S
1485 Exon 3 TCATTAACAT*GTCTTGGACC C > T
1545 Intron 3 GTGCTCAAGT*CCCTGACCTG G > A
1623 Exon 4 CTGCTATCTC*TGGAGCCTCA C > T
1651 Exon 4 GGTGATGAAC*CCAGGGTACA C > T P > S
1988 Intron 5 ACACGGCATG*GAGACAGGGA G > C
2050 Exon 6 CCTAGCACAA*GAGACACAAG CAA > - T > -
2091 Exon 6 CCCCAAGGGG*CGTTGTGTCT - > G frameshift
2092 Exon 6 CCCCAAGGGG*GTTGTGTCTT C > T R > C
* All polymorphisms except those at positions 1390 and 1412 are considered to be novel variants 
first identified here.
** SNP ID was obtained from the NCBI SNP database (http://www.ncbi.nlm.nih.gov/SNP)
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As shown in Table 5.5, among the twelve single-base substitutions, only three 
were at polymorphic frequencies and the other nine were rare variants. Of the 
three SNPs, one was novel and confined to the EBSP panel and private to the 
Shewa Arabs in Lake Chad. The two known SNPs, which were also the most 
frequent of all polymorphisms, were found in both panels, with the highest 
frequencies observed in Ethiopian groups. Interestingly, seven rare variants were 
confined to the Ethiopian panel and nearly half were private to the Anuak. The 
most frequent SNP was observed at position 1412 (rs4987133) at 3.7% in the 
Anuak. Therefore, all polymorphisms identified here are not regarded to be 
common (i.e., they are < 5%).
Most previous studies resequencing exons 3, 4, 5 and 6 of the CYP1A1 gene did 
not find any polymorphism in this region, with polymorphisms mainly confined to 
exons 2 (825 bp) and 7 (286 bp) (Solus et al. 2004; Jiang et al. 2005). The 
Environmental Genome Project (EGP) at NIEHS also found no polymorphism in 
this region among five diverse ethnic population groups including sub-Saharan 
Africans (Yoruba) and African Americans. However, two single variants (i.e.,
rs34260157 and rs4987133) were observed by the SNP500Cancer project (Packer 
et al. 2004) in a set of 24 Coriell samples of recent African origin. The predicted 
functional alteration of the CYP1A1 protein by the six non-synonymous SNPs 
identified was investigated.
Based on physiochemical properties of individual amino acids, the relative 
importance of each predicted change at the protein level was examined. The first 
SNP (R279W) is predicted to cause a dramatic change, due to a positively charged 
amino acid being replaced by a non-polar aromatic amino acid. The second SNP 
(I286T) results in the replacement of a non-polar residue with a polar one. The 
third (H288P) and the sixth (R405C) non-synonymous SNP result in replacement 
of a positively charged residue with a polar one. However, the fourth and the fifth 
SNP, despite changing the amino-acid residue, do not alter the physiochemical 
properties of their respective site on the peptide sequence. 
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Minor allele frequency (MAF) of each SNP was calculated in each individual 
population group and deviations from Hardy-Weinberg equilibrium (HWE) 
expectations were examined. All SNPs showed no sign of significant deviation 
from HWE expectations (p > 0.05). CYP1A1 haplotypes were generated by visual 
inspection without the need to infer phase since all 1244 chromosomes were 
unambiguous. 
Based on the haplotypes generated, estimators of linkage disequilibrium (LD) 
(i.e., D´ and r2) were calculated in each individual population group. Six 
population groups (Sena, Ghana, Somie, Malawi, Congo and Sudan) lacked two 
or more polymorphic loci. The results for the rest of the groups were very similar 
to each other, with D´ values of 1 and r2 values below 0.001. Furthermore, when 
samples from all populations were pooled together, values of D´ and r2 were 
unaffected.
Nei’s Gene diversity based on SNP haplotypes for the whole dataset (n = 622) 
was 0.052 ± 0.009. In individual groups, gene diversity ranged from 0.000-0.122 
(mean of 0.045 and variance of 0.002) with Somie, Malawi and Sudan having no 
gene diversity (samples being monomorphic) and Afar having the highest value. 
Averaged nucleotide diversity (π) in the whole dataset was 0.005 ± 0.012 and 
ranged from 0.000 – 0.011 in individual groups (mean of 0.004 and variance of 
0.0002) with the same order as observed for gene diversity.
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Table 5.5. Frequency distribution of variants identified in sub-Saharan African population groups.
*The number of chromosomes scanned at each polymorphic locus is shown in parenthesis. 
**Variable sites in each population group are shown in bold type.  ***Variable sites that can be defined as a SNP are shown in bold red.
Position
(A in ATG 
is +1)
EBSP
panel
Sena 
(SE)
Ghana 
(GH)
Somie 
(SO)
Malawi 
(MAL)
Lake 
Chad 
(LC)
Congo 
(CO)
Sudan 
(SU)
Ethiopia
panel
Oromo 
(OR)
Amhara 
(AM)
Anuak 
(AN)
Afar 
(AF)
Maale 
(MAA)
1383 0.000* 
(636)
0.000 
(100)
0.000 
(92)
0.000 
(116)
0.000 
(64)
0.000 
(102)
0.000 
(104)
0.000 
(58)
0.001 
(718)
0.000 
(152)
0.007 
(142)
0.000 
(144)
0.000 
(134)
0.000 
(146)
1390***   0.004 **
(636)
0.000 
(100)
0.011 
(92)
0.000 
(116)
0.000 
(64)
0.020 
(102)
0.000 
(104)
0.000 
(58)
0.014 
(718)
0.007 
(152)
0.000 
(142)
0.035 
(144)
0.030 
(134)
0.000 
(146)
1412 0.002
(636)
0.000 
(100)
0.000 
(92)
0.000 
(116)
0.000 
(64)
0.010 
(102)
0.000 
(104)
0.000 
(58)
0.013 
(718)
0.020 
(152)
0.000 
(142)
0.007 
(144)
0.037 
(134)
0.000 
(146)
1418 0.000 
(636)
0.000 
(100)
0.000 
(92)
0.000 
(116)
0.000 
(64)
0.000 
(102)
0.000 
(104)
0.000 
(58)
0.001 
(718)
0.000 
(152)
0.000 
(142)
0.007 
(144)
0.000 
(134)
0.000 
(146)
1455 0.002 
(636)
0.000 
(100)
0.000 
(92)
0.000 
(116)
0.000 
(64)
0.010 
(102)
0.000 
(104)
0.000 
(58)
0.000 
(718)
0.000 
(152)
0.000 
(142)
0.000 
(144)
0.000 
(134)
0.000 
(146)
1481 0.000 
(636)
0.000 
(100)
0.000 
(92)
0.000 
(116)
0.000 
(64)
0.000 
(102)
0.000 
(104)
0.000 
(58)
0.001 
(718)
0.000 
(152)
0.000 
(142)
0.007 
(144)
0.000 
(134)
0.000 
(146)
1485 0.000 
(636)
0.000 
(100)
0.000 
(92)
0.000 
(116)
0.000 
(64)
0.000 
(102)
0.000
(104)
0.000 
(58)
0.001 
(718)
0.000 
(152)
0.000 
(142)
0.007 
(144)
0.000 
(134)
0.000 
(146)
1545 0.003 
(636)
0.010 
(100)
0.000 
(92)
0.000 
(116)
0.000 
(64)
0.000 
(102)
0.010 
(104)
0.000 
(58)
0.000 
(718)
0.000 
(152)
0.000 
(142)
0.000 
(144)
0.000 
(134)
0.000 
(146)
1623 0.000 
(636)
0.000 
(100)
0.000 
(92)
0.000 
(116)
0.000 
(64)
0.000 
(102)
0.000 
(104)
0.000 
(58)
0.001 
(718)
0.007 
(152)
0.000 
(142)
0.000 
(144)
0.000 
(134)
0.000 
(146)
1651 0.000 
(636)
0.000 
(100)
0.000 
(92)
0.000 
(116)
0.000 
(64)
0.000 
(102)
0.000 
(104)
0.000 
(58)
0.004 
(718)
0.007 
(152)
0.007
(142)
0.000 
(144)
0.000 
(134)
0.007 
(146)
1988 0.003 
(680)
0.000 
(92)
0.000 
(102)
0.000 
(118)
0.000 
(84)
0.016 
(122)
0.000 
(102)
0.000 
(60)
0.000 
(718)
0.000 
(142)
0.000 
(146)
0.000 
(138)
0.000 
(112)
0.000 
(140)
2050 0.004
(680)
0.000 
(92)
0.000 
(102)
0.000 
(118)
0.012 
(84)
0.000 
(122)
0.020 
(102)
0.000 
(60)
0.000 
(718)
0.000 
(142)
0.000 
(146)
0.000 
(138)
0.000 
(112)
0.000 
(140)
2091 0.001 
(680)
0.000 
(92)
0.000 
(102)
0.000 
(118)
0.000 
(84)
0.000 
(122)
0.000 
(102)
0.017 
(60)
0.000 
(718)
0.000 
(142)
0.000 
(146)
0.000 
(138)
0.000 
(92)
0.000 
(102)
2092 0.000 
(680)
0.000 
(92)
0.000 
(102)
0.000 
(118)
0.000 
(84)
0.000 
(122)
0.000 
(102)
0.000 
(60)
0.001 
(718)
0.007 
(142)
0.000 
(146)
0.000 
(138)
0.000 
(112)
0.000 
(140)
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A reduced-median network of CYP1A1 SNP haplotypes was generated. Since all 
SNPs seem to have risen independently of each other (based on the observation 
that no compound haplotype was found), the network is a vivid example of a star-
shape haplotype tree (see Figure 5.5).
Figure 5.5. Reduced-median network of CYP1A1 haplotypes observed in sub-Saharan Africa.
5.3.1.2. Selection tests
In order to see whether the CYP1A1 gene has been under selection, five selective 
neutrality tests were implemented in each population group. Fu’s Fs, McDonald-
Kreitman test and Fu & Li’s D and F tests could not be calculated when all samples in 
a population group were monomorphic or polymorphisms were not present in the 
coding region. As shown in Table 5.6, both D and Fs are significant in three Ethiopian 
populations along with Shewa Arabs in Lake Chad. However, the other two Ethiopian 
groups show no significance for either of the two statistics. Among population groups, 
Sena, Ghana and Congo only show high significance for Fs and not for D. No 
significant departure of neutrality was found using the McDonald-Kreitman test. Fu 
and Li’s tests were not significant in some populations but both were consistently 
significant in three Ethiopian populations (Amhara, Anuak and Oromo).  
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Table 5.6. Selective neutrality test statistics and corresponding significance.
    
* Negative values of Tajima’s D, Fu’s Fs and Fu & Li’s D and F tests indicate departure from 
neutrality (larger negative statistic values display more significance) ** Significant neutrality statistics 
and corresponding p-values are shown in bold type
The same tests were also performed for the whole dataset. Tajima’s D and Fu’s Fs 
were -1.929 (p < 0.001) and -3.4 x 1038 (p < 0.001) respectively. Fisher’s exact test p-
value of McDonald Kreitman test was still non-significant (p = 1). Fu and Li’s 
selective parameters were more significant than when estimated in each population (D 
= -3.99 (p <<0.02) and F = -3.91 (p << 0.02)). Since most p-values obtained from 
different selection tests are given as intervals, the upper boundary value was used to 
obtain a conservative measure when carrying out Fisher’s Combined Probability Test 
(FCPT). The test statistic for FCPT was highly significant (P < 0.001) even though 
multiple testing was taken into account. Therefore, the results strongly suggest that a 
significant departure from neutrality has occurred in the CYP1A1 gene.
5.3.1.3. Inter-population analysis
Based on CYP1A1 SNP haplotypes, AMOVA fixation indices indicate that almost 
99.7 % of variation observed is within the individual population groups and the 
amount of variation between the two panels (EBSP and Ethiopia) was < 0.1% (p = 
0.72). Genetic differences among individual groups were also analysed by estimating 
pairwise genetic distances (K2P) based on the same haplotypes. 
Tajima's test Fu's test
McDonald-
Kreitman 
test Fu and Li's test
Population 
group D (p-value) Fs (p-value)
Fisher's 
exact test p-
value D (p-value) F (p-value)
Sena -1.040 (0.130)* -2.130 (<0.001)** NA -2.00 (0.05 < p < 0.10) -2.00 (0.05 < p < 0.10)
Ghana -1.042 (0.118) -2.111 (0.029) 1.00 -2.00 (0.05 < p < 0.10) -1.99 (0.05 < p < 0.10)
Malawi 0.000 (1.000) NA NA NA NA
Somie 0.000 (1.000) NA NA NA NA
Lake Chad -1.488 (0.015) -4.271 (0.001) 1.00 -1.46 (p > 0.10) -1.80 (p > 0.10)
Congo -1.028 (0.121) -2.219 (<0.001) NA -2.03 (0.05 < p < 0.10) -2.02 (0.05 < p < 0.10)
Sudan 0.000 (1.000) NA NA NA NA
Amhara -1.796 (0.002) -8.802 (<0.001) 1.00 -2.94 (p < 0.05) -2.86 (p < 0.05)
Afar -1.339 (0.038) -4.475 (<0.001) 0.33 0.67 (p > 0.10) 0.18 (p > 0.10)
Anuak -1.627 (0.008) -5.938 (<0.001) 0.40 -2.76 (p < 0.05) -2.81 (p < 0.05)
Oromo -0.981 (0.167) -1.858 (0.085) 0.33 -3.42 (p < 0.02) -3.40 (p < 0.02)
Maale -1.000 (0.122) -2.428 (0.014) 1.00 -2.09 (0.05 < p < 0.10) -2.06 (0.05 < p < 0.10)
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Figure 5.6. PCO plot of K2P pairwise distances among twelve sub-Saharan African and one 
European population groups. 
Percentages in parentheses are the amount of variation explained by each eigen vector. Abbreviations 
are the same as in Table 2. EU stands for the European population (EGP).
Among the 66 pairwise comparisons implemented, only two pairwise distances were 
significant at 5% level (Lake Chad vs Amhara and Afar vs Amhara) and the 
maximum pairwise genetic distance (0.021) was also observed between Afar and 
Amhara. After applying a Bonferroni correction, the two distances were no longer 
significant. A visual representation of the genetic relationship among these groups is 
shown in Figure 5.6. 
Furthermore, pairwise genetic differences were also assessed by ETPD using all 
CYP1A1 haplotypes. The pattern observed displayed a higher level of genetic 
differentiation among population groups than that observed by pairwise K2P values. 
Lake Chad was differentiated from Congo and Maale along with Amhara, while 
Ethiopian populations were almost all differentiated from each other except for 
Oromo, which displayed no significant genetic differentiation with any other 
130
Ethiopian population. Since all non-African populations are monomorphic for this 
region, no pairwise comparisons could be made among themselves since gene 
diversity in all populations was zero. Therefore, the European population was used as 
the representative of populations outside of sub-Saharan Africa. Due to lack of 
significant variation, all sub-Saharan African populations had non-significant genetic 
distances (FST <0.008, p > 0.26) with the European population. 
5.3.2. CYP1A2
5.3.2.1. Genetic variation in CYP1A2
Four of the SNPs characterised in EGP (with relative positions of 2392, 4409, 6509 
and 9570) were typed to generate haplotypes extending over most of the 7.5 kb gene 
(Intron1 to 3’UTR) in the EBSP ascertainment panel. The second SNP at position 
4409 is a non-synonymous change in exon 3, whereas the other three SNPs are 
intronic. All four SNPs were shown to be variable in the ascertainment panel, but not 
in all population groups (see Table 5.7). 
Table 5.7. Minor allele frequencies of the four SNPs in all population groups
Population group Position on gene sequence (EGP)
EBSP panel 2392 4409 6509 9570
Sena 0.010 0.020 0.070 0.150
Ghana 0.053 0.096 0.132 0.202
Somie 0.055 0.078 0.078 0.125
Malawi 0.050 0.080 0.070 0.110
Lake Chad 0.000 0.131 0.092 0.115
Congo 0.000 0.055 0.136 0.191
Sudan 0.017 0.067 0.067 0.117
Ethiopian panel
Oromo 0.000 0.050 0.086 0.114
Amharic 0.000 0.007 0.070 0.090
Anuak 0.070 0.105 0.033 0.092
Maale 0.000 0.055 0.068 0.096
Afar 0.000 0.028 0.050 0.085
EGP panel
African-Yoruba 0.040 0.120 0.080 0.150
African Americans 0.030 0.030 0.110 0.190
European 0.000 0.000 0.000 0.030
Hispanic 0.000 0.000 0.020 0.080
Asian 0.000 0.000 0.020 0.220
131
Figure 5.7 is a histogram of minor allele frequencies at the four SNP loci in twelve 
population groups. The 2392 and 9570 SNPs were found to have the lowest and 
highest heterozygosity in all population groups except for the Shewa Arabs in 
Lake Chad. The 4409 SNP was found be at the highest frequency in Lake Chad 
and present only in African and recent African-descent population groups (i.e. 
African Americans). Although the derived allele (non-synonymous change) at 
position 4409 (rs17861157) was present at a frequency range of 0.020-0.131
across the population groups in the ascertainment panel, this allele has not been 
reported in individuals without a recent African ancestry. In a parallel study 
(Browning 2009), allele frequencies for these four SNPs were obtained through 
resequencing in Ethiopian ascertainment panel. Similar minor allele frequencies 
were obtained to those in the EBSP region, with the exception that 2392 was 
present only in the Anuak (see Figure 5.7). Deviations from HWE expectations 
were examined for all four SNPs in each individual population group. Among all 
four SNPs tested in all populations, only Somie (at 4409) and Sena (at 6509) were 
found to show deviation from HWE expectations (p-values of 0.037 and 0.011 
respectively). However, when a Bonferroni correction was applied for testing of 
multiple groups, no locus departed significantly from Hardy-Weinberg 
equilibrium in any group.
CYP1A2 haplotypes were inferred using the ELB algorithm and parsimony. Six 
haplotypes were identified with the common haplotype being shared with the 
chimpanzee and macaque (see Figure 5.8). As estimator of LD, D´ was calculated 
for each ascertainment panel. In the EBSP ascertainment panel, all D´ value 
among all loci were equal to 1, indicating strong LD across the gene. However, 
when D´ was calculated for the Ethiopian acertainment panel, three out of six 
pairwise LD were below 1 (2392-6509, 2392-9570 and 4409-6509 had D´ equal to 
1)) which displays a lower level of LD in Ethiopia.
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Figure 5.7. The distribution of CYP1A2 derived haplotypes in EBSP, Ethiopian and EGP population groups. The modal ancestral haplotype ranged from 
0.649-0.974, where the lowest and highest frequencies were observed in the Ghanaian and European population groups (not shown).
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Furthermore, haplotype GCCC was observed only in the Ethiopian ascertainment 
panel (Afar and Oromo each having two chromosomes). This explains the lack of LD 
between 6509 and 9570 in the Ethiopian ascertainment panel since all four allelic 
combinations between these two SNPs were observed. 
Figure 5.8. A one-step mutation network of all inferred CYP1A2 haplotypes.
Interestingly, the non-synonymous allele (4409) was present in only one haplotype 
(GATC). At the protein level, the 4409 SNP (S298R) could result in a significant 
change in protein structure since substituting the amino acid serine for arginine could 
change the overall conformation, due to the increase of positive charge on the amino-
acid R group.
Nei’s gene diversity based on inferred CYP1A2 haplotypes for the whole sub-Saharan 
African dataset (n = 727) was 0.358 ± 0.016. In individual groups, gene diversity 
ranged from 0.181-0.549 (mean of 0.358 and variance of 0.011), with Amhara and 
Ghana having the lowest and highest values respectively.   
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5.3.2.2. Inter-population analysis          
                               
Based on AMOVA fixation indices, although 98.3 % of variation observed was 
within the individual population groups, the amount of variation among population 
groups was highly significant (FST = 0.017, p < 0.0001). Pairwise genetic distances 
(FST) were estimated based on CYP1A2 haplotypes. Among the 66 pairwise 
comparisons implemented, 22 pairwise distances were significant at 5% level. Among 
the population groups, Sudan had no significant distances, while Amhara, Afar and 
Anuak each had six including among themselves, except Amhara vs Afar. 
Figure 5.9. PCO plot of pairwise genetic distances (FST) of sub-Saharan African groups based on 
CYP1A2 haplotypes.
Percentages in brackets are the amount of variation explained by each eigen vector. Abbreviations are the 
same as in Table 5.5.
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The maximum pairwise genetic distance (FST = 0.105) was observed between Amhara 
and Ghana (see Figure 5.9). Based on the inferred haplotypes, ETPD was also used to 
examine pairwise genetic differentiation among groups. A similar pattern was displayed
to that observed by pairwise FST values. However, rather than Amhara or Afar, Ghana 
and Anuak showed the highest level of differentiation from other population groups 
(eight significant pairwise differences (p < 0.05)). The sub-Saharan African populations 
were then pooled into the two previously defined ascertainment panels representing 
EBSP and Ethiopia and compared with populations outside of Africa. Based on pairwise 
genetic distances (FST), EBSP was significantly different from all other populations, 
except for the African Americans.
Figure 5.10. Visual representation of genetic distances (FST) between the EBSP and 
Ethiopian ascertainment panel populations and populations outside Africa based on CYP1A2
haplotypes
AA, AS, HIS and ETH are abbreviations for African Americans, Asians, Hispanics and Ethiopians 
respectively.
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Although significant, the genetic distance between EBSP and Ethiopia (FST = 0.012) was 
the lowest of all the pairwise comparisons with EBSP. Ethiopia was also found to have 
significant genetic distances with the European (FST = 0.030) and Asian (FST = 0.055) 
populations. Among all, the largest pairwise genetic distance was observed between the 
European and Asian populations (FST = 0.153) (see Figure 5.10). 
The ETPD results were similar to those obtained based on pairwise FST values, however, 
with a few exceptions. The pairwise genetic differences between EBSP-Hispanics and 
Ethiopia-European were no longer significant, while the Asians and the African 
Americans, which had a non-significant FST (p = 0.161) were genetically differentiated (p 
= 0.022).
Furthermore, when individual groups within the two ascertainment panels were compared 
with the European population, the average genetic distance of Ethiopian populations was 
0.038 (lowest and highest observed in the Afar (0.014) and Anuak (0.085)), while EBSP 
populations had an average distance of 0.081 (lowest and highest observed in Sena 
(0.040) and Ghana (0.133)).
5.3.3. Variation in CYP1A cDNA and proteins
Using TranslatorX (Abascal et al. 2010), the cDNA sequence of exons 3, 4, 5 and 6 of 
both CYP1A genes (obtained from the NCBI CCDS database; 
http://www.ncbi.nlm.nih.gov/projects/CCDS/) were translated into their respective 
peptide sequences and aligned, based on the ClustalW alignment algorithm (see Figure 
5.11).
137
Figure 5.11. Pairwise alignment of CYP1A protein sequence encoded by exons 3, 4, 5 and 6.
Identical positions between the two polypetides are highlighted in blue. First amino acid encoded by each 
exon is shown in a red rectangle (exon-exon boundaries).
Based on the pairwise protein alignment, exons 3 and 5 had the lowest and highest 
percentage identity respectively (38.1% and 87.8% respectively). Exons 4 and 6 had 
relatively similar percentage identities of 83.3% and 82.8% respectively. A 2x2 Fisher’s 
exact test was used to determine whether the conservation of any of the four exons 
significantly differs from any other (see Table 5.8).
Table 5.8. Pairwise comparison of conservation among exons 3, 4, 5 and 6 based on percentage 
amino acid identities and the corresponding p values.
As an example, the level of conservation between CYP1A1 and CYP1A2 at exon 4 
compared with exon 3 is (83.3 -38.1)% = 45.2% and the p-value for this difference is 
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0.0002. Overall, exon 3 was significantly less conserved than all other exons, even after
applying the Bonferroni correction (p ≤ 0.0002).  
The peptide sequence was then back translated into cDNA sequence while adhering to 
the same alignment output (alignment based on codons and not single nucleotides) (see 
Figure 5.12). Non-synonymous SNP loci identified in exons 3, 4, 5 and 6 in CYP1A1
(this study) and CYP1A2 (Browning 2009) were analysed in the context of the pairwise 
alignment of the two respective cDNA sequences covering exons 3 to 6. 
Figure 5.12. Pairwise alignment of CYP1A cDNA sequences confined to exons 3, 4, 5 and 6.
       
Identical positions between the two genes are highlighted in blue. Exon boundaries (first nucleotide of the 
following exon) are shown with a red rectangle.
Using the Polyphen software, the position-specific independent count (PSIC) differential 
scores were calculated for all amino-acid substitutions and their phenotypic effects were 
predicted. According to the data, four non-synonymous variants resulting in amino-acid 
substitutions in CYP1A1 may have deleterious effects (see Table 5.9). Three of these 
substitutions, which have PSIC scores higher than 2.0, occur at sites conserved between 
the two closely related CYP1A proteins. The other substitutions, with almost no 
significant predicted phenotypic effect (PSIC scores below 1.5), occurred at sites that 
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were not conserved but the PSIC score between the alleles were low with no apparent 
phenotypic significance. Furthermore, in only one case, at position 405 of the CYP1A1 
sequence, did the derived allele result in the same amino acid (C; Cysteine) as observed 
in CYP1A2.
Furthermore, the cDNA sequences of both CYP1A genes were aligned in a pairwise 
manner with the genomes of three other primates (i.e., chimpanzee, gorilla and macaque),
using the comparative genomic alignment tool in Ensembl. CYP1A1 displayed 100% 
identity to its orthologue in chimpanzee. However, when compared with its orthologues 
in gorilla and macaque, it showed 99% and 94% sequence identity respectively. Human
CYP1A2 displayed 97% and 93% sequence identity when compared with gorilla and 
macaque. However, when compared with the chimpanzee, a lower level of conservation 
was observed. The chimpanzee CYP1A2 sequence, compared with the human sequence, 
was reported to have a short indel (1bp) in exon 3, which results in a frameshift, causing 
early truncation of the protein sequence.
Table 5.9. Amino-acid substitutions predicted from non-synonymous variants in CYP1A exons 3 
to 6 and the conservation of these residues between CYP1A1 and CYP1A2.
Protein AA change PSIC Phenotypic effect AA site conservation
PSIC between 
CYP1A AA 
residues
R279W 3.120 Probably damaging YES
I286T 1.723 Possibly damaging NO; I and F residues 1.013
H288P 2.821 Probably damaging YES
N309S 0.273 Benign YES
P337S 2.289 Probably damaging YES
CYP1A1
R405C 0.580 Benign NO; R and C residues 0.580
S298R 0.867 Benign NO; S and A residues 0.415
T395M 0.489 Benign NO; T and S residues 0.138CYP1A2
N397H 0.856 Benign NO: N and K residues 1.202
Note: At non-conserved amino-acid sites (between CYP1A proteins), alternative amino acids are shown in 
column five and the position-specific independent counts (PSIC) score difference between them is shown 
in the next column. Note all PSIC scores are below the significance threshold.
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5.4. Discussion
In the present study, we performed SNP discovery and determined SNP frequencies by 
resequencing exons 3 to 6 of CYP1A1. Genetic variation in CYP1A2 was also determined 
and analysed by genotyping four SNPs (spanning the entire gene) thought to define 
haplotypes that will capture most functional variation. 
5.4.1. CYP1A1 variation
Four exons, three introns (introns 3, 4 and 5) and two flanking introns (adjacent regions 
of introns 2 and 6) of CYP1A1 were re-sequenced in seven sub-Saharan African 
population groups representing West Africa and the EBSP and five Ethiopian 
populations. Unlike previous studies, which were based on very few African samples 
(Solus et al. 2004; Jiang et al. 2005), this study re-sequenced approximately 1000 bp of 
the middle part of the CYP1A1 gene in over 600 samples. In order to place this set of data 
in a worldwide context, corresponding re-sequencing data was retrieved for five 
populations (African Americans, Yoruba, Europeans, Hispanics and Asians) represented 
by the EGP panel. However, since no variation was observed in any of these populations 
for this segment of the CYP1A1 gene, only one population was used for comparative 
analysis. 
In addition to the two known polymorphisms in exon 3, identified by the SNP500 Cancer 
Project, another twelve variations were identified in sub-Saharan African populations. 
Except for two variants, found in intron 3 (rare variant) and intron 5 (SNP), all other 
variants occurred in coding exons. Among all 14 variations (of which three are SNPs), 
seven were specific to Ethiopian populations and five were specific to EBSP populations,
while the two known SNPs were present in both EBSP and Ethiopian panels. The first of 
the two known SNPs was the most frequent among all polymorphisms identified 
(maximum observed frequency of 3.5%). The second SNP was also frequent in Ethiopian 
populations but only present as a singleton in Lake Chad. The populations carrying the 
highest level of variation were the Anuak and Oromo, with five polymorphisms each, 
along with Lake Chad, with four polymorphisms (two known SNPs in common). In 
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contrast, Somie in Cameroon showed no variation for this segment of the CYP1A1 gene. 
CYP1A1 gene diversity and average nucleotide diversity were observed to be highest in 
African populations in this study, which is consistent with the observation that human 
genetic variation is highest in sub-Saharan Africa (Tishkoff et al. 2009). Furthermore, 
among sub-Saharan African populations, highest genetic diversity was observed in 
Ethiopian populations. This is consistent with anatomically modern human migrating out 
of Africa via Ethiopia and the occurrence of back-migration of Semitic speaking peoples 
into Ethiopia from the Near-East, which has resulted in Ethiopia becoming highly diverse 
genetically. The first major finding of this study is that previously reported lack of 
CYP1A1 genetic variation has been due to small sample sizes and a restricted set of 
populations analysed. 
CYP1A1 haplotypes were unambiguous in all individuals of sub-Saharan African 
populations since no compound heterozygote individual was observed and all variants 
had occurred independently on the background of the modal ancestral haplotype. LD 
results were also consistent with this observation since all D´ values were equal to 1 
among all polymorphisms in all populations typed. In CYP1A2, except for two 
haplotypes, an identical pattern was observed where each derived allele had occurred on 
the background of the modal ancestral haplotype (Browning 2009). 
Furthermore, the star-like network of CYP1A1 haplotypes is consistent with the central 
region of the gene being under strong negative (purifying) selection. Therefore, it is 
likely that these exons (especially exons 4 and 5) encode parts of the peptide sequence 
that are essential for the metabolic function of the enzyme. This level of conservation 
among human populations is consistent with the proposed role of CYP1A1 in endobiotic 
metabolism (Ingelman-Sundberg 2002; Nebert and Karp 2008).
5.4.2. CYP1A sequence variation comparison
Based on the variation observed in exons 3 to 6 in CYP1A1 (present study) and CYP1A2
(Browning 2009) genes, the most frequent derived haplotype (after the modal ancestral 
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haplotype) was observed at 4% in the Anuak and at 13% in the Lake Chad dataset 
respectively. The difference in the number of variants found in this region of CYP1A
genes is of significance. In Ethiopia alone, six non-synonymous and three synonymous 
SNPs were identified in CYP1A1 and no intronic SNPs were found. On the other hand, 
three non-synonymous SNPs and six intronic SNPs were identified in CYP1A2
(Browning 2009) (Freeman-Halton test p-value = 0.007). The lack of variation in introns 
3 (87 bp), 4 (91 bp) and 5 (145 bp) of CYP1A1, compared with CYP1A2 (comparative 
sizes of 455 bp, 269 bp and 936 bp for introns 3, 4 and 5) suggests that due to their short 
lengths, any changes in the intronic sequence could result in splicing defects and 
therefore they are highly conserved. Interestingly, as in CYP1A1, exon 5 of CYP1A2
carried no polymorphism (Browning 2009). This further corroborates that the amino-
acids encoded by exon 5 are of significance in CYP1A2 protein structure and 
functionality. The frequency spectrum of variants was much wider in the CYP1A2 gene 
compared with CYP1A1. For example, in Oromo, MAF of CYP1A1 variants were in the 
range of 0.007 – 0.02, while MAF of CYP1A2 variants ranged from 0.01 – 0.36 with 
MAF variances being significantly different (F = 0.0018, P < 0.0001). Overall, CYP1A1
seems to be much less diverse than CYP1A2. 
5.4.3. CYP1A1 interpretation of tests for selection
Strong evidence of purifying selection is provided by the conservation of the amino acids 
coded for by exons 3-6 of CYP1A1 over a long period, not only human and chimpanzee 
are identical, the commonality also includes the gorilla (Ensembl release 59; Aug 2010). 
While the tests for selection reported in the results section are consistent with such 
purifying selection, they lack power, as there are in all cases explanations other than 
purifying selection that could produce similar outputs, for example population expansion 
or sub-division. Evidence of conservation combined with population expansion is 
provided by the substantial number of polymorphic non-synonymous sites (6/428) but 
with none exceeding a frequency of 3.7% in any population. Paucity of data prevented 
evaluation of purifying selection based on relative reduction of intra-population diversity 
and pairwise genetic distances in coding regions with respect to non-coding regions 
(Hughes et al. 2003; 2005). However, based on the amino-acid sequence conservation 
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between the closely related CYP1A proteins, it was possible to make some inferences. 
Peptide sequences encoded by CYP1A exons 4, 5 and 6 show over 80% sequence identity 
indicating a high level of amino-acid residue conservation between the two paralogues. 
Interestingly, the most conserved part of these peptide sequences was encoded by exon 5 
(~ 88% identity), which was also found to be monomorphic in both genes in Ethiopia. A 
strong negative correlation (r = -0.909, p < 0.05) was observed between CYP1A exonic 
sequence identity and sum of exonic variants identified in each exon. This result indicates 
that the less conserved the coding exon is, the more variation it can tolerate. Therefore, it 
can be suggested that exons 4, 5 and 6 have been under strong purifying selection since 
they carry very few low frequency (≤ 2%) or no variants. A consequence of these 
observations is that it is reasonable to expect that possession of non-synonymous 
mutations in any of exons 4, 5, or 6 has a high chance of adverse consequences for the 
health of the individual, particularly if in the homozygous or compound heterozygous 
state. No homozygous or compound heterozygous individuals were identified.      
Purifying selection at these conservative non-synonymous loci was also evidenced by the 
observation that the modal ancestral haplotype (frequency range of 93.3% – 100%) in all 
populations encodes amino-acid residues that have been conserved throughout 
mammalian evolution. Furthermore, PSIC scores of predicted amino-acid changes by 
non-synonymous variants in highly conserved regions were much higher than those in 
less conserved regions. Interestingly, the PSIC scores between alternative amino acids at 
non-conserved sites were also lower than the significance threshold, providing further 
evidence of conservation.
5.4.4. CYP1A2 gene haplotypes
The frequency distribution of the four SNPs thought to cover most variation within the 
CYP1A2 gene was determined. SNP 2393 (intron 1) was observed only in the Anuak 
among Ethiopian groups, but was widely spread among the EBSP population groups. 
This is most probably due to the Anuak being closely related to the Nilo-Saharan 
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speaking peoples from which the Bantu speakers later emerged (almost half of the 
individuals in the population carry the modal EBSP NRY haplogroup (E1b1a)). The 
frequency spectrum of the non-synonymous SNP 4409 (exon 3) was also estimated. 
Based on the results, this allele seems to be present only in sub-Saharan Africans and 
individuals with recent African ancestry. This distribution is consistent with previous data 
characterising worldwide populations (Solus et al. 2004; Jiang et al. 2005). However, 
populations outside Africa have not been typed for this SNP in large sample sizes and 
therefore the absence of this SNP may be due to lack of sampling power.
The 4409 SNP (S298R) could result in a significant change in protein structure since 
substituting the amino acid serine for arginine could change the overall conformation, 
due to the increase of positive charge on the amino acid R group. Since this haplotype is 
at a reasonable frequency (maximum of 13%) in sub-Saharan Africa and its occurrence 
has been dated back to the origin of anatomically modern human (Browning 2009), its 
absence outside of populations of recent African descent could be due either to selection 
or drift resulting from an extreme bottleneck associated with the migration of 
anatomically modern human out of Africa approximately one hundred thousand years 
ago (Campbell and Tishkoff 2008). SNP 6509 (intron 6) was present in all population 
groups except the Europeans. The presence of this allele among the Hispanics may be the 
result of the African contribution to their gene pool during the Atlantic slave trade (see 
chapter 1). Unlike the first three SNPs, SNP 9570 (3’ UTR) was present in all population 
groups including the Europeans. LD analysis indicates that stronger allelic association is 
present on the 3’ end of the gene than the 5’ end. This is evident from significant r2
values for only the last two SNPs (p < 0.001) and not in any other combination, except 
for the first two SNPs in Sena (p = 0.044). According to the inferred haplotypes and the 
distribution of derived alleles, the data suggest that all SNPs seem to have occurred 
independently on the background of the ancestral haplotype but with differential success 
in propagation. Furthermore, haplotype analysis shows that the SNP 4409 is present only 
in one haplotype (GATC) and is not co-inherited with the other three SNPs. The 
frequency range of this haplotype was found to be wide (0.01-0.13), but limited to sub-
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Saharan African populations. Therefore, this haplotype may be of practical use in 
anthropological research.
Among all haplotypes, GATC is the most likely to be associated with a phenotype that is 
different from the others. It is, therefore, a candidate for investigation in future studies of 
CYP1A2 catalytic activity and group-based pharamacogenetic study in sub-Saharan 
Africa (Jiang et al. 2005). No other common coding-sequence haplotype has yet been 
observed in CYP1A2. Since no genetic variation has been found within and upstream of 
the gene that can unequivocally explain the observed phenotypic variation (Jiang et al. 
2006), it is reasonable to speculate that the variation at the phenotypic level is to some 
extent based on gene-gene interaction (e.g., interaction of CYP1A2 with other CYP 
enzymes) or the involvement of environmental factors. cDNA-directed recombinant 
CYP1A2 protein expression (cDNA carrying the 4409 SNP) and subsequent enzymatic 
assay would be able to determine whether this SNP can lead to an enzyme with altered 
function.
5.4.5. Genetic relationships of sub-Saharan African populations
CYP1A1 gene diversity was found to be low in all sub-Saharan African population 
groups. Therefore, since pairwise genetic distance (FST) is a function of diversity, most 
pairwise distances were not significant, based on CYP1A1 haplotypes, however, some 
inferences could be made. The Shewa Arabs in Lake Chad were found to be very close to 
the Anuak and the EBSP population groups were much more clustered than the Ethiopian 
populations. Consistent with this observation, diversity within EBSP populations was 
also very much lower than the Ethiopian populations. In particular, diversity was at its 
lowest in Malawi, Somie and Sudan. The higher level of differentiation among Ethiopian 
populations compared with EBSP populations is consistent with Ethiopia being a 
candidate for the region of origin of anatomically modern human and the migration of 
Semitic speaking peoples into the area some five millennia ago. Based on CYP1A2
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haplotypes, a very similar pattern was also observed using pairwise genetic distances, 
where Ethiopian populations were more diverse than EBSP populations. However, when 
EBSP and Ethiopian panels were represented as single populations and placed in a 
worldwide context, they showed great similarity and, as expected, African Americans 
were the closest group to both panels. Although ETPD and pairwise FST results were 
globally similar, some minor differences were observed.  
5.4.6. Conclusion
It is widely accepted that sub-Saharan Africa is the place of origin of anatomically 
modern human. However, in comparison with other regions in the world, especially 
Europe and Asia, studies investigating the distribution of potentially pharmacogenetically 
informative genetic variation have been sparse and limited to a few populations with 
small sample sizes. This study has contributed to redressing this imbalance by 
characterising two CYP genes in multiple sub-Saharan African populations with large 
sample sizes. Such studies are not only of benefit to the peoples of Africa, but are also of 
increasing importance in the planning of healthcare in the developed world, where the 
number of people with recent African ancestry is growing rapidly.
In conclusion, analysis of diversity in the two CYP1A genes in humans and their close 
primate relatives suggests that while there are strong forces acting to conserve the gene 
sequences, the diversity displayed by the peoples of sub-Saharan Africa, and Ethiopia in 
particular, presents an opportunity to research the detailed metabolic functions of the 
enzymes, which is not well understood. In addition, it should throw light on the 
implications for health of functional variation in the genes. It is possible that while 
variable levels of expression, when expression takes place, is of most interest in 
predicting drug efficacy and safety, the less common variation in protein structure may be 
more important in determining health.   In pursuit of these objectives it would be useful 
to study metabolic functioning (in vitro and in vivo) of the variants identified in this study 
and also re-sequence regulatory regions. This study demonstrates the benefits of 
analysing re-sequencing data in important exons in multiple populations that have 
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retained a high level of genetic diversity, within a framework that permits evaluation of 
both a) intra- and inter- ethnic group diversity in humans and, b) comparisons with other 
closely related primates, as a preliminary step prior to wider geographic surveys based on 
genotypes and in vitro and in vivo expression analysis. Currently, the three peripheral 
exons and intronic flanking regions, as well as the upstream regulatory region, of 
CYP1A1 are being resequenced with the expectation, based on resequencing of CYP1A2
in the same individuals, that these regions will be less well conserved than exons 3-6. 
Completion of this work will permit a more comprehensive comparison of the 
evolutionary histories of the two genes and assist in understanding possible causes of 
variation in their expression.  
6. Conclusion
This chapter discusses implications of the principal results from the four projects 
described in this thesis. These studies have utilised previously known and novel genetic 
variation in populations of sub-Saharan Africa (and some populations outside) to 
elucidate a) origins of a community in Colombia thought to be descended from African 
male slaves, b) major expansion routes (and corresponding dates) of Bantu-speaking 
peoples, c) ‘Out of Africa’ migratory pattern of the truncated variant of CASP12 and d) 
CYP1A functional variation in sub-Saharan Africa. Finally I discuss possible further 
research relating to the questions raised in this thesis.
6.1. Implications for the study of human history and evolution
Sub-Saharan Africa is thought to have the highest level of genetic diversity in the world 
(Bowcock et al. 1994; Excoffier 2002; Tishkoff et al. 2009). However, the majority of 
genetic studies in this region have been based on population samples of small size and 
with a restricted distribution. Currently available collections of DNA from sub-Saharan 
groups e.g. in the Coriell collection (Coriell Institute for Medical Research, Camden, NJ, 
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USA) are not, and make no claim to be, representative of all sub-Saharan African 
populations. In some studies there is insufficient power due to small sample sizes with 
the consequence that appropriate inferences cannot be drawn from the data (for example 
see Berniell-Lee et al. 2009). Sometimes samples from different groups are pooled 
without justification even though their ethnic identities are not the same (see Hammer et 
al. 1997). 
In genetic anthropological studies, to draw inferences about past demographic events 
sample sets of groups being studied should be relatively large and assigned to the groups 
on well described criteria relevant to the identity of each group (e.g. a shared language, 
culture, origin believes and social structure). The required sample size in any study will 
depend on the question investigated and the genetic profile of the group being studied. 
Even so, it should be noted that a single genetic outcome can usually be explained by 
multiple alternative demographic processes. 
Although linguists and anthropologists have called for more fine-scale genetic studies 
(MacEachern 2000), very few have been published with datasets that are both large and 
geographically extensive (for example see Veeramah et al. 2010). In Chapters 2 and 3, I 
have attempted to contribute to filling this gap.
Chapter 4 illustrates how well defined populations represented by large sample sizes 
together with an appropriate set of markers can allow meaningful inferences to be made. 
The results of this study are consistent with the Out of Africa model with the highest 
diversity observed in sub-Saharan Africa. A similar pattern to this has also been observed 
for other genes for example CD4 (Tishkoff et al. 1996) and FMO2 (Veeramah et al. 
2008b). Furthermore, this declining diversity gradient Out of Africa pattern is also 
evident in the distribution of variation observed in CYP1A drug metabolising enzyme 
coding genes (Chapter 5). In this case among multiple haplotypes present in sub-Saharan 
Africa, only one haplotype has a presence outside Africa (excluding groups with a recent 
African ancestry). 
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Close collaboration of historians, linguists, anthropologists and geneticists in inter-
disciplinary projects can result in contributions which complement each other to resolve 
questions related to past demographic events; potentially revealing the complex processes 
that shaped them. The Palenque study (Chapter 2) is an example of such collaboration in 
which contributions from other disciplines (e.g., history and linguistics) were of 
significance in the design of the study. The high resolution genetic data used to analyse 
routes of the EBSP (Chapter 3) also illustrate the added utility of detailed genetic analysis 
combined with linguistic and archaeological data compared with low resolution genetic 
data analysed in earlier studies of the EBSP. The power of this study was primarily a 
consequence of dense sampling of key regions of sub-Saharan Africa and the choice of 
appropriate markers selected to define the tips of NRY genealogical trees. Furthermore, 
the patterns described in Chapters 2 and 3, applied only to the paternally inherited NRY 
not to the maternally inherited mtDNA. It may be that in the EBSP there was differential 
greater reproductive success of the dominant migrating males and absorption of 
indigenous females. In the Palenque study the hypothesis tested was derived from a pre-
existing oral history that related only to males. There was no similar prior hypothesis that 
related to the female members of the community. 
Although NRY and mtDNA, due to low effective population size, resulting in greater 
susceptibility to genetic drift, and gender specificity have proved, on many occasions, to 
be good choices of genetic systems for studying historical questions (see Thomas et al. 
1998; 2000; 2002) autosomal markers, if analysed in large numbers, can be much more 
informative when undertaking gender non-specific demographic analysis. Currently, new 
large scale genotyping platforms such as Illumina ® Bead Arrays and Affymetrix ® SNP 
have been developed which makes it more feasible to initiate studies based on autosomal 
markers. Relatively low cost whole genome sequencing which is likely to be available in 
the near future will bring even more power to such studies.
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6.2. Implications for the use of pharmacogenetics in healthcare
As mentioned earlier, sub-Saharan Africa has greater human genetic diversity than any of 
the non African continents. As a consequence analysis of DNA from its inhabitants is 
very likely to reveal novel variation not reported outside Africa. Results obtained for the 
three autosomal genes investigated in this thesis (Chapters 4 and 5) fulfil this expectation. 
Analysis of multiple Ethiopian groups in pharmacogenetic studies is always likely to 
yield additional insights since Ethiopia is thought to be the most likely corridor through 
which anatomically modern human migrated ‘Out of Africa’. Consequently, it may have 
the highest genetic diversity of any similarly sized region in the world. (In addition, 
variation has also resulted from back migration into Africa e.g., the migration of the 
Semitic speaking peoples approximately 5,000 years ago (Campbell & Tishkoff 2008)). 
Re-sequencing of CYP1A1 in multiple sub-Saharan African population groups (Chapter 
5) is one example of greater genetic diversity being present in Ethiopia than in any other 
region sampled. 
Many studies have focused on typing Eurasian biased SNPs in sub-Saharan Africa, which 
have resulted in discrepancies of genotype-phenotype correlation studies in African 
populations (for example see Misimirembwa et al. 1996a). The limitation of this 
approach has been demonstrated by studies showing that markers strongly associated 
with a phenotype in European populations are not always present in sub-Saharan African 
populations displaying the same phenotype (Ingram et al. 2007). Although sequencing 
entire genomes in multiple population groups across the world is in progress within the 
‘1000 genomes project’ (http://www.1000genomes.org/), re-sequencing thousands of 
samples from multiple population groups in sub-Saharan Africa is currently economically 
unfeasible. A more practical approach for revealing pharmacogenetically useful insights 
into the extent of variation present in the general population is to focus on genes that code 
for transporter, receptor and metabolising proteins. One such class are those responsible 
for the metabolism of pharmaceutical drugs as well as endobiotic metabolism. In Chapter 
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5 I report how I used re-sequencing data from coding regions of CYP1A2 obtained from 
multiple population groups with sample sizes ≥ 50 to identify high frequency variants 
present in sub-Saharan Africa and to use them as tagSNPs to estimate the frequency 
spectrum of variant haplotypes in a wider set of populations across the sub-continent. 
Using this method, the cost of typing is substantially reduced since the number of 
markers typed is limited to a smaller set of defining polymorphisms. The objective was to 
assess the frequencies of potential functional variants at significant frequencies in one or 
more sub-Saharan African populations included in the ascertainment panels representing 
EBSP and Ethiopia.
The continent-wide presence of a variant with predicted functional change is not 
conclusive evidence of significant protein change. This deduction can only be made after 
the variant haplotype has been shown to produce the variant enzyme or to prevent 
expression. If a variant haplotype is causative of a significant difference in enzymatic 
activity its distribution and frequency can be assessed in different groups and guide future 
healthcare policies (e.g., selection of drug and dose to administer). The immediate effect 
of such policy should be a reduction in adverse drug reactions.
Individualised therapy is unlikely to materialise in the foreseeable future in sub-Saharan 
Africa, thus group-based pharmacogenetics is thought to be a plausible focus for future 
work (Daar & Singer 2005). Furthermore, as mentioned earlier, since characterising all 
populations for pharmacogenetically relevant polymorphisms is impractical, knowledge 
of relationships among populations and genetic distances among them at other loci, 
combined with linguistic and anthropological data may allow the prediction of 
pharmacogenetic profiles of uncharacterised populations living in the same region.
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6.3. Future work
Each of the four projects described in this thesis has been performed within severe 
constraints of limited time and available financial resources. Further research to 
substantiate, or refute, the reported results is therefore warranted. Below is a short 
summary of, in each case, further work that would be appropriate.
Chapter 2:
 Identification of one or more NRY SNPs that are present in the Yombe but not in 
the Chewa with a predicted date or dates of origin prior to the Atlantic slave trade. 
It would then be possible to genotype Palenque NRY to see if such SNP or SNPs 
were present. If one or more such SNPs were present that would provide 
additional evidence that it is more likely that there is a Yombe contribution to the 
paternal ancestry of the Palenque than a Chewa contribution. 
Chapter 3:
 Further characterisation of E1b1a7 chromosomes to get a better understanding of 
the demographic processes underlying the EBSP.
 Sampling more populations from the eastern route of EBSP from, for example, 
Kenya and Tanzania (thought to have E1b1a chromosomes) to fill the gap of 
Central-East Africa in this study.
 Typing polymorphisms in the coding region of mtDNA for better haplotype 
characterisation for use in identifying the maternal relationships among EBSP 
populations at a higher resolution.
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Chapter 4:
 Re-sequence intron 4 of CASP12 in additional well-defined sub-Saharan African 
populations to obtain a wider picture of truncated variant haplotypes in the region 
and to examine the genetic relationships among populations.
 Identification and characterisation of further STR markers in close proximity to 
the stop-codon locus. Since the power of discrimination increases with the 
number of STRs, this has the potential to give at a finer scale an indication of the 
distribution of truncated variant haplotypes. Thus, it may be possible to further 
differentiate populations (e.g. North African from Middle Eastern and European 
from Asian).
Chapter 5:
 Re-sequence exons 1, 2 and 7 of CYP1A1 to obtain full length coding sequence 
haplotypes and to see how well these exons have been conserved.
 Type further groups outside of sub-Saharan Africa for CYP1A2 tagSNPs. This 
should show whether the haplotype carrying the S298R mutation is an African 
specific variant or was not identified earlier in populations without a recent 
African ancestry due to the small sample sizes in studies in which this variant was 
characterised.
  cDNA-directed expression of CYP1A2 variant haplotypes in E.coli followed by 
an enzymatic assay to determine differential enzymatic activity of the variant and 
the ancestral haplotypes.
 Re-sequence the immediate upstream (positions -1 → -1000) region of both 
CYP1A genes to identify polymorphisms in functionally annotated transcription 
motifs which may be associated with phenotypic variation.
 Undertaking genotype-phenotype studies. CYP1A haplotypes of individuals can 
be inferred and using well-known substrates for both enzymes the metabolic 
activity of each enzyme can be determined. Correlations of the two variables 
could contribute to assessing how effectively group-based pharmacogenetics 
could be applied in sub-Saharan Africa.
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Appendix A: Extraction of DNA from Buccal 
Swabs 
     Gentra Protein Precipitation Method                   
                                                                                             
Preparing samples for Proteinase K digestion 
1.1 Prepare a sample extraction sheet of 24 samples. 
1.2 Using the sample extraction sheet, order set of 24 swab samples into a 
plastic rack. Please note that gloves must be worn whilst handling 
samples.
1.3 Bleach down the workbench before starting work. Scour around the PVC 
tape using a scalpel blade, and ensure that the swab is detached from 
the lid of the swab tube. If not, carefully break the swab away from the 
lid.
1.4   Turn on a water bath and ensure that it is set as 56oC and that distilled 
water is filled in to a depth of at least 3cm.
1.5 Take an 80 μl of 10 mg/ml of proteinase K and top it up to 50ml with the
Baxter sterile water into a 50ml lidded tube. Gently mix the diluted
proteinase K solution.
1.6 Add 500 μl of the proteinase K solution into each of the sample tubes. The 
same tip can be used, as long as it does not touch the sides of the sample
tubes. Ensure that all lids are securely fastened.
1.7 Place the rack into the water bath and incubate at 56oC overnight.
Preparing samples for extraction
2.1  Turn on the hood, clean the surface by bleach using the blue towels.
2.2  Get the 50xTE tube and aliquot 1ml into an orange lidded tube and top it 
up to 50ml with Baxter sterile water. 
2.3 Turn the incubator on at 56oC and place the 1xTE tube inside it. 
2.4  Place a rack in the hood and with 24 autoclaved white eppendorf tubes 
in it.
2.5 Aliquot 166.7 μl of protein precipitation solution (Gentra) in each 
eppendorf tube and close the lids loosely.
155
2.6 Check tubes in pair to ensure that every tube has the protein precipitation 
solution.
2.7 Write sample numbers on each tube using the sample extraction sheet.
2.8 Add 500 μl of digested buccal DNA (from section1) to each tube. Double 
check for consistency of the sample numbers on both the sample tube 
and the eppendorf tube and close the lids.
Extraction
3.1 Put back the digested sample tubes in a fridge.
3.2 Vortex the eppendorf tubes containing digested DNA and precipitation 
solution for 30 seconds. 
3.3 Place tubes in a cold rack and put them in freezer for 10mins. Take out the 
glycogen tube with cold blue rack at the same time to thaw.
3.4 Place 24 screw top tubes in a rack.
3.5 Write samples numbers on side and top of each screw top tubes.
3.6 Add 1 μl of glycogen in each screw –top tube; you should see a drop on 
the side.
3.7 Take out samples from freezer and centrifuge samples for 5min with 
maximum speed.
3.8 Add 500 μl of 100% isopropanol to each screw top tubes. You can use the 
same tip for all tubes but make sure you do not go deep in tubes.
3.9 Pour off the supernatant of the centrifuged samples into their respective 
screw top tubes and close the lid (screw top tube). You should see a 
yellow/orange protein pellet at the bottom of each eppendorf tube.       
3.10 Invert the screw top tubes rapidly for 15-20 seconds.
3.11 Leave the screw top tubes at room temperature for 5mins.
3.12 Centrifuge tubes for 5 mins at maximum speed.
3.13 Pour off supernatant gently; be careful to not move the DNA pellet.
3.14 Leave tubes inverted at 45 degrees on clean blue towel for 1min.
3.15 Add 500 μl of EtOH 70% to each tube (To make the 70% EtOH add 35ml of 
100% EtOH and 15ml of sterile water to a 50ml tube).
3.16 Centrifuge samples for 5min at maximum speed.
3.17 Pour off supernatant from the tubes gently and make sure not to move 
the DNA pellet.
3.18 Leave tubes inverted at 45 degrees for 15 mins.
3.19 Elute the DNA pellet in each screw top tube with 500 μl of preheated 1xTE 
which you had prepared and put in the incubator.
3.20 If samples are to be used straight away, incubate the samples at 56oC for 
about 2 hours. Otherwise put the samples in the fridge. 
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